SEntergy

Entergy Nuclear Operations, Inc.

Palisades Nuclear Plant

27780 Blue Star Memorial Highway

Covert, Ml 49043

Tel 269 764 2000

Terry A. Davis

Regulatory Assurance Manager

PNP 2014-044

April 30, 2014 10 CFR 50.36a

U. S. Nuclear Regulatory Commission

ATTN: Document Control Desk

Washington, DC 20555-0001

Subject: 2013 Annual Radioactive Effluent Release and Waste Disposal Report

Palisades Nuclear Plant

Docket 50-255

License No. DPR-20

Big Rock Point

Dockets 50-155 and 72-043

License No. DPR-6

Dear Sir or Madam:

Attached are the Entergy Nuclear Operations, Inc. 2013 Annual Radioactive Effluent

Release and Waste Disposal Reports for Palisades Nuclear Plant (PNP) and Big Rock

Point (BRP) Independent Spent Fuel Storage Installation (ISFSI). These reports are

submitted in accordance with 10 CFR 50.36a(a)(2).

Attachment 1 contains the report for PNP. Attachment 2 contains the report for the

BRP ISFSI.

These reports provide a summary of the quantities of radioactive liquid and gaseous

effluent releases and solid radioactive waste processed during the period of

January 1,2013, through December 31, 2013.
PNP 2014-044

Document Control Desk

Page 2

This letter contains no new commitments and no revision to existing commitments.

Sincerely,

TAD/bed

Attachment 1: Palisades Nuclear Plant 2013 Radioactive Effluent Release Report

Attachment 2: Big Rock Point Independent Spent Fuel Storage Installation 2013

Radioactive Effluent Release Report

CC Administrator, Region Ill, USNRC

Project Manager, Palisades, USNRC (w/o Attachments)

Resident Inspector, Palisades, USNRC

NRC NMSS Project Manager, USNRC (w/o Attachments)

American Nuclear Insurers (ANI)
Attachment 1

Palisades Nuclear Plant 2013 Radioactive Effluent Release Report

2013 Plant Operating History

Palisades Nuclear Plant (PNP) entered the reporting period on line on January 1, 2013,

at nominal full power. PNP performed a planned shutdown on February 15, 2013, to

address a leak in the component cooling water (CCW) heat exchanger and to repair the

main generator motor operated disconnect, 26H5. The unit attained criticality on

February 21, 2013, and returned to service on February 22, 2013. PNP performed a

controlled shutdown on May 5, 2013, due to exceeding allowable leakage of the safety

injection refueling water tank (T-58). The unit attained criticality on June 16, 2013, and

returned to service on June 17, 2013. PNP was on line for the remainder of 2013. The

unit generated 6,041,696 MWHrs of net electrical energy during 2013.

A. Gaseous Effluents

Tables 1A, "Gaseous Effluents - Summation of All Discharges," 1B, "Gaseous

Effluents - Ground-Level Release - Batch Mode," and 1C, "Gaseous Effluents -

Ground-Level Release - Continuous Mode," list and summarize gaseous effluents

released during this reporting period.

B. Liquid Effluents

Tables 2A, "Liquid Effluents - Summation of All Discharges," 2B, "Liquid Effluents -

Batch Mode," and 2C, "Liquid Effluents - Continuous Mode," list and summarize

liquid effluents released during this reporting period.

C. Solid Waste Storage and Shipments

Table 3, "Low-Level Waste," summarizes solid radioactive waste shipped for

processing or burial in 2013 for the following waste streams: resins, filters and

evaporator bottoms, dry active waste, irradiated components and other waste.

D. Dose Assessments

Table 4, "Dose Assessments, 10 CFR Part 50, Appendix I," and Table 5, "EPA

40 CFR Part 190, Individual in the Unrestricted Area," list annual dose to the

members of the public.

Page 1 of 16
E. Supplemental Information

1. Regulatory Limits

a. Noble Gases

The air dose in unrestricted areas due to noble gas released in

gaseous effluents shall be limited to the following:

" During the calendar quarter, to < 5 mrad for gamma radiation

and < 10 mrad for beta radiation.

" During the calendar year, to < 10 mrad gamma radiation and

< 20 mrad for beta radiation.

b. lodines - Particulates

The dose to a member of the public from radioiodines, radioactive

material in particulate form with half-lives greater than eight days,

and radionuclides other than noble gas, e.g., tritium, in gaseous

effluents released to unrestricted areas shall be limited to the

following:

* During any calendar quarter, to < 7.5 mrem to any organ

" During any calendar year, to < 15 mrem to any organ

c. Liquid Effluents

The dose or dose commitment to an individual from radioactive

material in liquid effluents released to unrestricted areas shall be

limited to the following:

• During any calendar quarter to < 1.5 mrem to the total body and

< 5 mrem to any organ.

" During any calendar quarter to < 3 mrem to the total body and <

10 mrem to any organ.

d. Total Dose

The dose or dose commitment to a real individual from all uranium

fuel cycle sources is limited to < 25 mrem to the total body or any

organ (except the thyroid, which is limited to < 75 mrem) over a

period of 12 consecutive months.

Page 2 of 16
2. Maximum Permissible Concentrations (Effluent Concentration Limits)

a. Gaseous Effluents

The dose rate due to radioactive material released in gaseous effluents

from the site shall be limited to the following:

" For noble gases: •- 500 mrem/yr to the total body and -< 3000

mrem/yr to the skin.

" For all radioiodines and for all radioactive materials in particulate

form with half-lives greater than eight days and for radionuclides

other than noble gases: -• 1500 mrem/yr to any organ.

The above limits are provided to ensure that radioactive material

discharged in gaseous effluents will not result in the exposure of an

individual in an unrestricted area to annual average concentrations

exceeding the limits of 10 CFR 20, Appendix B, Table 2, Column 1.

b. Liquid Effluents

The concentration of radioactive material released at any time from the

site to unrestricted areas shall be limited to the concentrations specified in

1 OCFR20, Appendix B, Table 2, Column 2, for radionuclides other than

dissolved or entrained noble gases. For dissolved or entrained noble

gases, the concentration shall be limited to 2E-4 pCi/mI total activity.

3. Average Energy

The average energy (E) of the radionuclide mixture in releases of fission

and activation gases as defined in Regulatory Guide 1.21, Appendix B,

Section A.3 is not applicable because the limits used for gaseous releases

are based on calculated dose to members of the public.

4. Measurements and Approximations of Total Radioactivity

a. Fission and activation gases are sampled and then analyzed on a

4096 channel analyzer with a high purity germanium (HpGe)

detector.

b. lodines are sampled and then analyzed on a 4096 channel

analyzer with a HpGe detector.

Page 3 of 16
c. Particulates are sampled and then analyzed on a 4096 channel

analyzer with a HpGe detector.

d. Liquid effluents are sampled and then analyzed on a 4096 channel

analyzer with a HpGe detector. Tritium analysis is performed using

liquid scintillation. Fe-55, Sr-89, and Sr-90 analyses are performed

by an offsite vendor. The vendor also analyzes for Ni-63 due to the

evaluation of 10 CFR 61 sample results.

5. Batch Releases - 2013

For PNP, these totals are not indicative of actual release volumes due to

PNP having two sets of tanks with different volumes in both the gaseous and

liquid release systems that are utilized for batch releases. The number of

batches performed in this section will fluctuate from year to year due to the

utilization of the smaller and larger tanks in different frequencies. This

information is better quantified in the tables contained later in this report.

a. Liquid

Number of batch releases for each quarter: 2 in the 1 st quarter

5 in the 2 nd quarter

2 in the 3rd quarter

4 in the 4th quarter

Total time period for batch releases: 9859 minutes

Maximum time period for a batch release: 1458 minutes

Average time period for a batch release: 758 minutes

Minimum time period for a batch release: 70 minutes

Average stream flow during periods of release of effluent into a flowing

stream: 64615 gpm

b. Gaseous

Number of batch releases for each quarter: 6 in the 1 st quarter

9 in the 2 nd quarter

4 in the 3rd quarter

2 in the 4t' quarter

Page 4 of 16
Total time period for batch releases: 5883 minutes

Maximum time period for a batch release: 1111 minutes

Average time period for a batch release: 280 minutes

Minimum time period for a batch release: 53 minutes

6. Abnormal Discharges

a. Liquid

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 1* 1*

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0.0166 0.844

4th Quarter

0

4th Quarter

0

b. Gaseous

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

4th Quarter

0

4th Quarter

0

* - Discussions of these releases are in Section 14 - "Other'

7. Non-Routine Planned Discharges

None.

8. Radioactive Waste Treatment System Changes

None.

9. Annual Land Use Census Changes

The garden critical receptor has changed and is now located in the SSE

sector at .69 miles. The residence critical receptor is unchanged in the SSE

sector at 0.8 miles. The goats remain located to the ENE at 2.62 miles and

are fed stored feed. During the 2013 land use census, it was identified that

a new beef cattle receptor is located in the SE sector at 4.27 miles. There

are no dairy cows located within five miles of the plant.

Page 5 of 16
10. Effluent Monitoring System Inoperability

There were three effluent monitors that were out of service for greater than

30 days.

RIA-2320, steam generator blowdown vent monitor, was declared inoperable

on November 6, 2012, due to indicating that it failed (CR-PLP-2012-7101).

The pathway was not in service, but there was suspected valve leakage into

the system so compensatory samples were being obtained as a

conservative measure as if it were in service. The monitor was returned to

service on April 15, 2013, under Work Order 333897.

RIA-2325, stack iodine/particulate monitor, was declared inoperable on

August 13, 2013, due to failing to bring in the high alarm during performance

of QR-22, "Process Monitor Function Checks - Quarterly" (CR-PLP-2013-

3526). Compensatory sampling was initiated per DWR-10, "Stack Effluent

Sampling and Calculation," and the Offsite Dose Calculation Manual

(ODCM), and continued until RIA-2325 was returned to service. The monitor

was returned to service on October 22, 2013, under Work Order 361036.

RIA-0631, condenser offgas monitor, was declared inoperable on

November 5, 2013, due to failing to respond to a source check during

performance of MR-1 4, "Process Monitor Function Checks - Monthly" (CRPLP-2013-4778). Compensatory sampling was initiated per the ODCM.

Troubleshooting remained in progress through the end of the year.

11. Offsite Dose Calculation Manual Changes

There was no revision to the ODCM during the report period.

12. Process Control Program Changes

None.

13. Errata/Corrections to Previous Reports

Supplemental Information section on Batch Release totals has been missing

starting with the 2009 Annual Report. This page is a summation of total

number of batch releases performed during the applicable year. For PNP,

these totals are not indicative of actual release volumes due to PNP having

two different sets of tanks with different volumes in both the gaseous and

liquid release systems that are utilized for batch releases. The number of

batches performed in this section will fluctuate from year to year due to the

use of the smaller and larger tanks in different frequencies. This information

is better quantified in the data tables contained in their respective reports.

Page 6 of 16
This errata information was evaluated under CR-PLP-2013-2513, Corrective

Action 7.

2009 Supplemental Information

Batch Releases

a. Liquid

Number of batch releases for each quarter: 10 in the 1st quarter

14 in the 2nd quarter

10 in the 32d quarter

5 in the 4 th quarter

Total time period for batch releases: 7787 minutes

Maximum time period for a batch release: 763 minutes

Average time period for a batch release: 211 minutes

Minimum time period for a batch release: 59 minutes

Average stream flow during periods of release of effluent into a flowing

stream: 80000 gpm

b. Gaseous

Number of batch releases for each quarter: 14 in the 1 st quarter

8 in the 2nd quarter

5 in the 3rd quarter

2 in the 4th quarter

Total time period for batch releases: 3244 minutes

Maximum time period for a batch release: 210 minutes

Average time period for a batch release: 112 minutes

Minimum time period for a batch release: 63 minutes

Page 7 of 16
Abnormal Discharges

a. Liquid

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

b. Gaseous

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

4th Quarter

0

4th Quarter

0

4th Quarter

0

4th Quarter

0

2010 Supplemental Information

Batch Releases

a. Liquid

Number of batch releases for each quarter: 5 in the 1 st quarter

3 in the 2 nd quarter

11 in the 3rd quarter

6 in the 4th quarter

Total time period for batch releases: 14411 minutes

Maximum time period for a batch release: 1544 minutes

Average time period for a batch release: 576 minutes

Minimum time period for a batch release: 70 minutes

Average stream flow during periods of release of effluent into a flowing

stream: 75520 gpm

Page 8 of 16
b. Gaseous

Number of batch releases for each quarter: 4 in the 1 st quarter

5 in the 2 nd quarter

9 in the 3rd quarter

11 in the 4 th quarter

Total time period for batch releases: 3431 minutes

Maximum time period for a batch release: 239 minutes

Average time period for a batch release: 118 minutes

Minimum time period for a batch release: 56 minutes

Abnormal Discharges

a. Liquid

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

4th Quarter

0

4th Quarter

0

b. Gaseous

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

4th Quarter

0

4th Quarter

0

Page 9 of 16
2011 Supplemental Information

Batch Releases

/

a. Liquid

Number of batch releases for each quarter: 2 in the 1st quarter

3 in the 2 nd quarter

4 in the 3d quarter

6 in the 4th quarter

Total time period for batch releases: 12223 minutes

Maximum time period for a batch release: 1655 minutes

Average time period for a batch release: 815 minutes

Minimum time period for a batch release: 74 minutes

Average stream flow during periods of release of effluent into a flowing

stream: 66667 gpm

b. Gaseous

Number of batch releases for each quarter: 7 in the 1 st quarter

9 in the 2 nd quarter

12 in the 32d quarter

3 in the 4th quarter

Total time period for batch releases: 7491 minutes

Maximum time period for a batch release: 1314 minutes

Average time period for a batch release: 242 minutes

Minimum time period for a batch release: 53 minutes

Page 10 of 16
Abnormal Discharges

a. Liquid

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 1 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 3.66 0

4th Quarter

0

4th Quarter

0

b. Gaseous

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

4th Quarter

0

4th Quarter

0

2012 Supplemental Information

Batch Releases

a. Liquid

Number of batch releases for each quarter: 8 in the 1 st quarter

12 in the 2nd quarter

2 in the 3rd quarter

4 in the 4th quarter

Total time period for batch releases: 26279 minutes

Maximum time period for a batch release: 2700 minutes

Average time period for a batch release: 1011 minutes

Minimum time period for a batch release: 81 minutes

Average stream flow during periods of release of effluent into a flowing

stream: 39996 gpm

Page 11 of 16
b. Gaseous

Number of batch releases for each quarter: 6 in the 1 st quarter

15 in the 2 nd quarter

9 in the 3d quarter

4 in the 4th quarter

Total time period for batch releases: 4201 minutes

Maximum time period for a batch release: 290 minutes

Average time period for a batch release: 124 minutes

Minimum time period for a batch release: 59 minutes

Abnormal Discharges

a. Liquid

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

4th Quarter

0

4th Quarter

0

b. Gaseous

Number of releases for each quarter

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

Total activity released in Curies (Ci)

1st Quarter 2nd Quarter 3rd Quarter

0 0 0

4th Quarter

0

4th Quarter

0

Page 12 of 16
14. Other

Groundwater Monitorinq

PNP has 14 ground water monitoring wells (MW) strategically placed within

the owner controlled area, to allow for detection of radioactive contamination

of ground water due to leaks or spills from plant systems. PNP added 18

temporary wells (TW) in 2009, to determine the potential source of tritium in

groundwater in the vicinity of MW-3. Tanks T-90, primary makeup tank,

T-91, utility water storage tank, and associated underground piping between

these tanks and the auxiliary building addition, are in this area.

Underground piping repairs to the T-90/T-91 overflow piping were completed

in 2013 following sleeving of the second half of the underground piping to

ensure system integrity. The first half of the piping was sleeved in 2011.

During the process of repairing the piping in September 2013, a small

amount of tritiated liquid was discharged from the pipe to the environment.

Indications of this discharged liquid were evident in the November and

December 2013 samples of TW-15 (peak on December 5, 2013, at 166,165

pci/L). TW-9, located nearest the site boundary and down-gradient of

TW-15 showed a slight increase (December, 5, 2013, at 2,151 pci/L from

< minimum detectable activity (MDA) on November 6, 2013) in tritium, due to

this discharged liquid.

Tritium levels for 2013 in MW-3 remained less than MDA, which is down

from 5,233 pCi/L in March 2012. The highest value in MW-2 was 702 pCi/L

in May 2013. MW-1 1 exhibited five detectable readings in 2013, with the

highest being 1,436 pCi/L in September 2013. Values of this magnitude

may be attributed to precipitation recapture of tritium, as indicated in the

PNP precipitation recapture study performed in 2011. The remaining

monitoring wells showed no activity throughout the year. No radionuclides

other than tritium have been detected in the groundwater.

Temporary well monitoring in 2013 indicated a possible continued leak from

the T-90/91 overflow piping to the surrounding environment early in the year.

This was documented in CR-PLP-2013-00304, and was repaired in the

summer of 2013, by the additional sleeving of T-90/T-91 overflow piping.

Tritium monitoring indicated positive results from the suspected piping leak

site with a slow declining trend in the direction of underground hydrological

flow. MW-3 and TW-9 are directly down-gradient from the elevated TW's.

MW-3 showed no elevated tritium results in 2013, and TW-9 showed only a

slight increase in tritium values associated with the repair operations.

Page 13 of 16
The tritiated water discharged in 2011 and 2013 from repair activities to the

T-90/T-91 overflow piping, were considered part of the same leak event first

reported to the NRC in 2007, therefore, no additional reports were made for

these leaks. After the leaks were repaired and reporting time had elapsed,

the NRC questioned whether these events could have warranted additional

reporting, due to the cause and effect nature associated with repair

activities, even though they originated from the same leak location.

Monitoring of the groundwater tritium plume continues to assess repair

effectiveness and follow the site hydrology data. Well locations are depicted

in Figure 1.

Depth to Local Water Table - The depth is approximately eight to nine feet.

Classification of Subsurface Aquifers - Not used for drinking water.

Expected Movement/Mobility of Groundwater Plume - Westerly direction

down-gradient toward Lake Michigan at approximately two feet per day.

Land Use Characteristics - PNP site property, water not used for drinking or

irrigation.

NRC Notification, Date and contact Organization - The NRC was notified on

December 10, 2007, by PNP.

Carbon-14

In 2010, PNP and other facilities participated in an EPRI task force to build a

model to accurately estimate gaseous C-14 releases, given some key sitespecific plant parameters (mass of the primary coolant, average thermal

neutron cross section, rated MW, etc). This work was completed in

November 2010. The estimates for C-14 were constructed using the

aforementioned EPRI methodology contained with EPRI 1021106,

"Estimation of Carbon-14 in Nuclear Power Plant Gaseous Effluents." Using

the C-14 curie estimates, the annual dose to man was derived from

guidance contained within Regulatory Guide 1.109. Because the dose

contribution of C-1 4 from liquid radioactive waste is much less than that

contributed by gaseous radioactive waste, evaluation of C-14 in liquid

radioactive waste is not required.

Page 14 of 16
Annual C-14 release PNP and subsequent doses for 2013:

Total Gaseous C-14 Released Curies = 7.43

Gaseous C-14 as C02 Curies = 2.23

Effective Child TB Dose, C-14 mrem = 0.0345

Effective Child Bone Dose, C-14 mrem = 0.173

The quarterly curies released are provided in Table A-i B. Airborne doses

due to C-14 are grouped under the category of Particulate, Iodine, and

Tritium which are contained in Table A-4.

Safety Injection Refuelingq Water (SIRW) Tank

A plant shutdown was initiated on May 5, 2013, at 0127 hours, due to safety

injection and refueling water (SIRW) tank leakage. With the increased

leakage from the tank into the surrounding roofing material, "water bladders"

had formed under the roofing material and were being monitored and

routinely drained. Leak rate had increased to the point of potential water

bladder rupture/overflow and allowed leakage onto the roof and into the roof

drain system. SIRW tank leakage migrated primarily to the south roof drain,

which is part of storm water drain system SW-2, with some small amount

traveling to the west roof drain, which is part of storm water drain system

SW-6.

NOTE: The east and west roof drains run to a common line which drains

into a separate storm water drain system (SW-6) that discharges into the

mixing basin, a monitored release path via RIA-1 323, circulating water

discharge radiation monitor, and was diluted by 40,000 gpm flow from the

dilution water pumps P-40A/B.

On May 6, 2013, radioactive water was identified in storm water drain

system, SW-2, located on the south side of the plant (CR-PLP-2013-2084).

Radioactivity levels identified: Gamma Emitters: 1.49E-5 uCi/mI and Tritium:

4.27E-2 uCi/mI. This activity aligns with activity from samples collected from

the SIRW roof south drain. The leakage into the south roof drain flowed

(open pipe) onto the component cooling water (CCW) roof, where the water

then ran down the CCW roof drain, which drains to the south storm water

drain system (SW-2). Via field observation, it was determined that the outlet

of this south storm water drain system constituted a potential unmonitored,

undiluted pathway; however, the outlet of this storm water drain system was

found completely plugged with sand and debris prior to reaching the beach.

Actions Taken:

* Water bladders were drained into the radiological controlled area

(RCA) via an established collection/drainage system.

Page 15 of 16
" Standing water was removed from the SIRW tank roof and the roof

was decontaminated.

" SW-2 storm water drain lines were vacuumed out into radioactive

material labeled drums.

" A bladder was installed into the storm water drain line prior to the

last manhole.

" The CCW roof drain was flushed with clean water to storm water

drain system SW-2.

* SW-2 flush water was sampled and pumped to the mixing basin for

monitored release.

* Flushing of SW-2 was performed until below ODCM levels. Most

sample points were less than minimum detectable.

" East and west roof drains were also flushed through to the mixing

basin and monitored via the normal plant process (normal REMP

sampling and monitoring).

On May 29, 2013, following a rain storm, the sand/debris plug separating the

storm water drain system (SW-2) from the beach was dislodged. One

sample of the beach within the immediate vicinity of the discharge identified

tritium and additional isotopes just above the lower limit of detection, but

below ODCM reporting requirements. The following day, split samples were

obtained with the NRC at four different locations on the beach between the

discharge and the lake. All sample results analyzed by PNP were nondetectable, with the exception of the sample closest to the storm water

system drain outlet, which had low levels of Sb-125. This was validated with

the NRC split sample.

Surveys were performed on the SW-2 outfall piping during September 2013.

10 CFR 50.75(g) paperwork is being processed to document the beach

sediment contamination for decommissioning work.

A dose calculation was performed and determined that if the entire quantity

of the leak, that was conservatively calculated (81.2 gallons), would have

flowed to the SW-2 storm water drain system, and subsequently made it to

Lake Michigan, then the dose to the public would be less than 0.1 % of the

federal limits. It is known that not all of the leakage made it to the lake since

volume was removed from the SW-2 storm water drain system. The outlet

of the SW-2 drain had been completely covered with sand/debris. The site

cleaned the storm water system prior to the May 29, 2013, rain storm. There

was no evidence that any liquid ever left the protected area boundary via an

unmonitored release path prior to May 29, 2013. This makes the dose

calculation very conservative. The Storm Water System is depicted in

Figure 2.

Page 16 of 16
FIGURE 1

GROUNDWATER MONITORING WELL LOCATIONS

I 

441 l~

4 4"- 9

N

9w•o, -u

wmw

" 9 4I*?

I

B -

Is i ý

MA'AM

f9"e 4.1

GROUNDWATER MONITORING WELL LOCATIONS

PALISADES NUCLEAR POWER PLANT

27780 BLUE STAR HWY.

Cot 44AbNW

Page 1 of I
FIGURE 2

DIAGRAM OF THE STORM WATER SYSTEM

Page 1 of 1
ATTACHMENT 1

Palisades - Table 1A

2013 Gaseous Effluents - Sum of All Releases

Summation All Releases of Units 1 Quarter 1 Quarter 2 Quarter 3 Quarter 4 Total Uncertainty (%) A ll R e e a s e s(% )

Fission and

Activation

Gases

1.94E+00 4.01 E-01 2.18E-02 6.50E-01 3.01 E+00 4.47

Ci

Average 2.49E-01 5.06E-02 2.52E-03 7.34E-02 9.54E-02

Release Rate PCi/s

% of Limit % 1.14E-03 2.66E-04 3.12E-05 1.02E-03 6.12E-04

Total I1-131 Ci 6.28E-05 2.34E-05 4.95E-05 5.60E-05 1.92E-04

Average 8.07E-06 2.98E-06 6.23E-06 7.05E-06 6.08E-06

Release Rate pCi/s

% of Limit % 9.73E-08 3.59E-08 7.51 E-08 8.49E-08 7.33E-08

Particulates Ci 0.OOE+00 0.OOE+00 0.OOE+00 6.78E-08 6.78E-08

Average 0.OOE+00 0.OOE+00 0.OOE+00 4.22E-09 2.15E-09

Release Rate PCi/s

% of Limit % 0.OOE+00 0.OOE+00 0.OOE+00 2.04E-08 5.13E-09

Tritium Ci 3.26E+00 2.16E+00 1.21E+00 1.55E+00 8.19E+00

Average 4.19E-01 2.75E-01 1.52E-01 1.96E-01 2.60E-01

Release Rate pCi/s

% of Limit % 1.01E-03 6.63E-04 3.66E-04 4.71 E-04 6.26E-04

Gross Alpha Ci 1.02E-06 ND ND ND 1.02E-06

C-14 Ci 1.98E+00 1.12E+00 2.17E+00 2.17E+00 7.44E+00

Average 2.55E-01 1.42E-01 2.73E-01 2.73E-01 2.36E-01

Release Rate PCi/s

% of Limit % 2.05E-06 1.14E-06 2.19E-06 2.19E-06 1.90E-06

-_j I. %J

I a l I

1 14.9 1

Page 1 of 1
ATTACHMENT 1

Palisades - Table 1B

2013 Gaseous Effluents - Ground Level Release, Batch Mode

Fission and Activation Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Gases

Ar-41 Ci ND ND ND ND

Kr-85 Ci ND ND ND ND

Kr-85m Ci ND ND ND ND

Kr-87 Ci ND ND ND ND

Kr-88 Ci ND ND ND ND

Xe-131m Ci 7.69E-04 4.15E-03 ND ND

Xe-133 Ci 1.20E+00 2.40E-01 2.58E-05 ND

Xe-133m Ci ND 1.34E-03 ND ND

Xe-1 35 Ci 4.51E-02 3.42E-04 ND ND

Xe-1 35m Ci ND ND ND ND

Xe-138 Ci ND ND ND ND

Total Ci 1.25E+00 2.46E-01 2.58E-05 O.OOE+00

lodines/Halogens Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

1-131 Ci 1.99E-08 ND ND ND

1-132 Ci ND ND ND ND

1-133 Ci ND ND ND ND

1-134 Ci ND ND ND ND

1-135 Ci ND ND ND ND

Total Ci 1.99E-08 O.OOE+00 O.OOE+00 O.OOE+00

Particulates Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Co-58 Ci ND ND ND ND

Co-60 Ci ND ND ND ND

Na-24 Ci ND ND ND ND

Cr-51 Ci ND ND ND ND

Mn-56 Ci ND ND ND ND

Sr-92 Ci ND ND ND ND

Nb-95 Ci ND ND ND ND

Zr-95 Ci ND ND ND ND

Ag-110m Ci ND ND ND ND

Total Ci O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00

Tritium Ci 1.18E-01 1.12E-01 NA NA

Gross Alpha Ci 5.109E-07 NA NA NA

C-14 Ci NA NA NA NA

ND = Measurements performed but no activity detected.

NA = Analysis not required and not performed

Page 1 of 1
ATTACHMENT 1

Palisades - Table 1C

2013 Gaseous Effluents - Ground Level Release, Continuous Mode

Fission and Activation Gases Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Ar-41 Ci 1.19E-01 4.62E-02 5.39E-03 1.96E-01

Kr-85 Ci ND ND ND ND

Kr-85m Ci 2.39E-02 2.52E-05 1.40E-04 8.28E-03

Kr-87 Ci 3.07E-03 5.71 E-03 6.29E-04 2.93E-02

Kr-88 Ci 8.57E-02 7.59E-03 1.11E-03 2.61E-02

Xe-131m Ci ND ND ND ND

Xe-133 Ci 1.79E-03 2.OOE-02 8.57E-04 2.19E-02

Xe-133m Ci ND ND ND ND

Xe-135 Ci 2.48E-01 2.54E-02 5.68E-03 1.18E-01

Xe-135m Ci 7.70E-02 1.21E-02 2.42E-03 5.36E-02

Xe-137 Ci 2.39E-03 3.28E-03 1.80E-03 6.59E-02

Xe-138 Ci 1.26E-01 3.46E-02 3.79E-03 1.30E-01

Total Ci 6.87E-01 1.55E-01 2.18E-02 6.50E-01

lodines/Halogens Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

1-131 Ci 6.27E-05 2.34E-05 4.95E-05 5.60E-05

1-132 Ci ND ND ND ND

1-133 Ci 4.49E-05 4.98E-05 7.86E-05 1.24E-04

1-135 Ci ND ND ND ND

Total Ci 1.08E-04 7.32E-05 1.28E-04 1.80E-04

Particulates Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Co-58 Ci ND ND ND ND

Co-60 Ci ND ND ND 3.36E-08

Mn-54 Ci ND ND ND ND

Cr-51 Ci ND ND ND ND

Co-57 Ci ND ND ND ND

Nb-95 Ci ND ND ND ND

Zr-95 Ci ND ND ND ND

Ag-11Om Ci ND ND ND ND

Sn-113 Ci ND ND ND ND

Sb-125 Ci ND ND ND ND

Cs-137 Ci ND ND ND 3.43E-08

Ce-144 Ci ND ND ND ND

Total Ci O.OOE+00 O.OOE+00 O.OOE+00 6.78E-08

Tritium Ci 3.14E+00 2.05E+00 1.21E+00 1.55E+OO

Gross Alpha Ci 5.11E-07 ND ND ND

C-14 Ci 1.98E+00 1.12E+00 2.17E+00 2.17E+00

ND = Measurements performed but no activity detected.

Page 1 of 1
ATTACHMENT 1

Palisades - Table 2A

2013 Liquid Effluents- Sum of All Releases

Summation of All Uncertainty Liquid Releases Units Quarter 1 Quarter 2 Quarter 3 Quarter 4 Total (%)

Fission and

Activation

Products

(excluding tritium,

gases, and gross

alDha) Ci 4.47E-04 2.75E-03 1.47E-04 2.93E-03 6.27E-03 A 79

Average

Concentration pCi/ml 2.09E-1 1 8.90E-1 1 3.67E-12 7.50E-1 1 4.77E-1 1

% of Limit % 2.66E-04 1.62E-03 6.36E-05 1.17E-03 7.93E-04

Tritium Ci 1.25E+02 1.29E+02 6.21E+01 1.20E+02 4.36E+02

Average

Concentration pCi/ml 5.84E-06 4.18E-06 1.55E-06 3.06E-06 3.32E-06

% of Limit % 5.84E-01 4.18E-01 1.55E-01 3.06E-01 3.32E-01

Dissolved and

Entrained Gases Ci 1.27E-04 O.OOE+00 O.OOE+00 3.32E-04 4.59E-04

Average

Concentration pCi/mI 5.95E-12 O.OOE+00 O.OOE+00 8.51E-12 3.49E-12

% Of Limit % 2.98E-06 O.OOE+00 O.OOE+00 4.26E-06 1.75E-06

Gross Alpha Ci O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00

Average

Concentration pJCi/ml O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00

Volume of

Primary System

Liquid Effluent

(Before Dilution) Liters 3.75E+05 6.28E+05 2.87E+05 5.79E+05 1.87E+06

Dilution Water

Used for Above Liters 2.14E+10 3.10E+10 4.01E+10 3.90E+10 1.31E+11

Volume of

Secondary or

Balance-of-Plant

Liquid Effluent

(e.g., low-activity

or unprocessed)

(Before Dilution) Liters 8.06E+09 8.32E+09 8.27E+09 8.01E+09 3.27E+10

Average Stream

Flow m3/s 2.75E+00 3.94E+00 5.05E+00 4.91E+00 4.16E+00

ZLI IrI

1 0.00 1

Dilution flow rate (gal/qtr) = # of Dilution pumps running x days running/qtr x 4000 gpm/pump x min/day

Page 1 of 1
ATTACHMENT 1

Palisades - Table 2B

2013 Liquid Effluents - Batch Mode

Fission and Activation Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Products

Cr-51 Ci ND ND ND ND

Mn-54 Ci ND ND ND ND

Fe-55 Ci 2.1OE-04 3.70E-04 4.22E-05 7.06E-04

Fe-59 Ci ND ND ND ND

Co-57 Ci ND ND ND ND

Co-58 Ci ND 5.33E-04 9.53E-06 2.62E-04

Co-60 Ci 1.13E-04 1.20E-03 7.31E-05 1.06E-03

Sr-89 Ci ND ND ND ND

Sr-90 Ci ND ND ND ND

Nb-95 Ci ND ND ND ND

Ag-11Orn Ci 9.97E-05 4.23E-04 ND 4.85E-04

Sn-113 Ci ND ND ND ND

Sb-124 Ci ND ND ND ND

Sb-125 Ci ND 2.06E-05 ND ND

1-131 Ci ND ND ND ND

1-133 Ci ND ND ND ND

1-135 Ci ND ND ND ND

Cs-134 Ci ND ND ND ND

Cs-137 Ci ND 1.25E-06 ND ND

Ni-63 Ci 2.43E-05 2.32E-04 2.25E-05 4.14E-04

Zn-65 Ci ND ND ND ND

Zr-95 Ci ND ND ND ND

La-140 Ci ND ND ND ND

Totals Ci 4.47E-04 2.78E-03 1.47E-04 2.93E-03

Dissolved and Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Entrained Gases

Kr-85 Ci ND ND ND ND

Xe-131m Ci ND ND ND ND

Xe-133 Ci 1.27E-04 ND ND 3.32E-04

Xe-133m Ci ND ND ND ND

Xe-135 Ci ND ND ND ND

Totals 1.27E-04 O.OOE+00 O.OOE+00 3.32E-04

Tritium [ Ci [ 1.25E+02 ] 1.29E+02 [ 6.20E+01 ] 1.20E+02

-Gross Alpha Ci ND ND ND ND

ND = None Detected

Page 1 of I
ATTACHMENT 1

Palisades - Table 2C

2013 Liquid Effluents - Continuous Mode

Fission and Activation Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Products

Cr-51 Ci ND ND ND ND

Mn-54 Ci ND ND ND ND

Fe-55 Ci ND ND ND ND

Co-58 Ci ND ND ND ND

Co-60 Ci ND ND ND ND

Sr-89 Ci ND ND ND ND

Sr-90 Ci ND ND ND ND

Nb-95 Ci ND ND ND ND

Ag-11im Ci ND ND ND ND

Sn-113 Ci ND ND ND ND

Sb-124 Ci ND ND ND ND

Sb-125 Ci ND ND ND ND

1-131 Ci ND ND ND ND

1-133 Ci ND ND ND ND

1-135 Ci ND ND ND ND

Cs-134 Ci ND ND ND ND

Cs-137 Ci ND ND ND ND

Ni-63 Ci ND ND ND ND

Totals Ci O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00

Dissolved and Units Quarter 1 Quarter 2 Quarter 3 Quarter 4

Entrained Gases

Kr-85 Ci ND ND ND ND

Xe-133 Ci ND ND ND ND

Xe-133m Ci ND ND ND ND

Xe-135 Ci ND ND ND ND

Xe-135m Ci ND ND ND ND

Totals O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00

Tritium Ci 3.54E-02 1.44E-02 1.33E-02 1.26E-02

Gross Alpha Ci ND ND ND ND

ND = None Detected

Page 1of 1
ATTACHMENT 1

Palisades - Table 3

2013 Low-Level Waste

1. Solid waste shipped offsite for burial or disposal (not irradiated

fuel)

1. Type of waste Unit Estimated amount Est Total

Error, %

a. Spent resin, filters, m3 1.66E+01 25

evaporator bottoms, etc. Curies 7.26E+01

b. Dry compressible waste, m3 5.18E+02 25

contaminated equipment, etc. Curies 1.97E+00

c. Irradiated components, m3 O.OOE+00

control rods, etc. Curies O.OOE+OO

d. Other (describe) m3 2.84E+01 25

DAW / Metal Waste / Oil Curies 1.67E-02

2. Estimate of Major Nuclide composition (by type of waste), list

nuclides as needed

a. Co-60 38% Mn-54 1% Cs-134 9%

Fe-55 3% Co-58 2%

Cs-137 16% Ag-110m 2%

Ni-63 26% Sb-125 3%

b. Co-60 12% Co-58 3% Sb-125 6%

Fe-55 35% Ni-63 39%

Cs-137 2% Nb-95 1%

Cr-51 1% Ru-106 1%

C.

d. H-3 1% Co-58 36% Ru-106 1%

C-14 1% Co-60 13% Ag-110m 4%

Cr-51 13% Ni-63 7% Sn-113 1%

Mn-54 1% Zr-95 5% Sb-125 1%

Fe-55 4% Nb-95 10% Cs-1 37 2%

Page 1 of 2
ATTACHMENT 1

Palisades - Table 3

2013 Low-Level Waste

3. Solid waste disposition

Number of shipments Mode of transportation

1 Truck

19 Truck

2 Truck

Irradiated fuel shipments (disposition)

Number of shipments Mode of transportation

Destination

Kingston, Tn

Oakridge, Tn

Erwin, Tn

Destination

0

Page 2 of 2
ATTACHMENT 1

Palisades - Table 4

2013 Dose Assessments, 10 CFR Part 50, Appendix I

Quarter 1 Quarter 2 Quarter 3 Quarter 4 Yearly

Liquid Effluent Dose Limit, Total 1.5 mrem 1.5 mrem 1.5 mrem 1.5 mrem 3 mrem

Body

Total Body Dose 2.19E-04 3.15E-03 6.31E-05 5.24E-04 3.95E-03

% Of Limit 0.01% 0.21% 0.00% 0.03% 0.13%

Liquid Effluent Dose Limit, Any 5 mrem 5 mrem 5 mrem 5 mrem 10 mrem

Organ

Organ Dose 2.22E-04 4.61E-03 6.39E-05 5.36E-04 5.44E-03

% of Limit 0.00% 0.09% 0.00% 0.01% 0.05%

Gaseous Effluent Dose Limit, 5 mrad 5 mrad 5 mrad 5 mrad 10 mrad

Gamma Air

Gamma Air Dose 3.72E-04 8.30E-05 9.78E-06 3.15E-04 7.80E-04

% of Limit 0.01% 0.00% 0.00% 0.01% 0.01%

Gaseous Effluent Dose Limit, 10 mrad 10 mrad 10 mrad 10 mrad 20 mrad

Beta Air

Beta Air Dose 2.59E-04 6.04E-05 6.51 E-06 2.17E-04 5.43E-04

% of Limit 0.003% 0.001% 0.000% 0.002% 0.003%

Gaseous Effluent Dose Limit, Any 7.5 mrem 7.5 mrem 7.5 mrem 7.5 mrem 15 mrem

Organ (Iodine, Tritium,

Particulates with >8 day half-life)

Gaseous Effluent Organ Dose 4.60E-02 2.59E-02 5.04E-02 5.04E-02 1.73E-01

(Iodine, Tritium, Particulates with

>8-Day half-life)

% of Limit 0.61% 0.35% 0.67% 0.67% 1.15%

Palisades - Table 5

2013 EPA 40 CFR Part 190, Individual in the Unrestricted Area

Whole Body Thyroid Any Other Organ

Dose Limit 25 mrem 75 mrem 25 mrem

Dose 9.79E-02 6.86E-03 5.44E-03

% of Limit 0.39% 0.01% 0.02%

Page 1 of 1
ENCLOSURE 1

PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL, REVISION 25

77 Pages Follow
ODCM

Revision 25

Issued Date 12/29/11

PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

TITLE: OFFSITE DOSE CALCULATION MANUAL

Process Applicability Exclusion II

DWFoster / 12/28/11

Procedure Sponsor Date

JJMiller I 12/15/11

Technical Reviewer Date

JHager I 12/15/11

User Reviewer Date

DHamilton / 12/19/11

General Manager Plant Operations Date
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

Table of Contents

G A SEO US EFFLU ENTS ............................................................................................... 1

A. ALARM/TRIP SETPOINT METHOD .............................................................. 1

1. Allowable Concentration ............................... 2

2. Monitor Response ........................................ 3

B. DOSE RATE CALCULATION .................................................................... 4

C. GASEOUS RADWASTE TREATMENT SYSTEM OPERATION ............. 19

1. System Description ...................................... 19

2. Determination of Satisfactory Operation ....... 19

D. RELEASE RATE FOR OFFSITE EC ....................................................... 20

E. PARTICULATE AND IODINE SAMPLING .............................................. 20

F. NOBLE GAS SAMPLING ........................................................................ 21

G. TRITIUM SAMPLING ............................................................................... 21

H. FIGURE - GASEOUS EFFLUENTS FLOW PATHS ............................... 22

LIQ UID EFFLUENTS ................................................................................................ 23

A. CONCENTRATION ................................................................................. 23

1. Requirements ............................................... 23

2. Prerelease Analysis .................................... 23

3. Effluent Concentration (EC) - Sum of the

Ratios ............................................................ 24

B. INSTRUMENT SETPOINTS ..................................................................... 25

1. Setpoint Determination ............................... 25

2. Composite Samplers .................................. 25

3. Post-Release Analysis ............................... 26

C . D O S E ...................................................................................................... 26

1. RETS Requirement ...................................... 26

2. Release Analysis ........................................ 26

D. OPERABILITY OF LIQUID RADWASTE EQUIPMENT .......................... 30

E. RELEASE RATE FOR OFFSITE EC (50 MREMIYR) .............................. 30

F. FIG U R ES .................................................................................................. 31
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

Table of Contents

Ill. URANIUM FUEL CYCLE DOSE ............................................................................. 33

A. SPECIFICATION ..................................................................................... 33

B. ASSUMPTIONS ....................................................................................... 33

C. DOSE CALCULATION ............................................................................ 34

IV. SOURCE REFERENCE DOCUMENTS .................................................................. 34

Attachment 1,

Attachment 2,

Attachment 3,

Attachment 4,

Attachment 5,

Attachment 6,

Attachment 7,

Attachment 8,

"Palisades Gaseous And Liquid Source Terms, Curies/Year"

"Basic Radionuclide Data"

"Dose Factors for Submersion in Noble Gases"

"Stable Element Transfer Data"

"Inhalation Dose Commitment Factors"

"External Dose Factors for Standing on Contaminated Ground (DFGi)

(mrem/hr per pCi/m 2)"'

"Bioaccumulation Factors (pCi/gm per pCi/ml)"

"Ingestion Dose Commitment Factors"
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

GASEOUS EFFLUENTS

A. ALARM/TRIP SETPOINT METHOD

Appendix A, Section III.B.1 requires that the dose rate due to radioactive materials

released in gaseous effluents from the site to areas at and beyond the SITE

BOUNDARY shall be limited to the following:

For noble gases: Less than or equal to 500 mrems/yr to the total body and

less than or equal to 3000 mrems/yr to the skin, and

For iodine-1 31, for iodine-1 33, for tritium, and for all radionuclides in

particulate form with half lives greater than 8 days: Less than or equal to

1500 mrems/yr to any organ.

Appendix A, Section III.A.1 requires gaseous effluent monitors to have alarm/trip

setpoints to ensure that offsite concentrations, when averaged over 1 hour, will not

be greater than Appendix A, Section III.B.1. This section of the ODCM describes the

methodology that will be used to determine these setpoints.

The methodology for determining alarm/trip setpoints is divided into two major parts.

The first consists of calculating an allowable concentration for the nuclide mixture to

be released. The second consists of determining monitor response to this mixture in

order to establish the physical settings on the monitors.

1
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

1. Allowable Concentration

NOTE: If a batch release is made while a continuous release or another batch release is

in progress, the sum of all values of Rk must be less than 10.0.

The total EC-fraction (Rk) for each release point will be calculated by the

relationship defined by Note 4 of Appendix B, 10 CFR 20:

Rk = X/Q x F x Zi Ci/ECi < 10.0 (1.1)

where:

C = Actual or measured concentration, at ambient temperature and

pressure of nuclide i (gCi/cc)

ECj = The EC of nuclide i from 10 CFR 20, Appendix B, Table 2

R(k) = The total EC-fraction for release point k

X/Q = Most conservative sector site boundary dispersion (sec/m3)

(listed in site procedure CH 6.41, Land Use Census)

F = Release flow rate (83,000 cfm = 39.2 m3/sec) for stack monitor

considerations; variable for other monitors

2
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

2. Monitor Response

Normal radioactivity releases consist mainly of well-decayed fission gases.

Therefore, monitor response calibrations are performed to fission gas typical

of normal releases (mainly Xe-133). Response of monitors used to define

fission product release rates under accident conditions may vary from that of

Xe-1 33, however. Monitor response for the two categories of monitor is

determined as follows:

a. Normal Release (aged fission gasses)

Total gas concentration (gCi/cc) at the monitor is calculated. The

detector response to isotopic activities (cpm/gCi/cc) is applied to

determine cpm expected. The setting for monitor alarms is established

at some factor (b) greater than 1 but less than 1IRk (Equation 1.1)

times the measured concentration (c):

s = b x c (1.2)

b. Accident Releases

Monitors are preset to alarm at or before precalculated offsite dose

rates would be achieved under hypothetical accident conditions.

These setpoints are established in accordance with Emergency Plan

requirements for defining Emergency Action Levels and associated

actions. Emergency Implementing Procedures contain

monitor-specific curves or calibration constants for conversion between

cpm and gCi/cc (or R/hr and iiCi/cc), depending on monitor type, for

fission product mixtures as a function of mixture decay time.

When these monitors are utilized for other than accident conditions,

either an appropriately decayed "accident" conversion curve may be

used, or a decayed fission gas calibration factor may be applied. In

these cases, setpoints are established as in 1 .A above.

Setpoints of accident monitors (if set to monitor normal releases) are

reset to the accident alarm settings at the end of normal release.

Setpoints of other release monitors are maintained at the level used at

the latest release (well below the level which would allow 10 times EC

to be exceeded at the site boundary), or are reset to approximately

three times background in order to detect leakage or inadvertent

releases of low level gases.

3
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

B. DOSE RATE CALCULATION

1. Dose rates are calculated for (1) noble gases and (2) iodines and particulates.

Dose rates as defined in this section are based on 10 CFR 50 Appendix I

limits of mrem per quarter and millirem per year. All dose pathways of major

importance in the Palisades environs are considered. NRCDose is the

Effluent Dose Calculation software that supports LADTAP, GASPAR, and

XOQDOQ which perform the actual dose calculations using the equations

supplied here.

a. Equations and assumptions for calculating doses from noble gases are

as follows:

1) Assumptions

a) Doses to be calculated are the maximum offsite point in

air, total body and skin.

b) Exposure pathway is submersion within a cloud of noble

gases.

c) Noble gas radionuclide mix is based on the historically

observed source term given in Attachment 2, plus

additional nuclides.

d) Basic radionuclide data are given in Attachment 2.

e) All releases are treated as ground-level.

f) Meteorological data expressed as joint-frequency

distribution of wind speed, wind direction, and

atmospheric stability for the period resulting in X/Q's and

D/Q's shown in site procedure CH 6.41, Land Use

Census.

g) Raw meteorological data consists of wind speed and

direction measurements at 10m and temperature

measurements at 1Om and 60m.

h) Dose is to be evaluated at the offsite exposure points

where maximum concentrations are expected to exist

(overland sector site boundaries), and nearest residents.

4
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

i) Potential maximum population (resident) exposure points

are identified in site procedure CH 6.41, Land Use

Census.

j) A semi-infinite cloud model is used.

k) Radioactive decay is considered for the plume.

I) Building wake effects on effluent dispersion are

considered.

m) A sector-average dispersion equation is used.

n) The wind speed classes that are used are as follows:

Wind Speed

Class Number Range (m/s)

1

2

3

4

5

6

7

0.0-0.4

0.4-1.5

1.5-3.0

3.0-5.0

5.0-7.5

7.5-10.0

> 10.0

Midpoint (m/s)

0.2

0.95

2.25

4.0

6.25

8.75

o) The stability classes that will be used are the standard A

through G classifications. The stability classes 1-7 will

correspond to A=1, B=2, ... , G=7.

p) Terrain effects are not considered.

5
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

2) Equations

To calculate the dose for any one of the exposure points, the

following equations are used.

For determining the air concentration of any radionuclide:

x, 1exp [ (Ai x (1.3)

j=1 k=I1 7 Zj Uj (21-x/n) Ui

where:

Xi = Air concentration of radionuclide i, PCi/m 3.

fJk = Joint relative frequency of occurrence of winds in

wind speed class j, stability class k, blowing

toward this exposure point, expressed as a

fraction.

Q = Average release rate of radionuclide i, RCi/s.

p = Fraction of radionuclide remaining in plume.

Yzk = Vertical dispersion coefficient for stability

class k (m).

Uj = Midpoint value of wind speed class interval j, m/s.

x = Downwind distance, m.

n = Number of sectors, 16.

- = Radioactive decay coefficient of radionuclide i, s-1.

27tx/n = Sector width at point of interest, m.

6
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

For determining the total body dose rate:

DrB= X DFBi (1.4)

where:

DTB = Total body dose rate, mrem/y.

Xi = Air concentration of radionuclide I, R.tCi/m 3.

DFB1 = Total body dose factor due to gamma radiation,

mrem/y per ý.Ci/m 3 (Attachment 3).

For determining the skin dose rate:

D= X, (DFS± + I. I1 DFY()

where:

D = Skin dose rate, mrem/y.

Xi = Air concentration of radionuclide i, ýiCi/m 3

DFSj = Skin dose factor due to beta radiation, mrem/y

1.5)

per

ACi/m 3 (Attachment 3).

1.11 = The average ratio of tissue to air energy

absorption coefficients, mrem/mrad.

DFYi = Gamma-to-air dose factor for

radionuclide i, mrad/y per RCi/m 3 (Attachment 3).

For determining dose rate to a point in air:

D. = I X, (DFYI or DFBI) (1.6)

where:

Da =

DFBi =

Air dose rate, mrad/yr.

Air dose factor for beta radiation (Attachment 3).

7
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

b. Equations and assumptions for calculating doses from radioiodines

and particulates are as follows:

1) Assumptions

a) Dose is to be calculated for the critical organ, thyroid, and

the critical age groups (adult, teen, child, infant), infant

(milk) and child (green, leafy vegetables).

b) Exposure pathways from iodines and particulates are

milk ingestion, ground contamination, green leafy

vegetables from home gardens, and inhalation.

c) The radioiodine and particulate mix is based on the

historically observed source term given in Attachment 2.

d) Basic radionuclide data are given in Attachment 3.

e) All releases are treated as ground-level.

f) Mean annual average X/Q's are given in site procedure

CH 6.41, Land Use Census.

g) Raw meteorological data for ground-level releases

consist of wind speed and direction measurements at

1Om and temperature measurements at 1Om and 60m.

h) Dose is to be evaluated at the potential offsite exposure

points where maximum doses to man are expected to

exist.

i) Real cow, goat and garden locations are considered.

j) Potential maximum exposure points (site procedure

CH 6.41, Land Use Census) considered are the nearest

cow, goat, and home garden locations in each sector.

k) Terrain effects and open terrain recirculation factors are

not considered.

I) Building wake effects on effluent dispersion are

considered.

m) Plume depletion and radioactive decay are considered

for air-concentration calculations.

8
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

n) Radioactive decay is considered for

ground-concentration calculations.

o) Deposition is calculated based on the curves given in

Figure 1.2.

p) Milk cows and goats obtain 100% of their food from

pasture grass May through October of each year. Use

default values of 0.58 for cows and 0.67 for goats for

fraction of year on pasture.

2) Equations

To calculate the dose for any one of the potential

maximum-exposure points, the following equations in

Section 1.2.2 are used.

a) Inhalation

Equation for calculating air concentration, Xi is the same

as in the Noble Gas Section (Equation 1.3).

For determining the organ dose rate:

D1= X 106 EXDFI, BR (1.7)

where:

Di = Organ dose rate due to inhalation, mrem/y.

X1 = Air concentration of radionuclide i, RCi/m 3.

DFli = Inhalation dose factor, mrem/pCi

(Attachment 5).

BR = Breathing rate 1400 m3/y infant;

3700 m3/y child; or 8000 m3/y teen and

adult.

1x10 6 = pCi/ptCi conversion factor.

9
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

b) Ground Contamination

For determining the ground concentration of any nuclide;

7

G=3x107 fkQ, DR exp(- A) 0.

Gi = x(2,T 3.15 x/n) (1.8

kl

where:

Gi = Ground concentration of radionuclide i,

pCi/m 2.

k = Stability class.

fk = Joint relative frequency of occurrence of

winds in stability class k blowing toward this

exposure point, expressed as a fraction.

Qi = Average release rate of radionuclide i,

ýICi/s.

DR = Relative deposition rate, m-1 (Fig 1.2).

x = Downwind distance, m.

n = Number of sectors, 16.

27rx/n = Sector width at point of interest, m.

k = Radioactive decay coefficient of

radionuclide i, y-1.

tb = Time for buildup of radionuclides on the

ground, 15 y.

3.15x10 7 = s/y conversion factor.

10
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

Figure 1.2 Corrected

10-3

10-4

uj

UJ

10

10-7

0.1 1.0 10.0 100.0 200.0

PLUME TRAVEL DISTANCE (KILOMETERS)

Figure 7. Relative Deposition for Ground Level Releases (All Atmospheric

Stability Classs)

11
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

For determining the total body or organ dose rate from

ground contamination:

DG= (8,760)(1X 106

)(0.7) 1G, DFGi (1.9)

where:

DG = Dose rate due to ground contamination,

mrem/y.

G1 = Ground concentration of radionuclide i,

PCi/m 2.

DFG = Dose factor for standing on contaminated

ground, mrem/h per pCi/m 2 (Attachment 6).

8,760 = Occupation time, h/y.

1x1 06 = pCi/pCi conversion factor.

0.7 = Shielding factor accounting for a distance of

1.0 meter above ordinary ground,

dimensionless.

Milk and Vegetation Ingestion

For determining the concentration of any nuclide (except

C-14 and H-3) in and on vegetation:

c)

7

CVi = 3,600 fkQ DR

k I (2;r x/n)

r[l - exp(-AEite)] B. [I-exp

Yv AE + IV p1(-Atb)] k[exp(-Ai th)]] (1.10)

where:

CVi

k

fk

= Concentration of radionuclide i in and on

vegetation, pCi/kg.

= Stability class.

= Frequency of this stability class and wind

direction combination, expressed as a

fraction.

12
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

Q•= Average release rate of radionuclide i,

jiCi/s.

DR = Relative deposition rate, m-1 (Figure 1.2).

x = Downwind distance, m.

n = Number of sectors, 16.

27rx/n = Sector width at point of interest, m.

r = Fraction of deposited activity retained on

vegetation (1.0 for iodines, 0.2 for

particulates).

XEi = Effective removal rate constant,

XEi = ki + w,, where ki is the radioactive

decay coefficient, h1, and Xw is a measure

of physical loss by weathering

(Xw = 0.0021 h-).

te = Period over which deposition occurs, 720 h.

Y = Agricultural yield, 0.7 kg/m 2.

B = Transfer factor from soil to vegetation of

radionuclide i (Attachment 4).

i = Radioactive decay coefficient of

radionuclide i, h-1.

tb = Time for buildup of radionuclides on the

ground, 1.31 x105 h (15Y).

p = Effective surface density of soil, 240 kg/m 2.

3,600 = s/h conversion factor.

th = Holdup time between harvest and

consumption of food (2,160 hours for stored

food).

13
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

For determining the concentration of C-14 in vegetation:

cV 14 =1 x 103 x14 (0.11/0.16) (1.11)

where:

CV14 = Concentration of C-14 in vegetation, giCi/kg.

X14= Air concentration of C-14, gCi/m 3.

0.11 = Fraction of total Plant mass that is natural

carbon.

0.16 = Concentration of natural carbon in the

atmosphere, g/m 3.

1x10 3 = g/kg conversion factor.

For determining the concentration of H-3 in vegetation:

CVT= 1 X 103 XT (0.75)(0.5/H) (1.12)

where:

CVT = Concentration of H-3 in vegetation, gCi/m 3.

XT = Air concentration of H-3, pCi/m 3.

0.75 = Fraction of total Plant mass that is water.

0.5 = Ratio of tritium concentration in Plant water

to tritium concentration in atmospheric

water.

H = Absolute humidity of the atmosphere, g/m 3

.

lx103 = g/kg conversion factor.

14
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

For determining the concentration of any nuclide in cow's

or goat's milk:

CMi = CVi FMi Qfexp (-Xi tf) (1.13)

where:

CMi = Concentration of radionuclide i (including

C-14 and H-3) in milk, pCi/l.

CV = Concentration of radionuclide i in and on

vegetation, p.Ci/kg.

FMj = Transfer factor from feed to milk for

radionuclide i, d/I (Attachment 4).

Qf = Amount of feed consumed by the milk

animal per day, kg/d (cow, 50 kg/d or

goat 6 kg/d).

Al = Radioactive decay coefficient of

radionuclide i, d1.

tf = Transport time of activity from feed to milk

to receptor, 2 days.

15
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

For determining the organ dose rate from ingestion of

green leafy vegetables and milk:

D=1x10 6 ZCMIDFiUM (1.14) i

where:

D = Organ dose rate due to ingestion, mrem/y.

CMi = Concentration of radionuclide i in

vegetables or milk, gCi/kg (or liters).

DFi = Ingestion dose factor, mrem/pCi

(Attachment 8).

UM = Ingestion rate for milk, 330 I/y; for

vegetables 26 kg/yr (child), no ingestion by

infant.

lx106 = pCi/ýtCi conversion factor.

d) Meat Inqestion (Beef)

To calculate the concentration of a nuclide in animal

flesh:

Cfi = Ff CVj Qf, exp (-Xit,) (1.15)

where:

C = Concentration of nuclide i in the animal

flesh, pCi/kg.

Ff = Fraction of animal's daily intake which

appears in each kg of flesh, days/kg

(Attachment 4).

CVi = Concentration of radionuclide i in the

animal's feed (Equation 1.10).

16
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

Qf = Amount of feed consumed by the cow per

day, 50 kg/d.

ts = Average time from slaughter to

consumption, 20 days.

To determine the organ dose from ingestion of beef:

D= -Cfi Df. Uf (1.16)

where:

Df = Ingestion dose factor for age group,

mrem/pCi (Attachment 8) for nuclide i.

Uf = Ingestion rate of meat for age group,

kg/y (child-41, teen-65, adult-1 10).

e) Organ Dose Rates

For determining the total body and organ dose rate from

iodines and particulates:

D = DI + DG + DM + Dv + DF (1.17)

where:

D Total organ dose rate, mrem/y.

D, Dose rate due to inhalation, mrem/y.

DG = Dose rate due to ground contamination,

mrem/y.

DM = Dose rate due to milk ingestion, mrem/y.

Dv = Dose rate due to vegetable ingestion,

mrem/y.

DF = Dose rate due to beef ingestion, mrem/y.

17
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

3) The maximum organ dose rate, maximum total body dose rate,

and maximum skin dose rate calculated in the previous section

(Sec 1.B) are used to calculate design basis quantities as

described in Section I.B.1.3.

c. Land Use Census

Appendix A, Sections J.3.b and J.3.c describe the requirements for an

annual land use census. Changes will be effective on January 1 of the

year following the year of the survey.

d. Gaseous Releases From the Steam Generator Blowdown Vent and

Atmosphere Release Valves

Releases from the steam generator blowdown vent and atmospheric

relief valves are difficult to quantify as there are no sampling

capabilities on these steam release systems. However, neither system

is a normal release path. The steam generator blowdown vent is

normally routed to the main condenser and recirculated. Radioactive

releases will be calculated by analyzing steam generator blowdown

liquid and assuming that 100 percent of Noble Gases, 10 percent of

the lodines and 1 percent of the Particulates will be released to the

environment in the steam phase. Volumes will be released to the

environment in the steam phase. Volumes will be calculated using

water balances or alternate means as available.

18
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

C. GASEOUS RADWASTE TREATMENT SYSTEM OPERATION

The gaseous radwaste treatment system (GRTS) described below shall be

maintained and operated to keep releases ALARA.

1. System Description

A flow diagram for the GRTS is given in Figure 1-1. The system consists of

three waste-gas compressor packages, six gas decay tanks, and the

associated piping, valves, and instrumentation. Gaseous wastes are received

from the following: degassing of the reactor coolant and purging of the

volume control tank prior to a cold shutdown and displacing of cover gases

caused by liquid accumulation in the tanks connected to the vent header.

Design of the system precludes hydrogen explosion by means of ignition

source elimination (diaphragm valves, low flow diaphragm compressors and

system electrical grounding), and minimization of leakage outside the system.

Explosive mixtures of hydrogen and oxygen have been demonstrated

compatible with the system by operational experience.

2. Determination of Satisfactory Operation

Doses will be calculated for batch and continuous releases as described in

Section I.B. These calculations will be used to ensure that the GRTS is

operating as designed. Because the Plant was designed to collect and hold

for decay a vast majority of the high level gases generated within the primary

system, and because the operating history of the Plant has demonstrated the

system's consistent performance well below Appendix I limits, no additional

operability requirements are specified.

19
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

D. RELEASE RATE FOR OFFSITE EC

10 CFR 20.1302 requires radioactive effluent releases to unrestricted areas be in

concentrations less than the limits specified in Appendix B, Table 2 when averaged

over a period not to exceed one year. (Note: there are no unrestricted areas

anywhere within the site boundary as defined by Figure 1-1.) Concentrations at this

level if inhaled or ingested continuously for one year will result in a dose of 50 mrem

whole body except for submersion dose isotopes (gaseous tritium and noble gasses)

which will results in a dose of 100 mrem whole body. 10 CFR 50.36a requires that

the release of radioactive materials be kept as low as reasonably achievable.

However, the section further states that the licensee is permitted the flexibility of

operation, to assure a dependable source of power even under unusual operating

conditions, to release quantities of material higher than a small percentage of

10 CFR 20.1302 limits but still within those limits. Appendix I to 10 CFR 50 provides

the numerical guidelines on limiting conditions for operations to meet the as low as

reasonably achievable requirement.

The GASPAR code has been run to determine the dose due to external radiation

and inhalation. The source term used is listed in Attachment 2. The meteorology

data is given in site procedure CH 6.41, Land Use Census. Dose using annual

average meteorology, to the most limiting organ of the person assume to be residing

at the site boundary with highest X/Q, is 2.15E-02 mrem (for one year). The release

rate which would result in a dose rate equivalent to 50 mrem/year (using the more

conservative total body limit) is the curies/year given in Attachment 2 multiplied by

50/2.15E-02 or 0.11 Ci/sec.

E. PARTICULATE AND IODINE SAMPLING

Particulate and iodine samples are obtained from the continuous sample stream

pulled from the Plant stack. Samples typically are obtained to represent an

integrated release from a gas batch (waste gas decay tank or Containment purge,

for example), or a series of samples are obtained to follow the course of a release.

In any event, sample intervals are weekly, at a minimum.

Because HEPA filters are present between most source inputs to the stack and the

sample point, releases of particulates normally are significantly less than pre-release

calculations indicate. This provides for conservatism in establishing setpoints and in

estimation of pre-release dose calculations. However, for the sake of maintaining

accurate release totals, monitor results (for gases) and sample results

(for particulates and iodines) utilized rather than the pre-release estimates, for

cumulative records.

20
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

Gamma analytical results for particulate and halogen filters are combined for

determination of total activity of particulates and halogens released. Sampling and

analysis will be performed per Appendix A, Table B-1 requirements.

F. NOBLE GAS SAMPLING

Noble gases will be sampled from Waste Gas Decay Tanks prior to release and the

Containment prior to purging. Analysis of these samples will be used for

accountability of noble gases. Off gas will be sampled at least weekly and used to

calculate monthly noble gas releases. Non-routine releases will be quantified from

the stack noble gas monitor (RE 2326) which has a LLD of 1 E-06 pCi/cc. Sampling

and analysis will be performed per Appendix A, Table B-1 requirements.

G. TRITIUM SAMPLING

Tritium has a low dose consequence to the public because of low energy decay.

The major contributors to tritium effluents are evaporation from the fuel pool and

reactor cavity (when flooded). Because of the low dose impact, gaseous tritium

sampling will not be required. Tritium effluents will be estimated using conservative

evaporation rate calculations from the fuel pool and reactor cavity.

21
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

H. FIGURE - GASEOUS EFFLUENTS FLOW PATHS

I s

I

C/3L

wo0

LL < u- (D w

C/)

w

0o

Ia.

22
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

LIQUID EFFLUENTS

A. CONCENTRATION

1. Requirements

Appendix A, Section lII.G requires that the concentration of radioactive

material released at any time from the site to unrestricted areas shall be

limited to ten times the Effluent Concentration (EC) specified in 10 CFR 20,

Appendix B, Table 2, Column 2 for nuclides other than dissolved or entrained

noble gases. For dissolved or entrained noble gases, the concentration shall

be limited to 2E-04 ttCi/ml total activity. To ensure compliance, the following

approach will be used for each release.

2. Prerelease Analysis

Most tanks will be recirculated through two volume changes prior to sampling

for release to the environment to ensure that a representative sample is

obtained. The appropriate recirculation time for those tanks too large to

provide two volume changes will be the time that the suspended particulate

concentration reaches steady state. Either a one-time test, or prior sampling

data, may be used to determine appropriate recirculation time.

Prior to release, a grab sample will be analyzed for each release, and the

concentration of each radionuclide determined.

n

C = iC, (2.1)

i=1

where:

C = Total concentration in the liquid effluent at the release

point, pCi/ml.

Ci Concentration of a single radionuclide i, ptCi/ml.

23
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

3. Effluent Concentration (EC) - Sum of the Ratios

The EC-Fraction (Ri) for each release point will be calculated by the

relationship defined by Note 4 of Appendix B, 10 CFR 20:

Rj I C- <•10.0 (2.2)

i ECi

where:

Ci Effluent concentration of radionuclide i, jtCi/ml.

ECQ The EC of radionuclide i, 10 CFR 20, Appendix B, Table 2,

Column 2 - gCi/ml.

Rj The Total EC-Fraction for the release point.

The sum of the ratios at the discharge to the lake must be _• 10 due to the

releases from any or all concurrent releases. The following relationship will

assure this criterion is met:

fl (Ri-1) + f2(R2 -1) + f3 (3 -1) F (2.3)

where:

fl ,f2,f3 = The effluent flow rate (gallons/minute) for the respective

releases, determined by Plant personnel.

R1,R2,R3 = The Total EC-Fractions for the respective releases as

determined by Equation 2.2.

F = Minimum required dilution flow rate. Normally, a

conservatively high dilution flow rate is used, that is, flow

rate used = (bi)(F) where bi is a conservative factor

greater than 1.0.

24
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

B. INSTRUMENT SETPOINTS

1. Setpoint Determination

Appendix A, Section III.F requires alarm setpoints for each liquid effluent

monitor will be established using Plant instructions to ensure the

requirements of Appendix A, Section III.G are not exceeded. Concentration,

flow rate, dilution, principal gamma emitter, geometry, and detector efficiency

are combined to give an equivalent setpoint in counts per minute (cpm). The

identification number for each liquid effluent radiation detector is contained in

Figure 2-2.

The respective alarm/trip setpoints at each release point will be set such that

the sum of the ratios at each point, as calculated by Equation 2.2, will not be

exceeded. The value of R is directly related to the total concentration

calculated by Equation 2.1. An increase in the concentration would indicate

an increase in the value of R. A large increase would cause the limits

specified in Section 2.1.1 to be exceeded. The minimum alarm/trip setpoint

value is equal to the release concentration, but for ease of operation it may be

desired that the setpoint (S) be set above the effluent concentration (C) by the

same factor (b) utilized in setting dilution flow. That is:

S = bxC (2.4)

Liquid effluent flow paths and release points are indicated in Figure 2.1.

2. Composite Samplers

Effluent pathways, Turbine Sump and Service Water, are equipped with

continuous compositors to meet the requirements of Appendix A, Table D-1.

These compositors are adjustable and normally set in a time mode and

collect three to six samples hourly, 24 hours a day with a total collection of

approximately one gallon per day. A representative sample is collected daily

from the compositor and saved for the weekly, monthly, and quarterly

analysis requirements of Appendix A, Table D-1. In the event that a

compositor is not operational, effluent releases via this pathway may continue

provided that grab samples are collected and analyzed for gross beta or

gamma radioactivity at least once per 24 hours per Appendix A, Table C-1,

Action 3.

25
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

3. Post-Release Analysis

A post-release analysis will be done using actual release data to ensure that

the limits specified in Section 1 were not exceeded.

A composite list on concentrations (CQ), by isotope, will be used with the

actual liquid radwaste (f) and dilution (F) flow rates (or volumes) during the

release. The data will be substituted into Equation 2.3 to demonstrate

compliance with the limits in Section 1. This data and setpoints will be

recorded in auditable records by Plant personnel.

C. DOSE

1. RETS Requirement

Appendix A, Section III.H.1 requires that the quantity of radionuclides

released by limited such that the dose or dose commitment to an individual

from radioactive materials in liquid effluents release to unrestricted areas from

the reactor (see Figure 2-1) will not exceed:

a. During any calendar quarter, 1.5 mrem to the total body and 5 mrem to

any organ, and

b. During any calendar year, 3 mrem to the total body and 10 mrem to

any organ.

To ensure compliance, quantities of activity of each radionuclide released will

be summed for each release and accumulated for each quarter as follows in

Section 2.

2. Release Analysis

Dose calculations shall be performed for each batch release, and weekly for

continuous releases unless documentation exists to demonstrate an activity

below which dose limits of Section I1.C.1 will not be exceeded.

a. Water Ingestion

The dose to an individual from ingestion of radioactivity from any

source as described by the following equation:

i

Oj (DCF)ij x li (2.5)

26
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

where:

Dj = Dose for the jth organ from radionuclides releases, mrem.

= The organ of interest.

(DCF)ij = Ingestion dose commitment factor for the jth organ from

the it" radionuclide mrem/pCi, see Attachment 8.

Ii = Activity ingested of the ith radionuclide, pCi.

li is described by:

(AX)(V)( 36 5 ) (1E0 6 ) (2.6) 11- (1 000)(d)

where

365

Ai

V

d

1000

1 E06

The d

= Days per year.

= Annual activity released of ith radionuclide, RCi.

= Average rate of water consumption (2000 mil/d - adult,

1400 mil/d - teen and child, 900 mil/d - infant, ICRP 23, p

358).

= Dilution water flow for year, ml.

= Dispersion factor from discharge to nearest drinking

water supply.

= Conversion gCi to pCi.

ose equation then becomes:

(3.65E05)(V) YX (DCF)ijxAimrem

i=1 (2.7)

27
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

b. Fish Ingestion

The dose to an individual from the consumption of fish is described by

Equation 2.10. In this case, the activity ingested of the ith radionuclide

(I) is described by:

AiBiF(1E0 9 ) =pci (2.8)

15d

where:

Ai = Annual released of ith radionuclide, [tCi.

Bi = Fish concentration factor of ith radionuclide ,t Ci/gm

pCi/ml

(see Attachment 7).

F = Amount of fish eaten per year (21 kg adult, 16 kg teen,

6.9 kg child, none infant).

15 = Dispersion factor from discharge to fish exposure point.

d = Dilution water flow for year, ml.

1 E09 = Conversion of .tCi, gm, and Kg to pCi.

Substitution of Equation 2.8 into Equation 2.5 gives:

i

D (6.7 E07)F Ai x Bi x DCFj mrem (2.9)

D d

28
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

c. Annual Analysis

A complete analysis utilizing the NRC computer code LADTAP with the

total source release will be done annually in conjunction with the

annual environmental report. This analysis will provide estimates of

dose to the total body and various organs in addition to the dose

limiting organs considered in the method of Section 2. The following

approach is utilized on LADTAP. The dose to the jth organ from m

radionuclides, Dj, is described by:

m

Dj Dij mrem (2.10) i=1

m

= V (DCF)ijxIjmrem (2.11)

i=1

where:

D = Dose to the jth organ from the ith radionuclide, mrem.

j = The organ of interest (bone, GI tract, thyroid, liver,

kidney, lung, or total body).

(DCF)ij = Adult ingestion dose commitment factor for the jth organ

from the ith radionuclide, mrem/pCi (see Attachment 8).

li = Activity ingested of the ith radionuclide, gCi.

I for water ingestion is described by:

Ii -='A,- ,ci (2.12)

vd

and for fish ingestion lI is described by:

li= AiBiFr pCi (2.13)

vd

29
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

where:

Ai = Activity release ofjth radionuclide during the year, pCi.

V = Average rate of water consumption (2000 mil/d).

F = Number of days during the year (365 d).

V = Dispersion factor from point of discharge to point of

exposure.

d Dilution water volume (ml).

Bi Fish concentration factor of the ith radionuclide,

pCi/gm

Attachment 7, p Ci/ml

F = Amount of fish eaten per day (57.5 gm/d).

D. OPERABILITY OF LIQUID RADWASTE EQUIPMENT

The Palisades liquid radwaste system is designed to reduce the radioactive

materials in liquid wastes prior to their discharge (through deep bed filtration and ion

exchange) so that radioactivity in liquid effluent releases to unrestricted areas (see

Figure 2-1) will not exceed the limits of Appendix A, III.H.1.

E. RELEASE RATE FOR OFFSITE EC (50 MREM/YR)

10 CFR 20.1302 requires radioactive effluent releases to unrestricted areas be less

than the limits specified in Appendix B, Table 2 when averaged over a period not to

exceed one year. Concentrations at this Effluent Concentration (EC) level, if

ingested for one year, will result in a dose of 50 millirem to the total body. In

addition, 10 CFR 50.36a requires that the release of radioactive materials be kept as

low as is reasonably achievable. Appendix I to 10 CFR 50 provides the numerical

guidelines on limiting conditions for operations to meet the as low as is reasonably

achievable requirement.

The LADTAP code has been run to determine the dose due to drinking water at

Plant discharge concentration (1,000 x nearest drinking water intake concentration).

The nominal average source term used is given in Attachment 2. Dose to the most

limiting organ of the person hypothetically drinking this water is 3.88E-03 mrem.

This is only 0.13% of the more conservative 50 mrem/yr total body value.

30
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

F. FIGURES

Figure 2-1

31
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

Figure 2-2

2 -

*~2

•Z

•N

.,<

I *n -

2.;

2

I,,

2

-4

2

I,'

C

2

-4

2

C

V'

rm

rm

Fa

m

z

'0"

z z

32
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

III. URANIUM FUEL CYCLE DOSE

A. SPECIFICATION

In accordance with Appendix A, Section 111.1.1, if either liquid or gaseous quarterly

releases exceed the quantity which would cause offsite doses more than twice the

limit of Appendix A, Sections II1.C.1, III.D.1, or III.H.1, then the cumulative dose

contributions from combined release plus direct radiation sources (from the reactor

unit and radwaste storage tanks) shall be calculated. The dose is to be determined

for the member of the public protected to be the most highly exposed to these

combined sources.

B. ASSUMPTIONS

1. The full time resident determined to be maximally exposed individual

(excluding infant) is assumed also to be a fisherman. This individual is

assumed to drink water and ingest local fish at the rates specified in

Sections I1.C.2.1 and I1.C.2.2.

2. Amount of shore line fishing (at accessible shoreline adjacent to site security

fence) is conservatively assumed as 48 hours per quarter (average of

approximately 1/2 hour per day each day of the quarter) for the second and

third quarters of the year, 36 hours for the fourth quarter and 16 hours for the

first quarter.

33
PALISADES NUCLEAR PLANT

OFFSITE DOSE CALCULATION MANUAL

Revision 25

C. DOSE CALCULATION

Maximum doses to the total body and internal organs of an individual shall be

determined by use of LADTAP and GASPAR computer codes, and doses to like

organs and total body summed. Added to this sum will be a mean dose rate,

calculated or measured for the shoreline due to Plant present curing the quarter in

question, times the assumed fishing time.

D40= DG + DL + (RT)(T) (2.15)

where:

D40= 40 CFR 190 dose (mrem).

DG = Limiting dose to an individual from gaseous source term (mrem).

DL = Limiting dose to an individual from liquid source term (mrem).

RT = Mean dose rate calculated to be applicable to Lake Michigan shoreline

adjacent to Plant site (mrem/hr).

T = Assumed shoreline fishing time for the quarter in questions (hours).

IV. SOURCE REFERENCE DOCUMENTS

1. Regulatory Guide 1.21, Measuring, Evaluating, and Reporting Radioactivity in

Solid Wastes and Releases of Radioacitve Materials in Liquid and Gaseous

Effluents from Light-Water-Cooled Nuclear Power Plants, RI.

2. Regulatory Guide 1.109, Calculation of Annual Doses to Man from Routine

Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10

CFR Part 50, Appendix I, RI.

3. NUREG-1301, Offsite Dose Calculation Manual Guidance: Standard Radiological

Effluent Controls for Pressurized Water Reactors, April 91.

4. NUREG-0472, Standard Radiological Effluent Technical Specifications for

Pressurized Water Reactors, R3.

5. NUREG/CR-4013, LADTAP II - Technical Reference and User Guide, April 86.

6. NUREG/CR-4653, GASPAR II - Technical Reference and User Guide, March 87.

7. CH 6.61, Revising the ODCM and ODCM Appendix A.

34
Proc No ODCM

Attachment 1

Revision 25

Page 1 of 1

PALISADES GASEOUS AND LIQUID SOURCE TERMS. CURIES/YEAR (1)

Nuclide

H-3

Kr-85

Kr-85m

Kr-87

Kr-88

Ar-41

Xe-1 31m

Xe-1 33

Xe-1 33m

Xe-1 35

Xe-1 35m

1-131

1-132

1-133

1-134

1-135

Na-24

Cr-51

Mn-54

Co-57

Co-58

Fe-59

Co-60

Se-75

Nb-95

Zr-95

Mo-99

Ru-103

Sb-127

Cs-1i34

Cs-136

Cs-137

Ba-140

La-140

Unidentified beta

Gaseous(2)

5.5

4.1

0.12

8.4E-02

2.1 E-01

3.1 E-02

2.2

1493

0.43

1.11

0.3

0.025

2.91 E-03

6.5E-03

4.8E-04

1.84E-02

1.5E-06

2.5E-04

4.1 E-04

2.1 E-06

8.6E-04

6.6E-06

1.1 E-03

3.7E-06

2.4E-05

4.7E-06

1.5E-07

0.3E-07

NA

4.5E-05

NA

2.6E-04

2.8E-07

7.5E-07

3.9E-04

Liquid(2)

159

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

3.21 E-03

NA

4.7E-05

NA

NA

NA

3.9E-03

7.8E-03

3.2E-05

2.9E-02

4.1 E-04

1.24E-02

NA

4.53E-04

1.79E-04

NA

0.1 E-05

3.5E-05

0.7

1.8E-06

1.36E-02

NA

1.1 E-04

3.3E-03

(1) Data derived from taking the effluents released

January-June 1982 and dividing by 4.

during July-December 1978 through

(2) Nuclide values listed as NA have not been observed at detectable levels in these waste

streams.
Proc No ODCM

Attachment 2

Revision 25

Page 1 of 2

BASIC RADIONUCLIDE DATA

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

NUCLIDE

Tritium

C-14

N-13

0-19

F-18

NA-24

P-32

AR-41

CR-51

MN-54

MN-56

FE-59

CO-58

CO-60

ZN-69m

ZN-69

3R-84

3R-85

KR-85m

KR-85

KR-87

KR-88

KR-89

RB-88

RB-89

SR-89

SR-90

SR-91

SR-92

SR-93

Y-90

Y-91m

Y-91

Y-92

Y-93

ZR-95

NB-95m

NB-95

MO-99

TC-99m

HALF-LIFE

(days)

4.49E 03

2.09E 06

6.94E-03

3.36E-04

7.62E-02

6.33E-01

1.43E 01

7.63E-02

2.78E 01

3.03E 02

1.07E-01

4.50E 01

7.13E 01

1.92E 03

5.75E-01

3.96E-02

2.21 E-02

2.08E-03

1.83E-01

3.93E 03

5.28E-02

1.17E-01

2.21 E-03

1.24E-02

1.07E-02

5.20E 01

1.03E 04

4.03E-01

1.13E-01

5.56E-03

2.67E 00

3.47E-02

5.88E 01

1.47E-01

4.29E-01

6.50E 01

3.75E 00

3.50E 01

2.79E 00

2.50E-01

LAMBDA

(ifs)

1.79E-09

3.84E-12

1.16E-03

2.39E-02

1.05E-04

1.27E-05

5.61 E-07

1.05E-04

2.89E-07

2.65E-08

7.50E-05

1.78E-07

1.12E-07

4.18E-09

1.39E-05

2.03E-04

3.63E-04

3.86E-03

4.38E-05

2.04E-09

1.52E-04

6.86E-05

3.63E-03

6.47E-04

7.50E-04

1.54E-07

7.79E-10

1.99E-05

7.1OE-05

1.44E-03

3.OOE-06

2.31 E-04

1.36E-07

5.46E-05

1.87E-05

1.23E-07

2.14E-06

2.29E-07

2.87E-06

3.21 E-05

BETA1

(MEV/DIS)

5.68E-03

4.95E-02

4.91 E-01

1.02E 00

2.50E-01

5.55E-01

6.95E-01

4.64E-01

3.86E-03

3.80E-03

8.29E-01

1.18E-01

3.41 E-02

9.68E-02

2.21 E-02

3.19E-01

1.28E 00

1.04E 00

2.53E-01

2.51 E-01

1.32E 00

3.61 E-01

1.36E 00

2.06E 00

1.01 E 00

5.83E-01

1.96E-01

6.50E-01

1.95E-01

9.20E-01

9.36E-01

2.73E-02

6.06E-01

1.44E 00

1.17E 00

1.16E-01

1.81E-01

4.44E-02

3.96E-01

1.56E-02

GAMMA1

(MEV/DIS)

0.0

0.0

1.02E 00

1.05E 00

1.02E 00

4.12E 00

0.0

1.28E 00

3.28E-02

8.36E-01

1.69E 00

1.19E 00

9.78E-01

2.50E 00

4.16E-01

0.0

1.77E 00

6.60E-02

1.59E-01

2.21 E-03

7.93E-01

1.96E 00

1.83E 00

6.26E-01

2.05E-00

8.45E-05

0.0

6.95E-01

1.34E 00

2.24E 00

0.0

5.30E-01

3.61 E-03

2.50E-01

8.94E-02

7.35E-01

6.06E-02

7.64E-01

1.50E-01

1.26E-01
Proc No ODCM

Attachment 2

Revision 25

Page 2 of 2

BASIC RADIONUCLIDE DATA

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

NUCLIDE

TC-99

TC-1 04

RU-106

TE-132

1-129

1-131

1-132

1-133

1-134

1-135

XE-131m

XE-133m

XE-133

XE-135m

XE-135

XE-137

XE-1 38

CS-1 34

CS-1 35

CS-1 36

CS-137

CS-138

BA-139

BA-140

LA-140

CE-144

PR-143

PR-144

HALF-LIFE

(days)

7.74E 07

1.25E-02

3.67E 02

3.24E 00

6.21E 09

8.05E 00

9.58E-02

8.75E-01

3.61E-02

2.79E-01

1.18E 01

2.26E 00

5.27E 00

1.08E-02

3.83E-01

2.71E 03

9.84E-03

7.48E 02

1.10E 09

1.30E 01

1.10E 04

2.24E-02

5.76E-02

1.28E 01

1.68E 00

2.84E 02

1.36E 01

1.20E-02

LAMBDA

(l/s)

1.04E-13

6.42E-04

2.19E-08

2.48E-06

1.29E-1 5

9.96E-07

8.37E-05

9.17E-06

2.22E-04

2.87E-05

6.80E-07

3.55E-06

1.52E-06

7.43E-04

2.09E-05

2.96E-03

8.15E-04

1.07E-08

7.29E-15

6.17E-07

7.29E-10

3.58E-04

1.39E-04

6.27E-07

4.77E-06

2.82E-08

5.90E-07

6.68E-04

BETA1

(MEV/DIS)

8.46E-02

1.60E 00

1.01 E-02

1.OOE-01

5.43E-02

1.94E-01

4.89E-01

4.08E-01

6.16E-01

3.68E-01

1.43E-01

1.90E-01

1.35E-01

9.58E-02

3.17E-01

1.77E 00

6.65E-01

1.63E-01

5.63E-02

1.37E-01

1.71 E-01

1.20E 00

8.96E-01

3.15E-01

5.33E-01

9.13E-02

3.14E-01

1.21 E 00

GAMMA1

(MEV/DIS)

0.0

1 .95E 00

0.0

2.33E-01

2.46E-02

3.81 E-01

2.24E 00

6.02E-01

2.59E 00

1.55E 00

2.01 E-02

4.15E-02

4.60E-02

4.32E-01

2.47E-01

1.88E-01

1.10E 00

1.55E 00

0.0

2.15E 00

5.97E-01

2.30E 00

3.53E-02

1.71 E-01

2.31E 00

1.93E-02

0.0

3.18E 00

1 Average energy per disintegration values were obtained from ICRP Publication No 38,

Radionuclide Transformations: Ener-gy and Intensity of Emissions 1983 and

NUREG/CR-1413 (ORNL/NUREG-70), a Radionuclide Decay Data Base - Index and

Summary Table, DC Kocher, May 1980.
Proc No ODCM

Attachment 3

Revision 25

Page 1 of I

DOSF FA(~TOR~ FflR ~IIRMFR~IflI4J IM MARl F ~A~F~*

DOSEFACTORSFOR SUBMERSIONIN NnRI F r.A-qF-qKr-85m

Kr-85

Kr-87

Kr-88

Kr-89

Xe-1 31 m

Xe-1 33m

Xe-1 33

Xe-135m

Xe-135

Xe-1 37

Xe-138

Ar-41

Gamma body

dose1

1.17E3

1.61 El

5.92E3

1.47E4

1.66E4

9.15E1

2.51E2

2.94E2

3.12E3

1.81E3

1.42E3

8.83E3

8.84E3

Gamma air

dose

2

1.23E3

1.72E1

6.17E3

1.52E4

1.73E4

1.56E2

3.27E2

3.53E2

3.36E3

1.92E3

1.51E3

9.21E3

9.30E3

Beta skin

dose1

1.46E3

1.34E3

9.73E3

2.37E3

1.01 E4

4.76E2

9.94E2

3.06E2

7.11E2

1.86E3

1.22E4

4.13E3

2.69E3

Beta air

dose

2

1.97E3

1.95E3

1.03E4

2.93E3

1.06E4

1.11E3

1.48E3

1.05E3

7.39E3

2.46E3

1.27E4

4.75E3

3.28E3

1. mrem/y per pCi/m 3

2. mrad/y per PCi/m 3

*Dose factors for exposure to a semi-infinite cloud of noble gases. Values were obtained from

USNRC Regulatory Guide 1.109, Revision 1 (October 1977).
Proc No ODCM

Aftachment 4

Revision 25

Page 1 of I

STABLE ELEMENT TRANSFER DATA

ELEMENT

H

C

Na

P

Cr

Mn

Fe

Co

Ni

Cu

Zn

Rb

Sr

Y

Zr

Nb

Mo

Tc

Ru

Rh

Ag

Te

I

Cs

Ba

La

Ce

Pr

Nd

W

Np

Fm - MILK (COW)

(DAYS/L)

1.OE-02

1.2E-02

4.OE-02

2.5E-02

2.2E-03

2.5E-04

1.2E-03

1.OE-03

6.7E-03

1.4E-02

3.9E-02

3.OE-02

8.OE-04

1.OE-05

5.OE-06

2.5E-03

7.5E-03

2.5E-02

1.OE-06

1.OE-02

5.OE-02

1.OE-03

6.OE-03

1.2E-02

4.OE-04

5.OE-06

1.OE-04

5.OE-06

5.OE-06

5.OE-04

5.OE-06

Fm - MILK (GOAT)

(DAYS/L)

1.7E-01

1.0E-01

4.0E-02

2.5E-01

2.2E-03

2.5E-04

1.3E-04

1.OE-03

6.7E-03

1.3E-02

3.9E-02

3.OE-02

1.4E-02

1.OE-05

5.OE-06

2.5E-03

7.5E-03

2.5E-02

1.OE-06

1.OE-02

5.OE-02

1.OE-03

6.OE-02

3.OE-01

4.OE-04

5.OE-06

1.OE-04

5.OE-06

5.OE-06

5.OE-04

5.OE-06

Ff - MEAT

(DAYS/KG)

1.2E-02

3.1 E-02

3.OE-02

4.6E-02

2.4E-03

8.OE-04

4.OE-02

1.3E-02

5.3E-02

8.OE-03

3.OE-02

3.1 E-02

6.OE-04

4.6E-03

3.4E-02

2.8E-01

8.OE-03

4.OE-01

4.OE-01

1.5E-03

1.7E-02

7.7E-02

2.9E-03

4.OE-03

3.2E-03

2.OE-04

1.2E-03

4.7E-03

3.3E-03

1.3E-03

2.OE-04

Biv

(VEG/SOIL)

4.8E-00

5.5E-00

5.2E-02

1.1E-00

2.5E-04

2.9E-02

6.6E-04

9.4E-03

1.9E-02

1.2E-01

4.OE-01

1.3E-01

1.7E-02

2.6E-03

1.7E-04

9.4E-03

1.2E-01

2.5E-01

5.OE-02

1.3E+01

1.5E-01

1.3E-00

2.OE-02

1.OE-02

5.OE-03

2.5E-03

2.5E-03

2.5E-03

2.4E-03

1.8E-02

2.5E-03
Proc No ODCM

Attachment 5

Revision 25

Page 1 of 16

INHALATION DOSE COMMITMENT FACTORS

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3* 0. 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07

BE10 9.49E-04 1.25E-04 2.65E-05 0. 0. 1.49E-03 1.73E-05

C14 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06

N13 4.39E-08 4.39E-08 4.39E-08 4.39E-08 4.39E-08 4.39E-08 4.39E-08

F18 3.92E-06 0. 3.33E-07 0. 0. 0. 6.10E-07

NA22 7.37E-05 7.37E-05 7.37E-05 7.37E-05 7.37E-05 7.37E-05 7.37E-05

NA24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06

P32 1.45E-03 8.03E-05 5.53E-05 0. 0. 0. 1.15E-05

AR39 0. 0. 0. 0. 0. 1.OOE-08 0.

AR41 0. 0. 0. 0. 0. 3.14E-08 0.

CA41 7.48E-05 0. 8.16E-06. 0. 0. 6.94E-02 2.96E-07

SC46 3.75E-04 5.41E-04 1.69E-04 0. 3.56E-04 0. 2.19E-05

CR51 0. 0. 6.39E-08 4.11E-08 9.45E-09 9.17E-06 2.55E-07

MN54 0. 1.81E-05 3.56E-06 0. 3.56E-06 7.14E-04 5.04E-06

MN56 0. 1.10E-09 1.58E-10 0. 7.86E-10 8.95E-06 5.12E-05

FE55 1.41 E-05 8.39E-06 2.38E-06 0. 0. 6.21E-05 7.82E-07

FE59 9.69E-06 1.68E-05 6.77E-06 0. 0. 7.25E-04 1.77E-05

C057 0. 4.65E-07 4.58E-07 0. 0. 2.71 E-04 3.47E-06

C058 0. 8.71 E-07 1.30E-06 0. 0. 5.55E-04 7.95E-06

C060 0. 5.73E-06 8.41 E-06 0. 0. 3.22E-03 2.28E-05

N159 1.81E-05 5.44E-06 3.1OE-06 0. 0. 5.48E-05 6.34E-07

N163 2.42E-04 1.46E-05 8.29E-06 0. 0. 1.49E-04 1.73E-06

N165 1.71 E-09 2.03E-10 8.79E-11 0. 0. 5.80E-06 3.58E-05

CU64 0. 1.34E-09 5.53E-10 0. 2.84E-09 6.64E-06 1.07E-05

ZN65 1.38E-05 4.47E-05 2.22E-05 0. 2.32E-05 4.62E-04 3.67E-05

ZN69M 8.98E-09 1.84E-08 1.67E-09 0. 7.45E-09 1.91 E-05 2.92E-05

ZN69 3.85E-11 6.91E-11 5.13E-12 0. 2.87E-11 1.05E-06 9.44E-06

SE79 0. 2.25E-06 4.20E-07 0. 2.47E-06 2.99E-04 3.46E-06

BR82 0. 0. 9.49E-06 0. 0. 0. 0.

BR83 0. 0. 2.72E-07 0. 0. 0. 0.

BR84 0. 0. 2.86E-07 0. 0. 0. 0.

BR85 0. 0. 1.46E-08 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 2.50E-09 0.

KR85M 0. 0. 0. 0. 0. 1.31E-08 0.

KR85 0. 0. 0. 0. 0. 1.16E-08 0.

KR87 0. 0. 0. 0. 0. 6.59E-08 0.

KR88 0. 0. 0. 0. 0. 1.38E-07 0.

KR89 0. 0. 0. 0. 0. 8.67E-08 0.

RB86 0. 1.36E-04 6.30E-05 0. 0. 0. 2.17E-06

RB87 0. 7.11E-05 2.64E-05 0. 0. 0. 2.99E-07

RB88 0. 3.98E-07 2.05E-07 0. 0. 0. 2.42E-07

RB89 0. 2.29E-07 1.47E-07 0. 0. 0. 4.87E-08

SR89 2.84E-04 0. 8.15E-06 0. 0. 1.45E-03 4.57E-05

SR90 2.92E-02 0. 1.85E-03 0. 0. 8.03E-03 9.36E-05

SR91 6.83E-08 0. 2.47E-09 0. 0. 3.76E-05 5.24E-05

SR92 7.50E-09 0. 2.79E-10 0. 0. 1.70E-05 1.OOE-04

*Includes a 50% increase to account for percutaneous transpiration.
Proc No ODCM

Attachment 5

Revision 25

Page 2 of 16

INHALATION DOSE COMMITMENT FACTORS

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 2.35E-06 0. 6.30E-08 0. 0. 1.92E-04 7.43E-05

Y91M 2.91 E-10 0. 9.90E-12 0. 0. 1.99E-06 1.68E-06

Y91 4.20E-04 0. 1. 12E-05 0. 0. 1.75E-03 5.02E-05

Y92 1.17E-08 0. 3.29E-10 0. 0. 1.75E-05 9.04E-05

Y93 1.07E-07 0. 2.91E-09 0. 0. 5.46E-05 1.19E-04

ZR93 2.24E-04 9.51E-05 6.18E-05 0. 3.19E-04 1.37E-03 1.48E-05

ZR95 8.24E-05 1.99E-05 1.45E-05 0. 2.22E-05 1.25E-03 1.55E-05

ZR97 1.07E-07 1.83E-08 8.36E-09 0. 1.85E-08 7.88E-05 1.OOE-04

NB93M 1.38E-04 3.59E-05 1.15E-05 0. 3.68E-05 2.09E-04 2.47E-06

NB95 1.12E-05 4.59E-06 2.70E-06 0. 3.37E-06 3.42E-04 9.05E-06

NB97 2.44E-10 5.21E-11 1.88E-11 0. 4.07E-11 2.37E-06 1.92E-05

M093 0. 6.46E-06 2.22E-07 0. 1.54E-06 3.40E-04 3.76E-06

M099 0. 1.18E-07 2.31E-08 0. 1.89E-07 9.63E-05 3.48E-05

TC99M 9.98E-13 2.06E-12 2.66E- 11 0. 2.22E-11 5.79E-07 1.45E-06

TC99 2.09E-07 2.68E-07 8.85E-08 0. 2.49E-06 6.77E-04 7.82E-06

TC101 4.65E-14 5.88E-14 5.80E-13 0. 6.99E-13 4.17E-07 6.03E-07

RU103 1.44E-06 0. 4.85E-07 0. 3.03E-06 3.94E-04 1.15E-05

RU105 8.74E-10 0. 2.93E-10 0. 6.42E-10 1.12E-05 3.46E-05

RU106 6.20E-05 0. 7.77E-06 0. 7.61 E-05 8.26E-03 1.17E-04

RH105 8.26E-09 5.41E-09 3.63E-09 0. 1.50E-08 2.08E-05 1.37E-05

PD107 0. 4.92E-07 4.11E-08 0. 2.75E-06 6.34E-05 7.33E-07

PD109 0. 3.92E-09 1.05E-09 0. 1.28E-08 1.68E-05 2.85E-05

AG110M 7.13E-06 5.16E-06 3.57E-06 0. 7.80E-06 2.62E-03 2.36E-05

AG111 3.75E-07 1.45E-07 7.75E-08 0. 3.05E-07 2.06E-04 3.02E-05

CD1 13M 0. 6.67E-04 2.64E-05 0. 5.80E-04 1.40E-03 1.65E-05

CD115M 0. 1.73E-04 6.19E-06 0. 9.41 E-05 1.47E-03 5.02E-05

SN123 2.09E-04 4.21E-06 7.28E-06 4.27E-06 0. 2.22E-03 4.08E-05

SN125 1.01E-05 2.51E-07 6.OOE-07 2.47E-07 0. 6.43E-04 7.26E-05

SN126 8.30E-04 1.44E-05 3.52E-05 3.84E-06 0. 4.93E-03 1.65E-05

SB124 2.71 E-05 3.97E-07 8.56E-06 7.18E-08 0. 1.89E-03 4.22E-05

SB125 3.69E-05 3.41E-07 7.78E-06 4.45E-08 0. 1.17E-03 1.05E-05

SB126 3.08E-06 6. 01E-08 1. 11E-06 2.35E-08 0. 6.88E-04 5.33E-05

SB127 2.82E-07 5.04E-09 8.76E-08 3.60E-09 0. 1.54E-04 3.78E-05

TE125M 3.40E-06 1.42E-06 4.70E-07 1.16E-06 0. 3.19E-04 9.22E-06

TE127M 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05

TE127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05

TE129M 1.01E-05 4.35E-06 1.59E-06 3.91 E-06 2.27E-05 1.20E-03 4.93E-05

TE129 5.63E- 11 2.48E-11 1.34E-11 4.82E- 11 1.25E-10 2.14E-06 1.88E-05

TE131M 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51E-05

TE131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06

TE132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.15E-05

TE133M 6.13E-11 3.59E-11 2.74E-11 5.52E-11 1.72E-10 3.92E-06 1.59E-05

TE1 34 3.18E-11 2.04E-11 1.68E-11 2.91E-11 9.59E-11 2.93E-06 2.53E-06

1129 2.16E-05 1.59E-05 1.16E-05 1.04E-02 1.88E-05 0. 2.12E-07

1130 4.54E-06 9.91E-06 3.98E-06 1.14E-03 1.09E-05 0. 1.42E-06

1131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 0. 7.56E-07
Proc No ODCM

Attachment 5

Revision 25

Page 3 of 16

INHALATION DOSE COMMITMENT FACTORS

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/5OY PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 1.21E-06 2.53E-06 8.99E-07 1.21 E-04 2.82E-06 0. 1.36E-06

1133 9.46E-06 1.37E-05 4.OOE-06 2.54E-03 1.60E-05 0. 1.54E-06

1134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 0. 9.21E-07

1135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 0. 1.31E-06

XE131M 0. 0. 0. 0. 0. 6.77E-09 0.

XE133M 0. 0. 0. 0. 0. 8.89E-09 0.

XE133 0. 0. 0. 0. 0. 7.41E-09 0.

XE135M 0. 0. 0. 0. 0. 8.05E-09 0.

XE135 0. 0. 0. 0. 0. 1.80E-08 0.

XE137 0. 0. 0. 0. 0. 8.30E-08 0.

XE138 0. 0. 0. 0. 0. 9.78E-08 0.

CS134M 1.32E-07 2.1OE-07 1.11E-07 0. 8.50E-08 2.OOE-08 1.16E-07

CS134 2.83E-04 5.02E-04 5.32E-05 0. 1.36E-04 5.69E-05 9.53E-07

CS135 1.OOE-04 8.66E-05 4.73E-06 0. 2.58E-05 1.01E-05 2.18E-07

CS136 3.45E-05 9.61E-05 3.78E-05 0. 4.03E-05 8.40E-06 1.02E-06

CS137 3.92E-04 4.37E-04 3.25E-05 0. 1.23E-04 5.09E-05 9.53E-07

CS138 3.61E-07 5.58E-07 2.84E-07 0. 2.93E-07 4.67E-08 6.26E-07

CS139 2.32E-07 3.03E-07 1.22E-07 0. 1.65E-07 2.53E-08 1.33E-08

BA139 1.06E-09 7.03E-13 3.07E-11 0. 4.23E-13 4.25E-06 3.64E-05

BA140 4.OOE-05 4.OOE-08 2.07E-06 0. 9.59E-09 1.14E-03 2.74E-05

BA141 1.12E-10 7.70E-14 3.55E-12 0. 4.64E-14 2.12E-06 3.39E-06

BA142 2.84E-11 2.36E-14 1.40E-12 0. 1.36E-14 1.11E-06 4.95E-07

LA140 3.61 E-07 1.43E-07 3.68E-08 0. 0. 1.20E-04 6.06E-05

LA141 4.85E-09 1.40E-09 2.45E-10 0. 0. 1.22E-05 5.96E-05

LA142 7.36E-10 2.69E-10 6.46E-11 0. 0. 5.87E-06 4.25E-05

CE141 1.98E-05 1.19E-05 1.42E-06 0. 3.75E-06 3.69E-04 1.54E-05

CE143 2.09E-07 1.38E-07 1.58E-08 0. 4.03E-08 8.30E-05 3.55E-05

CE144 2.28E-03 8.65E-04 1.26E-04 0. 3.84E-04 7.03E-03 1.06E-04

PR143 1.O0E-05 3.74E-06 4.99E-07 0. 1.41 E-06 3.09E-04 2.66E-05

PR144 3.42E-11 1.32E-11 1.72E-12 0. 4.80E-12 1.15E-06 3.06E-06

ND147 5.67E-06 5.81 E-06 3.57E-07 0. 2.25E-06 2.30E-04 2.23E-05

PM147 3.91 E-04 3.07E-05 1.56E-05 0. 4.93E-05 4.55E-04 5.75E-06

PM148M 5.OOE-05 1.24E-05 9.94E-06 0. 1.45E-05 1.22E-03 3.37E-05

PM148 3.34E-06 4.82E-07 2.44E-07 0. 5.76E-07 3.20E-04 6.04E-05

PM149 3.1OE-07 4.08E-08 1.78E-08 0. 4.96E-08 6.50E-05 3.01E-05

PM151 7.52E-08 1.1OE-08 5.55E-09 0. 1.30E-08 3.25E-05 2.58E-05

SM151 3.38E-04 6.45E-05 1.63E-05 0. 5.24E-05 2.98E-04 3.46E-06

SM153 1.53E-07 1. 18E-07 9.06E-09 0. 2.47E-08 3.70E-05 1.93E-05

EU152 7.83E-04 1.77E-04 1.72E-04 0. 5.94E-04 1.48E-03 9.88E-06

EU154 2.96E-03 3.46E-04 2.45E-04 0. 1.14E-03 3.05E-03 2.84E-05

EU155 5.97E-04 5.72E-05 3.46E-05 0. 1.58E-04 5.20E-04 5.19E-05

EU156 1.56E-05 9.59E-06 1.54E-06 0. 4.48E-06 6.12E-04 4.14E-05

TB160 1.12E-04 0. 1.40E-05 0. 3.20E-05 1.11E-03 2.14E-05

H0166M 1.45E-03 3.07E-04 2.51E-04 0. 4.22E-04 2.05E-03 1.65E-05

W181 4.86E-08 1.46E-08 1.67E-09 0. 0. 1.33E-05 2.63E-07

W185 1.57E-06 4.83E-07 5.58E-08 0. 0. 4.48E-04 1.12E-05

W187 9.26E-09 6.44E-09 2.23E-09 0. 0. 2.83E-05 2.54E-05
Proc No ODCM

Attachment 5

Revision 25

Page 4 of 16

INHALATION DOSE COMMITMENT FACTORS

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 8.62E-02 2.02E-02 3.43E-03 0. 6.85E-02 1.76E-01 3.79E-05

B1210 0. 1.33E-05 1.18E-06 0. 1.03E-04 9.96E-03 3.27E-05

P0210 2.98E-03 5.63E-03 7.12E-04 0. 1.30E-02 2.40E-01 4.36E-05

RN222 0. 0. 0. 0. 0. 9.88E-06 0.

RA223 1.56E-03 2.26E-06 3.12E-04 0. 4.16E-05 2.25E-01 3.04E-04

RA224 1.77E-04 4.00E-07 3.54E-05 0. 7.30E-06 7.91E-02 3.42E-04

RA225 2.57E-03 2.88E-06 5.13E-04 0. 5.31E-05 2.57E-01 2.87E-04

RA226 2.48E-01 1.46E-05 2.05E-01 0. 2.94E-04 7.83E-01 3.05E-04

RA228 1.60E-01 7.61E-06 1.80E-01 0. 1.53E-04 1.09E-00 5.19E-05

AC225 3.69E-03 4.72E-03 2.48E-04 0. 3.49E-04 1.96E-01 2.71 E-04

AC227 5.29E+00 8.76E-01 3.28E-01 0. 1.86E-01 1.62E+00 5.27E-05

TH227 1.82E-03 3.03E-05 5.24E-05 0. 1.13E-04 3.27E-01 3.53E-04

TH228 8.46E-01 1.10E-02 2.86E-02 0. 5.61E-02 4.65E+00 3.62E-04

TH229 1.34E+01 1.82E-01 6.62E-01 0. 8.99E-01 1.22E+01 3.29E-04

TH230 3.46E+00 1.79E-01 9.65E-02 0. 8.82E-01 2.18E+00 3.87E-05

TH232 3.86E+00 1.53E-01 2.29E-01 0. 7.54E-01 2.09E+00 3.29E-05

TH234 1.33E-05 7.17E-07 3.84E-07 0. 2.70E-06 1.62E-03 7.40E-05

PA231 9.1OE+00 3.OOE-01 3.62E-01 0. 1.62E+00 3.85E-01 4.61E-05

PA233 6.84E-06 1.32E-06 1.19E-06 0. 3.68E-06 2.19E-04 9.04E-06

U232 2.57E-01 0. 2.13E-02 0. 2.40E-02 1.49E+00 4.36E-05

U233 5.44E-02 0. 3.83E-03 0. 1.09E-02 3.56E-01 4.03E-05

U234 5.22E-02 0. 3.75E-03 0. 1.07E-02 3.49E-01 3.95E-05

U235 5.01 E-02 0. 3 52E-03 0. 1.01 E-02 3.28E-01 5.02E-05

U236 5.01E-02 0. 3.60E-03 0. 1.03E-02 3.35E-01 3.71E-05

U237 3.25E-07 0. 8.65E-08 0. 8.08E-07 9.13E-05 1.31 E-05

U238 4.79E-02 0. 3.29E-03 0. 9.40E-03 3.06E-01 3.54E-05

NP237 3.03E+00 2.32E-01 1.26E-01 0. 7.69E-01 3.49E-01 5.1OE-05

NP238 2.67E-06 6.73E-08 4.16E-08 0. 1.47E-07 9.19E-05 2.58E-05

NP239 2.65E-07 2.37E-08 1.34E-08 0. 4.73E-08 4.25E-05 1.78E-05

PU238 5.02E+00 6.33E-01 1.27E-01 0. 4.64E-01 9.03E-01 4.69E-05

PU239 5.50E+00 6.72E-01 1.34E-01 0. 4.95E-01 8.47E-01 4.28E-05

PU240 6.49E+00 6.71E-01 1.34E-01 0. 4.94E-01 8.47E-01 4.36E-05

PU241 1.55E-01 6.69E-03 3.11E-03 0. 1.15E-02 7.62E-04 8.97E-07

PU242 5.09E+00 6.47E-01 1.29E-01 0. 4.77E-01 8.15E-01 4.20E-05

PU244 5.95E+00 7.40E-01 1.48E-01 0. 5.46E-01 9.33E-01 6.26E-05

AM241 1.84E+00 8.44E-01 1.31E-01 0. 7.94E-01 4.06E-01 4.78E-05

AM242M 1.90E+00 8.24E-01 1.35E-01 0. 8.03E-01 1.64E-01 6.01 E-05

AM243 1.82E+00 8.10E-01 1.27E-01 0. 7.72E-01 3.85E-01 5.60E-05

CM242 8.58E-02 7.44E-02 5.70E-03 0. 1.69E-02 2.97E-01 5.1OE-05

CM243 1.73E+00 7.94E-01 1.06E-01 0. 3.91 E-01 4.24E-01 5.02E-05

CM244 1.43E+00 7.04E-01 8.89E-02 0. 3.21E-01 4.08E-01 4.86E-05

CM245 2.26E+00 8.80E-01 1.36E-01 0. 5.23E-01 3.92E-01 4.53E-05

CM246 2.24E+00 8.79E-01 1.36E-01 0. 5.23E-01 3.99E-01 4.45E-05

CM247 2.18E+00 8.64E-01 1.33E-01 0. 5.15E-01 3.92E-01 5.85E-05

CM248 1.82E+01 7.12E+00 1.10E+00 0. 4.24E+00 3.23E+00 9.43E-04

CF252 4.26E+00 0. 1.01E-01 0. 0. 1.37E+00 1.85E-04
Proc No ODCM

Attachment 5

Revision 25

Page 5 of 16

INHALATION DOSE COMMITMENT FACTORS

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3* 0. 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07

BE10 8.43E-04 9.83E-05 2.12E-05 0. 0. 7.41E-04 1.72E-05

C14 9.70E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06

N13 2.33E-08 2.33E-08 2.33E-08 2.33E-08 2.33E-08 2.33E-08 2.33E-08

F18 1.88E-06 0. 1.85E-07 0. 0. 0. 3.37E-07

NA22 4.41E-05 4.41E-05 4.41E-05 4.41E-05 4.41E-05 4.41E-05 4.41E-05

NA24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06

P32 7.04E-04 3.09E-05 2.67E-05 0. 0. 0. 1.14E-05

AR39 0. 0. 0, 0. 0. 4,89E-09 0.

AR41 0. 0. 0. 0. 0. 1.68E-08 0.

CA41 7.06E-05 0. 7.70E-06 0. 0. 7.21 E-02 2.94E-07

SC46 1.97E-04 2.70E-04 1.04E-04 0. 2.39E-04 0. 2.45E-05

CR51 0. 0. 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07

MN54 0. 1.16E-05 2.57E-06 0. 2.71E-06 4.26E-04 6.19E-06

MN56 0. 4.48E-10 8.43E-11 0. 4.52E-10 3.55E-06 3.33E-05

FE55 1.28E-05 6.80E-06 2.1OE-06 0. 0. 3.OOE-05 7.75E-07

FE59 5.59E-06 9.04E-06 4.51 E-06 0. 0. 3.43E-04 1.91 E-05

C057 0. 2.44E-07 2.88E-07 0. 0. 1.37E-04 3.58E-06

C058 0. 4.79E-07 8.55E-07 0. 0. 2.99E-04 9.29E-06

C060 0. 3.55E-06 6.12E-06 0. 0. 1.91E-03 2.60E-05

N159 1.66E-05 4.67E-06 2.83E-06 0. 0. 2.73E-05 6.29E-07

N163 2.22E-04 1.25E-05 7.56E-06 0. 0. 7.43E-05 1.71E-06

NI65 8.08E-10 7.99E-11 4.44E-11 0. 0. 2.21E-06 2.27E-05

CU64 0. 5.39E-10 2.90E-10 0. 1.63E-09 2.59E-06 9.92E-06

ZN65 1.15E-05 3.06E-05 1.90E-05 0. 1.93E-05 2.69E-04 4.41E-06

ZN69M 4.26E-09 7.28E-09 8.59E-10 0. 4.22E-09 7.36E-06 2.71 E-05

ZN69 1.81E-11 2.61E-11 2.41E-12 0. 1.58E-11 3.84E-07 2.75E-06

SE79 0. 1.23E-06 2.60E-07 0. 1.71 E-06 1.49E-04 3.43E-06

BR82 0. 0. 5.66E-06 0. 0. 0. 0.

BR83 0. 0. 1.28E-07 0. 0. 0. 0.

BR84 0. 0. 1.48E-07 0. 0. 0. 0.

BR85 0. 0. 6.84E-09 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 1.22E-09 0.

KR85M 0. 0. 0. 0. 0. 6.58E-09 0.

KR85 0. 0. 0. 0. 0. 5.66E-09 0.

KR87 0. 0. 0. 0. 0. 3.38E-08 0.

KR88 0. 0. 0. 0. 0. 6.99E-08 0.

KR89 0. 0. 0.- 0. 0. 4.55E-08 0.

RB86 0. 5.36E-05 3.09E-05 0. 0. 0. 2.16E-06

RB87 0. 3.16E-05 1.37E-05 0. 0. 0. 2.96E-07

RB88 0. 1.52E-07 9.90E-08 0. 0. 0. 4.66E-09

RB89 0. 9.33E-08 7.83E-08 0. 0. 0. 5.11E-10

SR89 1.62E-04 0. 4.66E-06 0. 0. 5.83E-04 4.52E-05

SR90 2.73E-02 0. 1.74E-03 0. 0. 3.99E-03 9.28E-05

SR91 3.28E-08 0. 1.24E-09 0. 0. 1.44E-05 4.70E-05

SR92 3.54E-09 0. 1.42E-10 0. 0. 6.49E-06 6.55E-05

*Includes a 50% increase to account for percutaneous transpiration.
Proc No ODCM

Attachment 5

Revision 25

Page 6 of 16

INHALATION DOSE COMMITMENT FACTORS

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 1.11E-06 0. 2.99E-08 0. 0. 7.07E-05 7.24E-05

Y91M 1.37E-10 0. 4.98E-12 0. 0. 7.60E-07 4.64E-07

Y91 2.47E-04 0. 6.59E-06 0. 0. 7.1OE-04 4.97E-05

Y92 5.50E-09 0. 1.57E-10 0. 0. 6.46E-06 6.46E-05

Y93 5.04E-08 0. 1.38E-09 0. 0. 2.01E-05 1.05E-04

ZR93 2.07E-04 7.80E-05 5.55E-05 0. 3.OOE-04 7.10E-04 1.47E-05

ZR95 5.13E-05 1.13E-05 1.O0E-05 0. 1.61E-05 6.03E-04 1.65E-05

ZR97 5.07E-08 7.34E-09 4.32E-09 0. 1.05E-08 3.06E-05 9.49E-05

NB93M 1.27E-04 3.17E-05 1.04E-05 0. 3.44E-05 1.04E-04 2.45E-06

NB95 6.35E-06 2.48E-06 1.77E-06 0. 2.33E-06 1.66E-04 1.OOE-05

NB97 1.16E-10 2.08E-11 9.74E-12 0. 2.31E-11 9.23E-07 7.52E-06

M093 0. 3.76E-06 1.35E-07 0. 1.06E-06 1.70E-04 3.78E-06

M099 0. 4.66E-08 1.15E-08 0. 1.06E-07 3.66E-05 3.42E-05

TC99M 4.81E-13 9.41E-13 1.56E-11 0. 1.37E-11 2.57E-07 1.30E-06

TC99 1.34E-07 1.49E-07 5.35E-08 0. 1.75E-06 3.37E-04 7.75E-06

TC101 2.19E-14 2.30E-14 2.91E-13 0. 3.92E-13 1.58E-07 4.41E-09

RU103 7.55E-07 0. 2.90E-07 0. 1.90E-06 1.79E-04 1.21E-05

RU105 4.13E-10 0. 1.50E-10 0. 3.63E-10 4.30E-06 2.69E-05

RU106 3.68E-05 0. 4.57E-06 0. 4.97E-05 3.87E-03 1.16E-04

RH105 3.91 E-09 2.1OE-09 1.79E-09 0. 8.39E-09 7.82E-06 1.33E-05

PD107 0. 2.65E-07 2.51E-08 0. 1.97E-06 3.16E-05 7.26E-07

PD109 0. 1.48E-09 4.95E-10 0. 7.06E-09 6.16E-06 2.59E-05

AG110M 4.56E-06 3.08E-06 2.47E-06 0. 5.74E-06 1.48E-03 2.71E-05

AG111 1.81E-07 5.68E-08 3.75E-08 0. 1.71E-07 7.73E-05 2.98E-05

CD113M 0. 4.93E-04 2.12E-05 0. 5.13E-04 6.94E-04 1.63E-05

CD115M 0. 7.88E-05 3.39E-06 0. 5.93E-05 5.86E-04 4.97E-05

SN123 1.29E-04 2.14E-06 4.19E-06 2.27E-06 0. 9.59E-04 4.05E-05

SN125 4.95E-06 9.94E-08 2.95E-07 1.03E-07 0. 2.43E-04 7.17E-05

SN126 6.23E-04 1.04E-05 2.36E-05 2.84E-06 0. 3.02E-03 1.63E-05

SB124 1.55E-05 2.00E-07 5.41E-06 3.41 E-08 0. 8.76E-04 4.43E-05

SB125 2.66E-05 2.05E-07 5.59E-06 2.46E-08 0. 6.27E-04 1.09E-05

SB126 1.72E-06 2.62E-08 6.16E-07 1.OOE-08 0. 2.86E-04 5.67E-05

SB127 1.36E-07 2.09E-09 4.70E-08 1.51E-09 0. 6.17E-05 3.82E-05

TE125M 1.82E-06 6.29E-07 2.47E-07 5.20E-07 0. 1.29E-04 9.13E-06

TE127M 6.72E-06 2.31E-06 8.16E-07 1.64E-06 1.72E-05 4.00E-04 1.93E-05

TE127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.91E-09 2.71E-06 1.52E-05

TE129M 5.19E-06 1.85E-06 8.22E-07 1.71E-06 1.36E-05 4.76E-04 4.91E-05

TE129 2.64E-11 9.45E-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.89E-06

TE131M 3.63E-08 1.60E-08 1.37E-08 2.64E-08 1.08E-07 5.56E-05 8.32E-05

TE131 5.87E-12 2.28E-12 1.78E-12 4.59E-12 1.59E-11 5.55E-07 3.60E-07

TE132 1.30E-07 7.36E-08 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05

TE133M 2.93E-11 1.51E-11 1.50E-11 2.32E-11 1.01E-10 1.60E-06 4.77E-06

TE134 1.53E-11 8.81E-12 9.40E-12 1.24E-11 5.71E-11 1.23E-06 4.87E-07

1129 1.05E-05 6.40E-06 5.71E-06 4.28E-03 1.08E-05 0. 2.15E-07

1130 2.21E-06 4.43E-06 2.28E-06 4.99E-04 6.61E-06 0. 1.38E-06

1131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 0. 7.68E-07
Proc No ODCM

Attachment 5

Revision 25

Page 7 of 16

INHALATION DOSE COMMITMENT FACTORS

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 5.72E-07 1.10E-06 5.07E-07 5.23E-05 1.69E-06 0. 8.65E-07

1133 4.48E-06 5.49E-06 2.08E-06 1.04E-03 9.13E-06 0. 1.48E-06

1134 3.17E-07 5.84E-07 2.69E-07 1.37E-05 8.92E-07 0. 2.58E-07

1135 1.33E-06 2.36E-06 1. 12E-06 2.14E-04 3.62E-06 0. 1.20E-06

XE131M 0. 0. 0. 0. 0. 3.30E-09 0.

XE133M 0. 0. 0. 0. 0. 4.36E-09 0.

XE133 0. 0. 0. 0. 0. 3.66E-09 0.

XE135M 0. 0. 0. 0. 0. 4.48E-09 0.

XE135 0. 0. 0. 0. 0. 9.09E-09 0.

XE137 0. 0. 0. 0. 0. 4.07E-08 0.

XE138 0. 0. 0. 0. 0. 5.17E-08 0.

CS134M 6.33E-08 8.92E-08 6.12E-08 0. 4.94E-08 8.35E-09 7.92E-08

CS134 1.76E-04 2.74E-04 6.07E-05 0. 8.93E-05 3.27E-05 1.04E-06

CS135 6.23E-05 4.13E-05 4.45E-06 0. 1.53E-05 5.22E-06 2.17E-07

CS136 1.76E-05 4.62E-05 3.14E-05 0. 2.58E-05 3.93E-06 1.13E-06

CS137 2.45E-04 2.23E-04 3.47E-05 0. 7.63E-05 2.81 E-05 9.78E-07

CS138 1.71E-07 2.27E-07 1.50E-07 0. 1.68E-07 1.84E-08 7.29E-08

CS139 1.09E-07 1.15E-07 5.80E-08 0. 9.08E-08 9.36E-09 7.23E-12

BA139 4.98E-10 2.66E-13 1.45E-11 0. 2.33E-13 1.56E-06 1.56E-05

BA140 2.OOE-05 1.75E-08 1.17E-06 0. 5.71E-09 4.71E-04 2.75E-05

BA141 5.29E-11 2.95E-14 1.72E-12 0. 2.56E-14 7.89E-07 7.44E-08

BA142 1.35E-11 9.73E-15 7.54E-13 0. 7.87E-15 4.44E-07 7.41E-10

LA140 1.74E-07 6.08E-08 2.04E-08 0. 0. 4.94E-05 6.1OE-05

LA141 2.28E-09 5.31E-10 1.15E-10 0. 0. 4.48E-06 4.37E-05

LA142 3.50E-10 1.11E-10 3.49E-11 0. 0. 2.35E-06 2.05E-05

CE141 1.06E-05 5.28E-06 7.83E-07 0. 2.31E-06 1.47E-04 1.53E-05

CE143 9.89E-08 5.37E-08 7.77E-09 0. 2.26E-08 3.12E-05 3.44E-05

CE144 1.83E-03 5.72E-04 9.77E-05 0. 3.17E-04 3.23E-03 1.05E-04

PR143 4.99E-06 1.50E-06 2.47E-07 0. 8.11E-07 1.17E-04 2.63E-05

PR144 1.61E-11 4.99E-12 8.10E-13 0. 2.64E-12 4.23E-07 5.32E-08

ND147 2.92E-06 2.36E-06 1.84E-07 0. 1.30E-06 8.87E-05 2.22E-05

PM147 3.52E-04 2.52E-05 1.36E-05 0. 4.45E-05 2.20E-04 5.70E-06

PM148M 3.31 E-05 6.55E-06 6.55E-06 0. 9.74E-06 5.72E-04 3.58E-05

PM148 1.61 E-06 1.94E-07 1.25E-07 0. 3.30E-07 1.24E-04 6.01E-05

PM149 1.47E-07 1.56E-08 8.45E-09 0. 2.75E-08 2.40E-05 2.92E-05

PM151 3.57E-08 4.33E-09 2.82E-09 0. 7.35E-09 1.24E-05 2.50E-05

SM151 3.14E-04 4.75E-05 1.49E-05 0. 4.89E-05 1.48E-04 3.43E-06

SM153 7.24E-08 4.51E-08 4.35E-09 0. 1.37E-08 1.37E-05 1.87E-05

EU152 7.42E-04 1.37E-04 1.61E-04 0. 5.73E-04 9.OOE-04 1.14E-05

EU154 2.74E-03 2.49E-04 2.27E-04 0. 1.09E-03 1.66E-03 2.98E-05

EU155 5.60E-04 4.05E-05 3.18E-05 0. 1.51E-04 2.79E-04 5.39E-05

EU156 7.89E-06 4.23E-06 8.75E-07 0. 2.72E-06 2.54E-04 4.24E-05

TB160 7.79E-05 0. 9.67E-06 0. 2.32E-05 5.34E-04 2.28E-05

H0166M 1.34E-03 2.81E-04 2.37E-04 0. 4.01E-04 1.13E-03 1.63E-05

W181 2.66E-08 6.52E-09 8.99E-10 0. 0. 5.71E-06 2.61E-07

W185 8.31E-07 2.08E-07 2.91E-08 0. 0. 1.86E-04 1.11E-05

W187 4.41E-09 2.61E-09 1.17E-09 0. 0. 1.11E-05 2.46E-05
Proc No ODCM

Attachment 5

Revision 25

Page 8 of 16

INHALATION DOSE COMMITMENT FACTORS

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 8.03E-02 1.85E-02 3.18E-03 0. 6.31E-02 8.74E-02 3.75E-05

B1210 0. 5.11E-06 5.65E-07 0. 5.76E-05 3.70E-03 3.21E-05

P0210 1.70E-03 2.76E-03 4.09E-04 0. 8.85E-03 1.05E-01 4.32E-05

RN222 0. 0. 0. 0. 0. 4.82E-06 0.

RA223 7.69E-04 8.89E-07 1.54E-04 0. 2.36E-05 8.48E-02 3.OOE-04

RA224 8.44E-05 1.53E-07 1.69E-05 0. 4.06E-06 2.92E-02 3.34E-04

RA225 1.28E-03 1.14E-06 2.56E-04 0. 3.02E-05 9.74E-02 2.84E-04

RA226 2.34E-01 7.66E-06 1.92E-01 0. 2.03E-04 3.90E-01 3.02E-04

RA228 1.49E-01 3.94E-06 1.68E-01 0. 1.04E-04 5.37E-01 5.14E-05

AC225 1.81E-03 1.87E-03 1.21E-04 0. 1.99E-04 7.37E-02 2.67E-04

AC227 4.96E+00 8.05E-01 3.07E-01 0. 1.77E-01 8.04E-01 5.22E-05

TH227 9.24E-04 1.26E-05 2.67E-05 0. 6.67E-05 1.26E-01 3.49E-04

TH228 8.06E-01 1.04E-02 2.72E-02 0. 5.41E-02 3.34E+00 3.59E-04

TH229 1.28E+01 1.76E-01 6.31E-01 0. 8.68E-01 1.04E+01 3.27E-04

TH230 3.30E+00 1.73E-01 9.20E-02 0. 8.52E-01 1.85E+00 3.84E-05

TH232 3.68E+00 1.47E-01 1.28E-01 0. 7.28E-01 1.77E+00 3.27E-05

TH234 6.94E-06 3.07E-07 2.OOE-07 0. 1.62E-06 6.31 E-04 7.32E-05

PA231 8.62E+00 2.86E-01 3.43E-01 0. 1.56E+00 1.92E-01 4.57E-05

PA233 4.14E-06 6.48E-07 7.25E-07 0. 2.38E-06 9.77E-05 8.95E-06

U232 2.19E-01 0. 1.56E-02 0. 1.67E-02 7.42E-01 4.33E-05

U233 4.64E-02 0. 2.82E-03 0. 7.62E-03 1.77E-01 4.OOE-05

U234 4.46E-02 0. 2.76E-03 0. 7.47E-03 1.74E-01 3.92E-05

U235 4.27E-02 0. 2.59E-03 0. 7.01 E-03 1.63E-01 4.98E-05

U236 4.27E-02 0. 2.65E-03 0. 7.16E-03 1.67E-01 3.67E-05

U237 1.57E-07 0. 4.17E-08 0. 4.53E-07 3.40E-05 1.29E-05

U238 4.09E-02 0. 2.42E-03 0. 6.55E-03 1.53E-01 3.51 E-05

NP237 2.88E+00 2.21E-01 1.19E-01 0. 7.41E-01 1.74E-01 5.06E-05

NP238 1.26E-06 2.56E-08 1.97E-08 0. 8.16E-08 3.39E-05 2.50E-05

NP239 1.26E-07 9.04E-09 6.35E-09 0. 2.63E-08 1.57E-05 1.73E-05

PU238 4.77E+00 6.05E-01 1.21E-01 0. 4.47E-01 6.08E-01 4.65E-05

PU239 5.24E+00 6.44E-01 1.28E-01 0. 4.78E-01 5.72E-01 4.24E-05

PU240 5.23E+00 6.43E-01 1.27E-01 0. 4.77E-01 5.71 E-01 4.33E-05

PU241 1.46E-01 6.33E-03 2.93E-03 0. 1.1OE-02 5.06E-04 8.90E-07

PU242 4.85E+00 6.20E-01 1.23E-01 0. 4.60E-01 5.50E-01 4.16E-05

PU244 5.67E+00 7.1 E-01 1.41E-01 0. 5.27E-01 6.30E-01 6.20E-05

AM241 1.74E+00 7.85E-01 1.24E-01 0. 7.63E-01 2.02E-01 4.73E-05

AM242M 1.79E+00 7.65E-01 1.27E-01 0. 7.71E-01 8.14E-02 5.96E-05

AM243 1.72E+00 7.53E-01 1.20E-01 0. 7.42E-01 1.92E-01 5.55E-05

CM242 6.33E-02 4.84E-02 4.20E-03 0. 1.34E-02 1.31 E-01 5.06E-05

CM243 1.61E+00 7.33E-01 9.95E-02 0. 3.74E-01 2.10E-01 4.98E-05

CM244 1.33E+00 6.48E-01 8.31E-02 0. 3.06E-01 2.02E-01 4.82E-05

CM245 2.14E+00 8.16E-01 1.28E-01 0. 5.03E-01 1.95E-01 4.49E-05

CM246 2.13E+00 8.15E-01 1.28E-01 0. 5.03E-01 1.99E-01 4.41 E-05

CM247 2.07E+00 8.02E-01 1.26E-01 0. 4.95E-01 1.95E-01 5.80E-05

CM248 1.72E+01 6.61E+00 1.04E+00 0. 4.08E+00 1.61E+00 9.35E-04

CF252 3.92E+00 0. 9.33E-02 0. 0. 6.62E-01 1.84E-04
Proc No ODCM

Attachment 5

Revision 25

Page 9 of 16

INHALATION DOSE COMMITMENT FACTORS

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3* 0. 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07

BE10 2.78E-04 4.33E-05 7.09E-06 0. 0. 3.84E-04 1.77E-05

C14 3.25E-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07

N13 8.65E-09 8.65E-09 8.65E-09 8.65E-09 8.65E-09 8.65E-09 8.65E-09

F18 6.52E-07 0. 7.1OE-08 0. 0. 0. 3.89E-08

NA22 1.76E-05 1.76E-05 1.76E-05 1.76E-05 1.76E-05 1.76E-05 1.76E-05

NA24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06

P32 2.36E-04 1.37E-05 8.95E-06 0. 0. 0. 1.16E-05

AR39 0. 0. 0. 0. 0. 4.OOE-09 0.

AR41 0. 0. 0. 0. 0. 1.44E-08 0.

CA41 4.05E-05 0. 4.38E-06 0. 0. 1.01E-01 3.03E-07

SC46 7.24E-05 1.41E-04 4.18E-05 0. 1.35E-04 0. 2.98E-05

CR51 0. 0. 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07

MN54 0. 6.39E-06 1.05E-06 0. 1.59E-06 2.48E-04 8.35E-06

MN56 0. 2.12E-10 3.15E-11 0. 2.24F-10 1.90E-06 7.18E-06

FE55 4.18E-06 2.98E-06 6.93E-07 0. 0. 1.55E-05 7.99E-07

FE59 1.99E-06 4.62E-06 1.79E-06 0. 0. 1.91E-04 2.23E-05

C057 0. 1.18E-07 1.15E-07 0. 0. 7.33E-05 3.93E-06

C058 0. 2.59E-07 3.47E-07 0. 0. 1.68E-04 1.19E-05

CO60 0. 1.89E-06 2.48E-06 0. 0. 1.09E-03 3.24E-05

N159 5.44E-06 2.02E-06 9.24E-07 0. 0. 1.41 E-05 6.48E-07

N163 7.25E-05 5.43E-06 2.47E-06 0. 0. 3.84E-05 1.77E-06

N165 2.73E-10 3.66E-11 1.59E-11 0. 0. 1.17E-06 4.59E-06

CU64 0. 2.54E-10 1.06E-10 0. 8.01E-10 1.39E-06 7.68E-06

ZN65 4.82E-06 1.67E-05 7.80E-06 0. 1.08E-05 1.55E-04 5.83E-06

ZN69M 1.44E-09 3.39E-09 3.11E-10 0. 2.06E-09 3.92E-06 2.14E-05

ZN69 6.04E-12 1.15E-11 8.07E-13 0. 7.53E-12 1.98E-07 3.56E-08

SE79 0. 5.43E-07 8.71E-08 0. 8.13E-07 7.71E-05 3.53E-06

BR82 0. 0. 2.28E-06 0. 0. 0. 0.

BR83 0. 0. 4.30E-08 0. 0. 0. 0.

BR84 0. 0. 5.41 E-08 0. 0. 0. 0.

BR85 0. 0. 2.29E-09 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 9.97E-10 0.

KR85M 0. 0. 0. 0. 0. 5.46E-09 0.

KR85 0. 0. 0. 0. 0. 4.63E-09 0.

KR87 0. 0. 0. 0. 0. 2.82E-08 0.

KR88 0. 0. 0. 0. 0. 5.81E-08 0.

KR89 0. 0. 0. 0. 0. 3.85E-08 0.

RB86 0. 2.38E-05 1.05E-05 0. 0. 0. 2.21 E-06

RB87 0. 1.40E-05 4.58E-06 0. 0. 0. 3.05E-07

RB88 0. 6.82E-08 3.40E-08 0. 0. 0. 3.65E-15

RB89 0. 4.40E-08 2.91E-08 0. 0. 0. 4.22E-17

SR89 5.43E-05 0. 1.56E-06 0. 0. 3.02E-04 4.64E-05

SR90 1.35E-02 0. 8.35E-04 0. 0. 2.06E-03 9.56E-05

SR91 1.10E-08 0. 4.39E-10 0. 0. 7.59E-06 3.24E-05

SR92 1.19E-09 0. 5.08E-11 0. 0. 3.43E-06 1.49E-05

*Includes a 50% increase to account for percutaneous transpiration.
Proc No ODCM

Attachment 5

Revision 25

Page 10 of 16

INHALATION DOSE COMMITMENT FACTORS

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 3.73E-07 0. 1.OOE-08 0. 0. 3.66E-05 6.99E-05

Y91M 4.63E-11 0. 1.77E-12 0. 0. 4.OOE-07 3.77E-09

Y91 8.26E-05 0. 2.21E-06 0. 0. 3.67E-04 5.11E-05

Y92 1.84E-09 0. 5.36E-11 0. 0. 3.35E-06 2.06E-05

Y93 1.69E-08 0. 4.65E-10 0. 0. 1.04E-05 7.24E-05

ZR93 6.83E-05 3.38E-05 1.84E-05 0. 1.16E-04 3.67E-04 1.60E-05

ZR95 1.82E-05 5.73E-06 3.94E-06 0. 8.42E-06 3.36E-04 1.86E-05

ZR97 1.72E-08 3.40E-09 1.57E-09 0. 5.15E-09 1.62E-05 7.88E-05

NB93M 4.14E-05 1.36E-05 3.41E-06 0. 1.59E-05 5.36E-05 2.52E-06

NB95 2.32E-06 1.29E-06 7.08E-07 0. 1.25E-06 9.39E-05 1.21E-05

NB97 3.92E-11 9.72E-12 3.55E-12 0. 1.14E-11 4.91E-07 2.71E-07

M093 0. 1.66E-06 4.52E-08 0. 5.06E-07 8.81 E-05 3.99E-06

M099 0. 2.11E-08 4.03E-09 0. 5.14E-08 1.92E-05 3.36E-05

TC99M 1.73E-13 4.83E-13 6.24E-12 0. 7.20E-12 1.44E-07 7.66E-07

TC99 4.48E-08 6.58E-08 1.79E-08 0. 8.35E-07 1.74E-04 7.99E-06

TC101 7.40E-15 1.05E-14 1.03E-13 0. 1.90E-13 8.34E-08 1.09E-16

RU103 2.63E-07 0. 1.12E-07 0. 9.29E-07 9.79E-05 1.36E-05

RU105 1.40E-10 0. 5.42E-11 0. 1.76E-10 2.27E-06 1.13E-05

RU106 1.23E-05 0. 1.55E-06 0. 2.38E-05 2.01E-03 1.20E-04

RH105 1.32E-09 9.48E-10 6.24E-10 0. 4.04E-09 4.09E-06 1.23E-05

PD107 0. 1.17E-07 8.39E-09 0. 9.39E-07 1.63E-05 7.49E-07

PD109 0. 6.56E-10 1.66E-10 0. 3.36E-09 3.19E-06 1.96E-05

AG110M 1.73E-06 1.64E-06 9.99E-07 0. 3.13E-06 8.44E-04 3.41 E-05

AG111 6.07E-08 2.52E-08 1.26E-08 0. 8.17E-08 4.OOE-05 3.OOE-05

CD113M 0. 2.17E-04 7.1OE-06 0. 2.43E-04 3.59E-04 1.68E-05

CD115M 0. 3.48E-05 1.14E-06 0. 2.82E-05 3.03E-04 5.1OE-05

SN123 4.31E-05 9.44E-07 1.40E-06 7.55E-07 0. 4.96E-04 4.16E-05

SN125 1.66E-06 4.42E-08 9.99E-08 3.45E-08 0. 1.26E-04 7.29E-05

SN126 2.18E-04 5.39E-06 8.24E-06 1.42E-06 0. 1.72E-03 1.68E-05

SB124 5.38E-06 9.92E-08 2.1OE-06 1.22E-08 0. 4.81E-04 4.98E-05

SB125 9.23E-06 1.01E-07 2.15E-06 8.80E-09 0. 3.42E-04 1.24E-05

SB126 6.19E-07 1.27E-08 2.23E-07 3.50E-09 0. 1.55E-04 6.01 E-05

SB127 4.64E-08 9.92E-10 1.75E-08 5.21E-10 0. 3.31E-05 3.94E-05

TE125M 6.1OE-07 2.80E-07 8.34E-08 1.75E-07 0. 6.70E-05 9.38E-06

TE127M 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05

TE127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05

TE129M 1.74E-06 8.23E-07 2.81 E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05

TE129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07

TE131M 1.23E-08 7.51E-09 5.03E-09 9.06E-09 5.49E-08 2.97E-05 7.76E-05

TE131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09

TE132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61E-05 5.79E-05

TE133M 1.01E-11 7.33E-12 5.71E-12 8.18E-12 5.07E-11 8.71E-07 1.23E-07

TE134 5.31E-12 4.35E-12 3.64E-12 4.46E-12 2.91E-11 6.75E-07 1.37E-09

1129 3.53E-06 2.94E-06 4.90E-06 3.66E-03 5.26E-06 0. 2.29E-07

1130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 0. 1.14E-06

1131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 0. 8.11E-07
Proc No ODCM

Attachment 5

Revision 25

Page 11 of 16

INHALATION DOSE COMMITMENT FACTORS

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 0. 1.59E-07

1133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 0. 1.29E-06

1134 1.11E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 0. 2.55E-09

1135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 0. 8.69E-07

XE131M 0. 0. 0. 0. 0. 2.70E-09 0.

XE133M 0. 0. 0. 0. 0. 3.59E-09 0.

XE133 0. 0. 0. 0. 0. 2.99E-09 0.

XE135M 0. 0. 0. 0. 0. 3.88E-09 0.

XE135 0. 0. 0. 0. 0. 7.55E-09 0.

XE137 0. 0. 0. 0. 0. 3.33E-08 0.

XE138 0. 0. 0. 0. 0. 4.38E-08 0.

CS134M 2.20E-08 4.35E-08 2.35E-08 0. 2.54E-08 4.56E-09 2.02E-08

CS134 6.28E-05 1.41E-04 6.86E-05 0. 4.69E-05 1.83E-05 1.22E-06

CS135 2.08E-05 1.82E-05 4.47E-06 0. 7.30E-06 2.70E-06 2.23E-07

CS136 6.44E-06 2.42E-05 1.71E-05 0. 1.38E-05 2.22E-06 1.36E-06

CS137 8.38E-05 1.06E-04 3.89E-05 0. 3.80E-05 1.51E-05 1.06E-06

CS138 5.82E-08 1.07E-07 5.58E-08 0. 8.28E-08 9.84E-09 3.38E-11

CS139 3.65E-08 5.12E-08 1.97E-08 0. 4.34E-08 4.86E-09 1.66E-23

BA139 1.67E-10 1.18E-13 4.87E-12 0. 1.11E-13 8.08E-07 8.06E-07

BA140 6.84E-06 8.38E-09 4.40E-07 0. 2.85E-09 2.54E-04 2.86E-05

BA141 1.78E-11 1.32E-14 5.93E-13 0. 1.23E-14 4.11E-07 9.33E-14

BA142 4.62E-12 4.63E-15 2.84E-13 0. 3.92E-15 2.39E-07 5.99E-20

LA140 5.99E-08 2.95E-08 7.82E-09 0. 0. 2.68E-05 6.09E-05

LA141 7.63E-10 2.35E-10 3.87E-11 0. 0. 2.31E-06 1.54E-05

LA142 1.20E-10 5.31E-11 1.32E-11 0. 0. 1.27E-06 1.50E-06

CE141 3.55E-06 2.37E-06 2.71E-07 0. 1.11E-06 7.67E-05 1.58E-05

CE143 3.32E-08 2.42E-08 2.70E-09 0. 1.08E-08 1.63E-05 3.19E-05

CE144 6.11E-04 2.53E-04 3.28E-05 0. 1.51E-04 1.67E-03 1.08E-04

PR143 1.67E-06 6.64E-07 8.28E-08 0. 3.86E-07 6.04E-05 2.67E-05

PR144 5.37E-12 2.20E-12 2.7 2E-13 0. 1.26E-12 2.19E-07 2.94E-14

ND147 9.83E-07 1.07E-06 6.41 E-08 0. 6.28E-07 4.65E-05 2.28E-05

PM147 1.15E-04 1.10E-05 4.50E-06 0. 2.1OE-05 1.14E-04 5.87E-06

PM148M 1.32E-05 3.35E-06 2.62E-06 0. 5.07E-06 3.20E-04 4.1OE-05

PM148 5.44E-07 8.88E-08 4.48E-08 0. 1.60E-07 6.52E-05 6.14E-05

PM149 4.91E-08 6.89E-09 2.84E-09 0. 1.31E-08 1.24E-05 2.79E-05

PM151 1.20E-08 1.99E-09 1.01E-09 0. 3.57E-09 6.56E-06 2.27E-05

SM151 1.07E-04 2.10E-05 4.86E-06 0. 2.27E-05 7.68E-05 3.53E-06

SM153 2.43E-08 2.01E-08 1.47E-09 0. 6.56E-09 7.11E-06 1.77E-05

EU152 2.96E-04 7.19E-05 6.30E-05 0. 3.34E-04 5.01E-04 1.35E-05

EU154 9.43E-04 1.23E-04 8.60E-05 0. 5.44E-04 9.12E-04 3.34E-05

EU155 2.OOE-04 1.96E-05 1.21E-05 0. 7.65E-05 1.51E-03 5.97E-05

EU156 2.70E-06 2.03E-06 3.30E-07 0. 1.36E-06 1.37E-04 4.56E-05

TB160 3.04E-05 0. 3.79E-06 0. 1.20E-05 2.97E-04 2.60E-05

H0166M 4.40E-04 1.36E-04 9.87E-05 0. 2.OOE-04 6.24E-04 1.68E-05

Wl81 8.90E-09 2.88E-09 3.01E-10 0. 0. 2.95E-06 2.69E-07

W185 2.78E-07 9.17E-08 9.73E-09 0. 0. 9.60E-05 1.14E-05

W187 1.50E-09 1.22E-09 4.29E-10 0. 0. 5.92E-06 2.21E-05
Proc No ODCM

Attachment 5

Revision 25

Page 12 of 16

INHALATION DOSE COMMITMENT FACTORS

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 3.09E-02 8.28E-03 1.07E-03 0. 2.95E-02 4.52E-02 3.87E-05

B1210 0. 2.26E-06 1.89E-07 0. 2.74E-05 1.91E-03 3.19E-05

P0210 5.68E-04 1.22E-03 1.37E-04 0. 4.21E-03 5.41E-02 4.45E-05

RN222 0. 0. 0. 0. 0. 3.94E-06 0.

RA223 2.57E-04 3.93E-07 5.14E-05 0. 1.12E-05 4.39E-02 3.04E-04

RA224 2.83E-05 6.77E-08 5.65E-06 0. 1.93E-06 1.51E-02 3.29E-04

RA225 4.28E-04 5.04E-07 8.56E-05 0. 1.44E-05 5.04E-02 2.89E-04

RA226 1.33E-01 3.38E-06 9.87E-02 0. 9.67E-05 2.02E-01 3.11E-04

RA228 5.34E-02 1.74E-06 5.88E-02 0. 4.97E-05 2.78E-01 5.30E-05

AC225 6.04E-04 8.25E-04 4.06E-05 0. 9.47E-05 3.81E-02 2.70E-04

AC227 2.49E+00 3.69E-01 1.48E-01 0. 1.07E-01 4.16E-01 5.38E-05

TH227 3.09E-04 5.56E-06 8.93E-06 0. 3.18E-05 6.50E-02 3.57E-04

TH228 2.60E-01 4.37E-03 8.78E-03 0. 2.45E-02 1.69E+00 3.70E-04

TH229 9.06E+00 1.36E-01 4.45E-01 0. 6.67E-01 5.05E+00 3.36E-04

TH230 2.34E+00 1.34E-01 6.49E-02 0. 6.55E-01 8.98E-01 3.95E-05

TH232 2.61E+00 1.14E-01 9.21E-02 0. 5.60E-01 8.60E-01 3.36E-05

TH234 2.32E-06 1.35E-07 6.71E-08 0. 7.73E-07 3.26E-04 7.49E-05

PA231 5.32E+00 2.OOE-01 2.07E-01 0. 1.12E+00 9.91E-02 4.71E-05

PA233 1.68E-06 3.24E-07 2.89E-07 0. 1.22E-06 5.39E-05 1.OOE-05

U232 7.31 E-02 0. 5.23E-03 0. 7.94E-03 3.84E-01 4.46E-05

U233 1.55E-02 0. 9.42E-04 0. 3.63E-03 9.18E-02 4.12E-05

U234 1.48E-02 0. 9.23E-04 0. 3.55E-03 8.99E-02 4.04E-05

U235 1.42E-02 0. 8.67E-04 0. 3.34E-03 8.44E-02 5.13E-05

U236 1.42E-02 0. 8.86E-04 0. 3.41 E-03 8.62E-02 3.79E-05

U237 5.25E-08 0. 1.40E-08 0. 2.16E-07 1.76E-05 1.29E-05

U238 1.36E-02 0. 8.10E-04 0. 3.12E-03 7.89E-02 3.62E-05

NP237 1.77E+00 1.54E-01 7.21E-02 0. 5.35E-01 8.99E-02 5.22E-05

NP238 4.23E-07 1.13E-08 6.59E-09 0. 3.88E-08 1.75E-05 2.38E-05

NP239 4.23E-08 3.99E-09 2.21E-09 0. 1.25E-08 8.11E-06 1.65E-05

PU238 2.86E+00 4.06E-01 7.22E-02 0. 3.10E-01 3.12E-01 4.79E-05

PU239 3.31 E+00 4.50E-01 8.05E-02 0. 3.44E-01 2.93E-01 4.37E-05

PU240 3.31 E+00 4.49E-01 8.04E-02 0. 3.43E-01 2.93E-01 4.46E-05

PU241 6.97E-02 3.57E-03 1.40E-03 0. 6.47E-03 2.60E-04 9.17E-07

PU242 3.07E+00 4.33E-01 7.75E-02 0. 3.31E-01 2.82E-01 4.29E-05

PU244 3.59E+00 4.96E-01 8.88E-02 0. 3.79E-01 3.23E-01 6.39E-05

AM241 1.06E+00 4.07E-01 7.1OE-02 0. 5.32E-01 1.05E-01 4.88E-05

AM242M 1.07E+00 3.93E-01 7.15E-02 0. 5.30E-01 4.21E-02 6.14E-05

AM243 1.06E+00 3.92E-01 6.95E-02 0. 5.21 E-01 9.91 E-02 5.72E-05

CM242 2.12E-02 2.14E-02 1.41E-03 0. 6.40E-03 6.76E-02 5.21E-05

CM243 8.45E-01 3.50E-01 5.OOE-02 0. 2.34E-01 1.09E-01 5.13E-05

CM244 6.46E-01 3.03E-01 3.88E-02 0. 1.81 E-01 1.05E-01 4.96E-05

CM245 1.32E+00 4.11E-01 7.53E-02 0. 3.52E-01 1.01E-01 4.63E-05

CM246 1.31E+00 4.11E-01 7.52E-02 0. 3.51E-01 1.03E-01 4.54E-05

CM247 1.28E+00 4.04E-01 7.41 E-02 0. 3.46E-01 1.01 E-01 5.97E-05

CM248 1.06E+01 3.33E+00 6.11E-01 0. 2.85E+00 8.32E-01 9.63E-04

CF252 1.29E+00 0. 3.07E-02 0. 0. 3.43E-01 1.89E-04
Proc No ODCM

Attachment 5

Revision 25

Page 13 of 16

INHALATION DOSE COMMITMENT FACTORS

ADULT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3* 0. 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07

BE10 1.98E-04 3.06E-05 4.96E-06 0. 0. 2.22E-04 1.67E-05

C14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07

N13 6.27E-09 6.27E-09 6.27E-09 6.27E-09 6.27E-09 6.27E-09 6.27E-09

F18 4.71 E-07 0. 5.19E-08 0. 0. 0. 9.24E-09

NA22 1.30E-05 1.30E-05 1.30E-05 1.30E-05 1.30E-05 1.30E-05 1.30E-05

NA24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06

P32 1.65E-04 9.64E-06 6.26E-06 0. 0. 0. 1.08E-05

AR39 0. 0. 0. 0. 0. 2.08E-09 0.

AR41 0. 0. 0. 0. 0. 8.06E-09 0.

CA41 3.83E-05 0. 4.13E-06 0. 0. 3.83E-06 2.86E-07

SC46 5.51E-05 1.07E-04 3.11E-05 0. 9.99E-05 0. 3.23E-05

CR51 0. 0. 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07

MN54 0. 4.95E-06 7.87E-07 0. 1.23E-06 1.75E-04 9.67E-06

MN56 0. 1.55E-10 2.29E-11 0. 1.63E-10 1.18E-06 2.53E-06

FE55 3.07E-06 2.12E-06 4.93E-07 0. 0. 9.01 E-06 7.54E-07

FE59 1.47E-06 3.47E-06 1.32E-06 0. 0. 1.27E-04 2.35E-05

C057 0. 8.65E-08 8.39E-08 0. 0. 4.62E-05 3.93E-06

C058 0. 1.98E-07 2.59E-07 0. 0. 1.16E-04 1.33E-05

C060 0. 1.44E-06 1.85E-06 0. 0. 7.46E-04 3.56E-05

N159 4.06E-06 1.46E-06 6.77E-07 0. 0. 8.20E-06 6.11E-07

N163 5.40E-05 3.93E-06 1.81 E-06 0. 0. 2.23E-05 1.67E-06

N165 1.92E-10 2.62E-11 1.14E-11 0. 0. 7.OOE-07 1.54E-06

CU64 0. 1.83E-10 7.69E-11 0. 5.78E-10 8.48E-07 6.12E-06

ZN65 4.05E-06 1.29E-05 5.82E-06 0. 8.62E-06 1.08E-04 6.68E-06

ZN69M 1.02E-09 2.45E-09 2.24E-10 0. 1.48E-09 2.38E-06 1.71E-05

ZN69 4.23E-12 8.14E-12 5.65E-13 0. 5.27E-12 1.15E-07 2.04E-09

SE79 0. 3.83E-07 6.09E-08 0. 5.69E-07 4,47E-05 3.33E-06

BR82 0. 0. 1.69E-06 0. 0. 0. 1.30E-06

BR83 0. 0. 3.01E-08 0. 0. 0. 2.90E-08

BR84 0. 0. 3.91E-08 0. 0. 0. 2.05E-13

BR85 0. 0. 1.60E-09 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 5,19E-10 0.

KR85M 0. 0. 0. 0. 0. 2.91 E-09 0.

KR85 0. 0. 0. 0. 0. 2.41 E-09 0.

KR87 0. 0. 0. 0. 0. 1.53E-08 0.

KR88 0. 0. 0. 0. 0. 3.13E-08 0.

KR89 0. 0. 0. 0. 0. 2.13E-08 0.

RB86 0. 1.69E-05 7.37E-06 0. 0. 0. 2.08E-06

RB87 0. 9.86E-06 3.21 E-06 0. 0. 0. 2.88E-07

RB88 0. 4.84E-08 2.41E-08 0. 0. 0. 4.18E-19

RB89 0. 3.20E-08 2.12E-08 0. 0. 0. 1.16E-21

SR89 3.80E-05 0. 1.09E-06 0. 0. 1.75E-04 4.37E-05

SR90 1.24E-02 0. 7.62E-04 0. 0. 1.20E-03 9.02E-05

SR91 7.74E-09 0. 3.13E-10 0. 0. 4.56E-06 2.39E-05

SR92 8.43E-10 0. 3.64E-11 0. 0. 2.06E-06 5.38E-06

*Includes a 50% increase to account for percutaneous transpiration.
Proc No ODCM

Attachment 5

Revision 25

Page 14 of 16

INHALATION DOSE COMMITMENT FACTORS

ADULT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 2.61E-07 0. 7.01E-09 0. 0. 2.12E-05 6.32E-05

Y91M 3.26E-11 0. 1.27E-12 0. 0. 2.40E-07 1.66E-10

Y91 5.78E-05 0. 1.55E-06 0. 0. 2.13E-04 4.81E-05

Y92 1.29E-09 0. 3.77E- 11 0. 0. 1.96E-06 9.19E-06

Y93 1.18E-08 0. 3.26E-10 0. 0. 6.06E-06 5.27E-05

ZR93 5.22E-05 2.92E-06 1.37E-06 0. 1.11E-05 2.13E-05 1.51E-06

ZR95 1.34E-05 4.30E-06 2.91E-06 0. 6.77E-06 2.21E-04 1.88E-05

ZR97 1.21 E-08 2.45E-09 1.13E-09 0. 3.71E-09 9.84E-06 6.54E-05

NB93M 3.1OE-05 1.01E-05 2.49E-06 0. 1.16E-05 3.11E-05 2.38E-06

NB95 1.76E-06 9.77E-07 5.26E-07 0. 9.67E-07 6.31 E-05 1.30E-05

NB97 2.78E-11 7.03E-12 2.56E-12 0. 8.18E-12 3.OOE-07 3.02E-08

M093 0. 1.17E-06 3.17E-08 0. 3.55E-07 5.11E-05 3.79E-06

M099 0. 1.51E-08 2.87E-09 0. 3.64E-08 1.14E-05 3.1OE-05

TC99M 1.29E-13 3.64E-13 4.63E-12 0. 5.52E-12 9.55E-08 5.20E-07

TC99 3.13E-08 4.64E-08 1.25E-08 0. 5.85E-07 1.01E-04 7.54E-06

TC101 5.22E-15 7.52E-15 7.38E-14 0. 1.35E-13 4.99E-08 1.36E-21

RU103 1.91 E-07 0. 8.23E-08 0. 7.29E-07 6.31E-05 1.38E-05

RU105 9.88E-11 0. 3.89E-11 0. 1.27E-10 1.37E-06 6.02E-06

RU106 8.64E-06 0. 1.09E-06 0. 1.67E-05 1.17E-03 1.14E-04

RH105 9.24E-10 6.73E-10 4.43E-10 0. 2.86E-09 2.41E-06 1.09E-05

PD107 0. 8.27E-08 5.87E-09 0. 6.57E-07 9.47E-06 7.06E-07

PD109 0. 4.63E-10 1.16E-10 0. 2.35E-09 1.85E-06 1.52E-05

AG110M 1.35E-06 1.25E-06 7.43E-07 0. 2.46E-06 5.79E-04 3.78E-05

AG111 4.25E-08 1.78E-08 8.87E-09 0. 5.74E-08 2.33E-05 2.79E-05

CD113M 0. 1.54E-04 4.97E-06 0. 1.71E-04 2.08E-04 1.59E-05

CD115M 0. 2.46E-05 7.95E-07 0. 1.98E-05 1.76E-04 4.80E-05

SN123 3.02E-05 6.67E-07 9.82E-07 5.67E-07 0. 2.88E-04 3.92E-05

SN125 1.16E-06 3.12E-08 7.03E-08 2.59E-08 0. 7.37E-05 6.81 E-05

SN126 1.58E-04 4.18E-06 6.00E-06 1.23E-06 0. 1.17E-03 1.59E-05

SB124 3.90E-06 7.36E-08 1.55E-06 9.44E-09 0. 3.10E-04 5.08E-05

SB125 6.67E-06 7.44E-08 1.58E-06 6.75E-09 0. 2.18E-04 1.26E-05

SB126 4.50E-07 9.13E-09 1.62E-07 2.75E-09 0. 9.57E-05 6.01 E-05

SB127 3.30E-08 7.22E-10 1.27E-08 3.97E-10 0. 2.05E-05 3.77E-05

TE125M 4.27E-07 1.98E-07 5.84E-08 1.31E-07 1.55E-06 3.92E-05 8.83E-06

TE127M 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5.72E-06 1.20E-04 1.87E-05

TE1 27 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06

TE1 29M 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05

TE129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08

TE131M 8.74E-09 5.45E-09 3.63E-09 6.88E-09 3.86E-08 1.82E-05 6.95E-05

TE131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09

TE132 3.25E-08 2.69E-08 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05

TE133M 7.24E-12 5.40E-12 4.17E-12 6.27E-12 3.74E-11 5.51E-07 5.49E-08

TE134 3.84E-12 3.22E-12 1.57E-12 3.44E-12 2.18E-11 4.343-07 2.97E-11

1129 2.48E-06 2.11E-06 6.91E-06 5.54E-03 4.53E-06 0. 2.22E-07

1130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 0. 9.61E-07

1131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 0. 7.85E-07
Proc No ODCM

Attachment 5

Revision 25

Page 15 of 16

INHALATION DOSE COMMITMENT FACTORS

ADULT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 0. 5.08E-08

1133 1.08E-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 0. 1.11E-06

1134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 0. 1.26E-10

1135 3.35E-07 8.73E-07 3.21E-07 5.60E-05 1.39E-06 0. 6.56E-07

XE131M 0. 0. 0. 0. 0. 1.40E-09 0.

XE133M 0. 0. 0. 0. 0. 1.89E-09 0.

XE133 0. 0. 0. 0. 0. 1.57E-09 0.

XE135M 0. 0. 0. 0. 0. 2.22E-09 0.

XE135 0. 0. 0. 0. 0. 4.05E-09 0.

XE137 0. 0. 0. 0. 0. 1.74E-08 0.

XE138 0. 0. 0. 0. 0. 2.44E-08 0.

CS134M 1.59E-08 3.20E-08 1.72E-08 0. 1.83E-08 2.93E-09 7.92E-09

CS134 4.66E-05 1.06E-04 9.1OE-05 0. 3.59E-05 1.22E-05 1.30E-06

CS135 1.46E-05 1.29E-05 5.99E-06 0. 5.11E-06 1.57E-06 2.11E-07

CS136 4.88E-06 1.83E-05 1.38E-05 0. 1.07E-05 1.50E-06 1.46E-06

CS137 5.98E-05 7.76E-05 5.35E-05 0. 2.78E-05 9.40E-06 1.05E-06

CS138 4.14E-08 7.76E-08 4.05E-08 0. 6.OOE-08 6.07E-09 2.33E-13

CS139 2.56E-08 3.63E-08 1.39E-08 0. 3.05E-08 2.84E-09 5.49E-31

BA139 1.17E-10 8.32E-14 3.42E-12 0. 7.78E-14 4.70E-07 1.12E-07

BA140 4.88E-06 6.13E-09 3.21E-07 0. 2.09E-09 1.59E-04 2.73E-05

BA141 1.25E-11 9.41E-15 4.20E-13 0. 8.75E-15 2.42E-07 1.45E-17

BA142 3.29E-12 3.38E-15 2.07E-13 0. 2.86E-15 1.49E-07 1.96E-26

LA140 4.30E-08 2.17E-08 5.73E-09 0. 0. 1.70E-05 5.73E-05

LA141 5.34E-10 1.66E-10 2.71E-11 0. 0. 1.35E-06 7.31E-06

LA142 8.54E-11 3.88E-11 9.65E-12 0. 0. 7.91 E-07 2.64E-07

CE141 2.49E-06 1.69E-06 1.91E-07 0. 7.83E-07 4.52E-05 1.50E-05

CE143 2.33E-08 1.72E-08 1.91E-09 0. 7.60E-09 9.97E-06 2.83E-05

CE144 4.29E-04 1.79E-04 2.30E-05 0. 1.06E-04 9.72E-04 1.02E-04

PR143 1.17E-06 4.69E-07 5.80E-08 0. 2.70E-07 3.51 E-05 2.50E-05

PR144 3.76E-12 1.56E-12 1.91E-13 0. 8.81 E-13 1.27E-07 2.69E-18

ND147 6.59E-07 7.62E-07 4.56E-08 0. 4.45E-07 2.76E-05 2.16E-05

PM147 8.37E-05 7.87E-06 3.19E-06 0. 1.49E-05 6.60E-05 5.54E-06

PM148M 9.82E-06 2.54E-06 1.94E-06 0. 3.85E-06 2.14E-04 4.18E-05

PM148 3.84E-07 6.37E-08 3.20E-08 0. 1.20E-07 3.91 E-05 5.80E-05

PM149 3.44E-08 4.87E-09 1.99E-09 0. 9.19E-09 7.21E-06 2.50E-05

PM151 8.50E-09 1.42E-09 7.21E-10 0. 2.55E-09 3.94E-06 2.OOE-05

SM151 8.59E-05 1.48E-05 3.55E-06 0. 1.66E-05 4.45E-05 3.25E-06

SM153 1.70E-08 1.42E-08 1.04E-09 0. 4.59E-09 4.14E-06 1.58E-05

EU152 2.38E-04 5.41E-05 4.76E-05 0. 3.35E-04 3.43E-04 1.59E-05

EU154 7.40E-04 9.1 E-05 6.48E-05 0. 4.36E-04 5.84E-04 3.40E-05

EU155 1.01E-04 1.43E-05 9.21E-06 0. 6.59E-05 9.46E-05 5.95E-06

EU156 1.93E-06 1.48E-06 2.40E-07 0. 9.95E-07 8.56E-05 4.50E-05

TB160 2.21E-05 0. 2.75E-06 0. 9.1OE-06 1.92E-04 2.68E-05

H0166M 3.37E-04 1.05E-04 8.O0E-05 0. 1.57E-04 3.94E-04 1.59E-05

W181 6.23E-09 2.03E-09 2.17E-10 0. 0. 1.71E-06 2.53E-07

W185 1.95E-07 6.47E-08 6.81E-09 0. 0. 5.57E-05 1.07E-05

W187 1.06E-09 8.85E-10 3.1OE-10 0. 0. 3.63E-06 1.94E-05
Proc No ODCM

Attachment 5

Revision 25

Page 16 of 16

INHALATION DOSE COMMITMENT FACTORS

ADULT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 2.64E-02 6.73E-03 8.37E-04 0. 2.12E-02 2.62E-02 3.65E-05

B1210 0. 1.59E-06 1.32E-07 0. 1.92E-05 1.11E-03 2.95E-05

P0210 3.97E-04 8.60E-04 9.58E-05 0. 2.95E-03 3.14E-02 4.19E-05

RN222 0. 0. 0. 0. 0. 2.05E-06 0.

RA223 1.80E-04 2.77E-07 3.60E-05 0. 7.85E-06 2.55E-02 2.84E-04

RA224 1.98E-05 4.78E-08 3.96E-06 0. 1.35E-06 8.77E-03 3.01E-04

RA225 3.00E-04 3.56E-07 5.99E-05 0. 1.01 E-05 2.92E-02 2.71E-04

RA226 1.25E-01 2.39E-06 9.14E-02 0. 6.77E-05 1.17E-01 2.94E-04

RA228 4.41E-02 1.23E-06 4.78E-02 0. 3.48E-05 1.61 E-01 5.OOE-05

AC225 4.23E-04 5.82E-04 2.84E-05 0. 6.63E-05 2.21 E-02 2.52E-04

AC227 2.30E+00 3.05E-01 1.36E-01 0. 9.82E-02 2.41 E-01 5.08E-05

TH227 2.17E-04 3.92E-06 6.25E-06 0. 2.22E-05 3.77E-02 3.34E-04

TH226 2.OOE-01 3.39E-03 6.77E-03 0. 1.89E-02 1.01E+00 3.49E-04

TH229 8.88E+00 1.33E-01 4.36E-01 0. 6.52E-01 3.49E+00 3.17E-04

TH230 2.29E+00 1.31 E-01 6.36E-02 0. 6.40E-01 6.21E-01 3.73E-05

TH232 2.56E+00 1.12E-01 9.04E-02 0. 5.47E-01 5.96E-01 3.17E-05

TH234 1.63E-06 9.56E-08 4.70E-08 0. 5.41 E-07 1.89E-04 7.03E-05

PA231 5.08E+00 1.91 E-01 1.98E-01 0. 1.07E+00 5.75E-02 4.44E-05

PA233 1.21E-06 2.42E-07 2.09E-07 0. 9.15E-07 3.52E-05 1.02E-05

U232 5.14E-02 0. 3.66E-03 0. 5.56E-03 2.22E-01 4.21E-05

U233 1.09E-02 0. 6.60E-04 0. 2.54E-03 5.32E-02 3.89E-05

U234 1.04E-02 0. 6.46E-04 0. 2.49E-03 5.22E-02 3.81 E-05

U235 1.OOE-02 0. 6.07E-04 0. 2.34E-03 4.90E-02 4.84E-05

U236 1.OOE-02 0. 6.20E-04 0. 2.39E-03 5.OOE-02 3.57E-05

U237 3.67E-08 0. 9.77E-09 0. 1.51 E-07 1.02E-05 1.20E-05

U238 9.58E-03 0. 5.67E-04 0. 2.18E-03 4.58E-02 3.41E-05

NP237 1.69E+00 1.47E-01 6.87E-02 0. 5.1OE-01 5.22E-02 4.92E-05

NP238 2.96E-07 8.OOE-09 4.61E-09 0. 2.72E-08 1.02E-05 2.13E-05

NP239 2.87E-08 2.82E-09 1.55E-09 0. 8.75E-09 4.70E-06 1.49E-05

PU238 2.74E+00 3.87E-01 6.90E-02 0. 2.96E-01 1.82E-01 4.52E-05

PU239 3.19E+00 4.31E-01 7.75E-02 0. 3.30E-01 1.72E-01 4.13E-05

PU240 3.18E+00 4.30E-01 7.73E-02 0. 3.29E-01 1.72E-01 4.21E-05

PU241 6.41E-02 3.28E-03 1.29E-03 0. 5.93E-03 1.52E-04 8.65E-07

PU242 2.95E+00 4.15E-01 7.46E-02 0. 3.17E-01 1.65E-01 4.05E-05

PU244 3.45E+00 4.76E-01 8.54E-02 0. 3.64E-01 1.89E-01 6.03E-05

AM241 1.01 E+00 3.59E-01 6.71 E-02 0. 5.04E-01 6.06E-02 4.60E-05

AM242M 1.02E+00 3.46E-01 6.73E-02 0. 5.01E-01 2.44E-02 5.79E-05

AM243 1.01 E+00 3.47E-01 6.57E-02 0. 4.95E-01 5.75E-02 5.40E-05

CM242 1.48E-02 1.51E-02 9.84E-04 0. 4.48E-03 3.92E-02 4.91E-05

CM243 7.86E-01 2.97E-01 4.61E-02 0. 2.15E-01 6.31E-02 4.84E-05

CM244 5.90E-01 2.54E-01 3.51 E-02 0. 1.64E-01 6.06E-02 4.68E-05

CM245 1.26E+00 3.59E-01 7.14E-02 0. 3.33E-01 5.85E-02 4.36E-05

CM246 1.25E+00 3.59E-01 7.13E-02 0. 3.33E-01 5.96E-02 4.29E-05

CM247 1.22E+00 3.53E-01 7.03E-02 0. 3.28E-01 5.85E-02 5.63E-05

CM248 1.01 E+01 2.91 E+00 5.79E-01 0. 2.70E+00 4.82E-01 9.09E-04

CF252 9.78E-01 0. 2.33E-02 0. 0. 1.99E-01 1.78E-04
Proc No ODCM

Attachment 6

Revision 25

Page 1 of 2

EXTERNAL DOSE FACTORS FOR STANDING ON CONTAMINATED GROUND (DFG!)

(mrem/hr per pCi/m2 )

ELEMENT TOTAL BODY SKIN

H-3 0.0 0.0

C-14 0.0 0.0

Na-24 2.50E-08 2.90E-08

P-32 0.0 0.0

Cr-51 2.20E-10 2.60E-10

Mn-54 5.80E-09 6.80E-09

Mn-56 1.1OE-08 1.30E-08

Fe-55 0.0 0.0

Fe-59 8.OOE-09 9.40E-09

Co-58 7.OOE-09 8.20E-09

Co-60 1.70E-08 2.OOE-08

Ni-63 0.0 0.0

Ni-65 3.70E-09 4.30E-09

Cu-64 1.50E-09 1.70E-09

Zn-65 4.OOE-09 4.60E-09

Zn-69 0.0 0.0

Br-83 6.40E-11 9.30E-11

Br-84 1.20E-08 1.40E-08

Br-85 0.0 0.0

Rb-86 6.30E-10 7.20E-10

Rb-88 3.50E-09 4.OOE-09

Rb-89 1.50E-08 1.80E-08

Sr-89 5.60E-13 6.50E-13

Sr-91 7.1OE-09 8.30E-09

Sr-92 9.OOE-09 1.OOE-08

Y-90 2.20E-12 2.60E-12

Y-91 m 3.80E-09 4.40E-09

Y-91 2.40E-11 2.70E-11

Y-92 1.60E-09 1.90E-09

Y-93 5.70E-10 7.80E-10

Zr-95 5.OOE-09 5.80E-09

Zr-97 5.50E-09 6.40E-09

Nb-95 5.1OE-09 6.OOE-09

Mo-99 1.90E-09 2.20E-09

Tc-99m 9.60E-10 1.1OE-09

Tc-101 2.70E-09 3.OOE-09
Proc No ODCM

Attachment 6

Revision 25

Page 2 of 2

EXTERNAL DOSE FACTORS FOR STANDING ON CONTAMINATED GROUND (DFG!)

(mrem/hr per pCi/m2)

ELEMENT

Ru-103

Ru-105

Ru-106

Ag-110m

Te-1 25m

Te-127m

Te-127

Te- 129m

Te-129

Te-131m

Te-1 31

Te-132

1-130

1-131

1-132

1-133

1-134

1-135

Cs-1 34

Cs-1 36

Cs-1 37

Cs-1 38

Ba-1 39

Ba-140

Ba-141

Ba-142

La-140

La-142

Ce-141

Ce-143

Ce-144

Pr-143

Pr-144

Nd-147

W-187

Np-239

TOTAL BODY

3.60E-09

4.50E-09

1.50E-09

1.80E-08

3.50E-1 1

1.10E-12

1.O0E-11

7.70E-10

7.10E-10

8.40E-09

2.20E-09

1.70E-09

1.40E-08

2.80E-09

1.70E-08

3.70E-09

1.60E-08

1.20E-08

1.20E-08

1.50E-08

4.20E-09

2.1OE-08

2.40E-09

2.1OE-09

4.30E-09

7.90E-09

1.50E-08

1.50E-08

5.50E-10

2.20E-09

3.20E-10

0.0

2.00E-1 0

1.00E-09

3.1OE-09

9.50E-10

SKIN

4.20E-09

5.1 OE-09

1.80E-09

2.1OE-08

4.80E-1 1

1.30E-12

1.1OE-11

9.OOE-10

8.40E-10

9.90E-09

2.60E-06

2.OOE-09

1.70E-08

3.40E-09

2.OOE-08

4.50E-09

1.90E-08

1.40E-08

1.40E-08

1.70E-08

4.90E-09

2.40E-08

2.70E-09

2.40E-09

4.90E-09

9.OOE-09

1.70E-08

1.80E-08

6.20E-10

2.50E-09

3.70E-10

0.0

2.30E-10

1.20E-09

3.60E-09

1.10E-09
Proc No ODCM

Attachment 7

Revision 25

Page 1 of I

BIOACCUMULATION FACTORS

ttCi/_m per uCi/ml

FRESHWATER

ELEMENT FISH

H

C

NA

P

CR

MN

FE

CO

NI

Cu

ZN

BR

RB

SR

Y

ZR

NB

MO

TC

RU

RH

TE

I

CS

BA

LA

CE

PR

ND

W

NP

9.OE-01

4.6E 03

1.0E 02

1.OE 05

2.OE 02

4.OE 02

1.OE 02

5.OE 01

1.OE 02

5.OE 01

2.OE 03

4.2E 02

2.OE 03

3.OE 01

2.5E 01

3.3E 00

3.OE 04

1.OE 01

1.5E 01

1.OE 01

1.OE 01

4.OE 02

1.5E 01

2.OE 03

4.OE 00

2.5E 01

1.0E 00

2.5E 01

2.5E 01

1.2E 03

1.0E 01
Proc No ODCM

Attachment 8

Revision 25

Page 1 of 16

INGESTION DOSE COMMITMENT FACTORS

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3 0. 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.083-07

BE10 1.71E-05 2.49E-06 5.16E-07 0. 1.64E-06 0. 2.78E-05

C14 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06

N13 5.85E-08 5.85E-08 5.85E-08 5.835E-08 5.85E-08 5.85E-08 5.85E-08

F18 5.19E-06 0. 4.43E.07 0. 0. 0. 1.22E-06

NA22 9.83E-05 9.83E-05 9.83E-05 9.83E-05 9.83E-05 9.83E-05 9.83E-05

NA24 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05

P32 1.70E-03 1.00E-04 6.59E-05 0. 0. 0. 2.30E-05

AR39 0. 0. 0. 0. 0. 0. 0.

AR41 0. 0. 0. 0. 0. 0. 0.

CA41 3.74E-04 0. 4.08E-05 0. 0. 0. 1.91 E-07

SC46 3.75E-08 5.41 E-08 1.69E-08 0. 3.56E-08 0. 3.53E-05

CR51 0. 0. 1.41E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07

MN54 0. 1.99E-05 4.51 E-06 0. 4.41 E-06 0. 7.31 E-06

MN56 0. 8.18E-07 1.41 E-07 0. 7.03E-07 0. 7.43E-05

FE55 1.39E-05 8.98E-06 2.40E-06 0. 0. 4.39E-06 1.14E-06

FE59 3.08E-05 5.38E-05 2.12E-05 0. 0. 1.59E-05 2.57E-05

C057 0. 1.15E-06 1.87E-06 0. 0. 0. 3.92E-06

C058 0. 3.60E-06 8.98E-06 0. 0. 0. 8.97E-06

C060 0. 1.08E-05 2.55E-05 0. 0. 0. 2.57E-05

N159 4.78E-05 1.45E-05 8.17E-06 0. 0. 0. 7.16E-07

N163 6.34E-04 3.92E-05 2.20E-05 0. 0. 0. 1.95E-06

N165 4.70E-06 5.32E-07 2.42E-07 0. 0. 0. 4.05E-05

CU64 0. 6.09E-07 2.82E-07 0. 1.03E-06 0. 1.25E-05

ZN65 1.84E-05 6.31 E-05 2.91 E-05 0. 3.06E-05 0. 5.33E-05

ZN69M 1.50E-06 3.06E-06 2.79E-07 0. 1.24E-06 0. 4.24E-05

ZN69 9.33E-08 1.68E-07 1.25E-08 0. 6.98E-08 0. 1.37E-05

SE79 0. 2.10E-05 3.90E-06 0. 2.43E-05 0. 5.58E-07

BR82 0. 0. 1.27E-05 0. 0. 0. 0.

BR83 0. 0. 3.63E-07 0. 0. 0. 0.

BR84 0. 0. 3.82E-07 0. 0. 0. 0.

BR85 0. 0. 1.94E-08 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 0. 0.

KR85M 0. 0. 0. 0. 0. 0. 0.

KR85 0. 0. 0. 0. 0. 0. 0.

KR87 0. 0. 0. 0. 0. 0. 0.

KR88 0. 0. 0. 0. 0. 0. 0.

KR89 0. 0. 0. 0. 0. 0. 0.

RB86 0. 1.70E-04 8.40E-05 0. 0. 0. 4.35E-06

RB87 0. 8.88E-05 3.52E-05 0. 0. 0. 5.98E-07

RB88 0. 4.98E-07 2.73E-07 0. 0. 0. 4.85E-07

RB89 0. 2.86E-07 1.97E-07 0. 0. 0. 9.74E-08

SR89 2.51E-03 0. 7.20E-05 0. 0. 0. 5.16E-05

SR90 1.85E-02 0. 4.71 E-03 0. 0. 0. 2.31 E-04

SR91 5.OOE-05 0. 1.81E-06 0. 0. 0. 5.92E-05

SR92 1.92E-05 0. 7.13E-07 0. 0. 0. 2.07E-04
Proc No ODCM

Attachment 8

Revision 25

Page 2 of 16

INGESTION DOSE COMMITMENT FACTORS

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 8.69E-08 0. 2.33E-09 0. 0. 0. 1.20E-04

Y91M 8.10E-10 0. 2.76E-11 0. 0. 0. 2.70E-06

Y91 1.13E-06 0. 3.01E-08 0. 0. 0. 8.1OE-05

Y92 7.65E-09 0. 2.15E-10 0. 0. 0. 1.46E-04

Y93 2.43E-08 0. 6.62E-10 0. 0. 0. 1.92E-04

ZR93 1.93E-07 9.18E-08 5.54E-08 0. 2.71E-07 0. 2.39E-05

ZR95 2.06E-07 5.02E-08 3.56E-08 0. 5.41 E-08 0. 2.50E-05

ZR97 1.48E-08 2.54E-09 1.16E-09 0. 2.56E-09 0. 1.62E-04

NB93M 1.23E-07 3.33E-08 1.04E-08 0. 3.25E-08 0. 3.98E-06

NB95 4.20E-08 1.73E-08 1.OOE-08 0. 1.24E-08 0. 1.46E-05

NB97 4.59E-10 9.79E-11 3.53E-11 0. 7.65E-11 0. 3.09E-05

M093 0. 5.65E-05 1.82E-06 0. 1.13E-05 0. 1.21E-06

M099 0. 3.40E-05 6.63E-06 0. 5.08E-05 0. 1.12E-05

TC99M 1.92E-09 3.96E-09 5.1OE-08 0. 4.26E-08 2.07E-09 1.15E-06

TC99 1.08E-06 1.46E-06 4.55E-07 0. 1.23E-05 1.42E-07 6.31 E-06

TC101 2.27E-09 2.86E-09 2.83E-08 0. 3.40E-08 1.56E-09 4.86E-07

RU103 1.48E-06 0. 4.95E-07 0. 3.08E-06 0. 1.80E-05

RU105 1.36E-07 0. 4.58E-08 0. 1.00E-06 0. 5.41E-05

RU106 2.41E-05 0. 3.01 E-06 0. 2.85E-05 0. 1.83E-04

RH105 1.09E-06 7.13E-07 4.79E-07 0. 1.98E-06 0. 1.77E-05

PD107 0. 1.19E-06 8.45E-08 0. 6.79E-06 0. 9.46E-07

PD109 0. 1.50E-06 3.62E-07 0. 5.51E-06 0. 3.68E-05

AG110M 9.96E-07 7.27E-07 4.81E-07 0. 1.04E-06 0. 3.77E-05

AG 111 5.20E-07 2.02E-07 1.07E-07 0. 4.22E-07 0. 4.82E-05

CD113M 0. 1.77E-05 6.52E-07 0. 1.34E-05 0. 2.66E-05

CD115M 0. 1.42E-05 4.93E-07 0. 7.41 E-06 0. 8.09E-05

SN123 2.49E-04 3.89E-06 6.50E-06 3.91E-06 0. 0. 6.58E-05

SN125 7.41E-05 1.38E-06 3.29E-06 1.36E-06 0. 0. 1. 11E-04

SN126 5.53E-04 7.26E-06 1.80E-05 1.91E-06 0. 0. 2.52E-05

SB124 2.14E-05 3.15E-07 6.63E-06 5.68E-08 0. 1.34E-05 6.60E-05

SB125 1.23E-05 1.19E-07 2.53E-06 1.54E-08 0. 7.72E-06 1.64E-05

SB126 8.06E-06 1.58E-07 2.91 E-06 6.19E-08 0. 5.07E-06 8.35E-05

SB127 2.23E-06 3.98E-08 6.90E-07 2.84E-08 0. 1. 15E-06 5.91E-05

TE125M 2.33E-05 7.79E-06 3.15E-06 7.84E-06 0. 0. 1.11E-05

TE127M 5.85E-05 1.94E-05 7.08E-06 1.69E-05 1.44E-04 0. 2.36E-05

TE127 1.OOE-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 0. 2.1 E-05

TE129M 1.OOE-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 0. 5.97E-05

TE1 29 2.84E-07 9.79E-08 6.63E-08 2.38E-07 7.07E-07 0. 2.27E-05

TE1 31M 1.52E-05 6.12E-06 5.05E-06 1.24E-05 4.21E-05 0. 1.03E-04

TE131 1 76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 0. 7.11 E-06

TE132 2.08E-05 1.03E-05 9.61 E-06 1.52E-05 6.44E-05 0. 3.81E-05

TE133M 3.91E-07 1.79E-07 1.71E-07 3.45E-07 1.22E-06 0. 1.93E-05

TE134 2.67E-07 1.34E-07 1.38E-07 2.39E-07 9.03E-07 0. 3.06E-06

1129 2.86E-05 2.12E-05 1.55E-05 1.36E-02 2.51E-05 0. 4.24E-07

1130 6.OOE-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 0. 2.83E-06

1131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 0. 1.51E-06
Proc No ODCM

Attachment 8

Revision 25

Page 3 of 16

INGESTION DOSE COMMITMENT FACTORS

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 0. 2.73E.06

1133 1.25E-05 1.82E-05 5.33E-06 3.31E-03 2.14E-05 0. 3.08E-06

1134 8.69E-07 1.78E-06 6.33E-07 4.15E-05 1.99E-06 0. 1.84E-06

1135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 0. 2.62E-06

XE131M 0. 0. 0. 0. 0. 0. 0.

XE133M 0. 0. 0. 0. 0. 0. 0.

XE133 0. 0. 0. 0. 0. 0. 0.

XE135M 0. 0. 0. 0. 0. 0. 0.

XE135 0. 0. 0. 0. 0. 0. 0.

XE137 0. 0. 0. 0. 0. 0. 0.

XE138 0. 0. 0. 0. 0. 0. 0.

CS134M 1.76E-07 2.93E-07 1.48E-07 0. 1.13E-07 2.60E-08 2.32E-07

CS134 3.77E-04 7.03E-04 7.1OE-05 0. 1.81E-04 7.42E-05 1.91E-06

CS135 1.33E-04 1.21 E-04 6.30E-06 0. 3.44E-05 1.31E-05 4.37E-07

CS136 4.59E-05 1.35E-04 5.04E-05 0. 5.38E-05 1.10E-05 2.05E-06

CS137 5.22E-04 6.11E-04 4.33E-05 0. 1.64E-04 6.64E-05 1.91E-06

CS138 4.81E-07 7.82E-07 3.79E-07 0. 3.90E-07 6.09E-08 1.25E-06

C$139 3.1OE-07 4.24E-07 1.62E-07 0. 2.19E-07 3.30E-08 2.66E-08

BA139 8.81E-07 5.84E-10 2.55E-08 0. 3.51E-10 3.54E-10 5.58E-05

BA140 1.71E-04 1.71E-07 8.81 E-06 0. 4.06E-08 1.05E-07 4.20E-05

BA141 4.25E-07 2.91E-10 1.34E-08 0. 1.75E-10 1.77E-10 5.19E-06

BA142 1.84E-07 1.53E-10 9.06E-09 0. 8.81E-11 9.26E-11 7.59E-07

LA140 2.11E-08 8.32E-09 2.14E-09 0. 0. 0. 9.77E-05

LA141 2.89E-09 8.38E-10 1.46E-10 0. 0. 0. 9.61E-05

LA142 1.1OE-09 4.04E-10 9.67E-11 0. 0. 0. 6.86E-05

CE141 7.87E-08 4.80E-08 5.65E-09 0. 1.48E-08 0. 2.48E-05

CE143 1.48E-08 9.82E-06 1.12E-09 0. 2.86E-09 0. 5.73E-05

CE144 2.98E-06 1.22E-06 1.67E-07 0. 4.93E-07 0. 1.71E-04

PR143 8.18E-08 3.04E-08 4.03E-09 0. 1.13E-08 0. 4.29E-05

PR144 2.74E-10 1.06E-10 1.38E-11 0. 3.84E-11 0. 4.93E-06

ND147 5.53E-08 5.68E-08 3.48E-09 0. 2.19E-08 0. 3.60E-05

PM147 3.88E-07 3.27E-08 1.59E-08 0. 4.88E-08 0. 9.27E-06

PM148M 1.65E-07 4.18E-08 3.28E-08 0. 4.80E-08 0. 5.443-05

PM148 6.32E-08 9.13E-09 4.60E-09 0. 1.09E-08 0. 9.74E-05

PM149 1.38E-08 1.81E-09 7.90E-10 0. 2.20E-09 0. 4.86E-05

PM151 6.18E-09 9.01E-10 4.56E-10 0. 1.07E-09 0. 4.17E-05

SM151 2.90E-07 6.67E-08 1.44E-08 0. 4.53E-08 0. 5.58E-06

SM153 7.72E-09 5.97E-09 4.58E-10 0. 1.25E-09 0. 3.12E-05

EU152 6.74E-07 1.79E-07 1.51E-07 0. 5.02E-07 0. 1.59E-05

EU154 2.64E-06 3.67E-07 2.20E-07 0. 9.95E-07 0. 4.58E-05

EU155 5.42E-07 6.25E-08 3.23E-08 0. 1.40E-07 0. 8.37E-05

EU156 1.14E-07 7.06E-08 1.12E-08 0. 3.26E-08 0. 6.67E-05

TB160 2.59E-07 0. 3.24E-08 0. 7.37E-08 0. 3.45E-05

H0166M 1.25E-06 2.69E-07 2.13E-07 0. 3.57E-07 0. 0.

W181 8.85E-08 2.72E-08 3.04E-09 0. 0. 0. 3.82E-07

W185 3.62E-06 1.13E-06 1.29E-07 0. 0. 0. 1.62E-05

W187 9.03E-07 6.28E-07 2.17E-07 0. 0. 0. 3.69E-05
Proc No ODCM

Attachment 8

Revision 25

Page 4 of 16

INGESTION DOSE COMMITMENT FACTORS

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 5.28E-02 1.42E-02 2.38E-03 0. 4.33E-02 0. 5.62E-05

B1210 4.16E-06 2.68E-05 3.58E-07 0. 2.08E-04 0. 5.27E-05

P0210 3.1OE-03 5.93E-03 7.41E-04 0. 1.26E-02 0. 6.61E-05

RN222 0. 0. 0. 0. 0. 0. 0.

RA223 4.41E-02 6.42E-05 8.82E-03 0. 1.17E-03 0. 3.43E-04

RA224 1.46E-02 3.29E-05 2.91 E-03 0. 6.OOE-04 0. 3.86E-04

RA225 5.78E-02 6.42E-05 1.15E-02 0. 1.19E-03 0. 3.24E-04

RA226 6.20E-01 4.76E-05 5.14E-01 0. 8.71 E-04 0. 3.44E-04

RA228 4.32E-01 2.58E-05 4.86E-01 0. 4.73E-04 0. 5.86E-05

AC225 3.92E-05 5.03E-05 2.63E-06 0. 3.69E-06 0. 4.36E-04

AC227 4.49E-03 7.67E-04 2.79E-04 0. 1.56E-04 0. 8.50E-05

TH227 1.20E-04 2.01 E-06 3.45E-06 0. 7.41 E-06 0. 5.70E-04

TH228 2.47E-03 3.38E-05 8.36E-05 0. 1.58E-04 0. 5.84E-04

TH229 1.48E-02 1.94E-04 7.29E-04 0. 9.29E-04 0. 5.31 E-04

TH230 3.80E-03 1.90E-04 1.06E-04 0. 9.12E-04 0. 6.24E-05

TH232 4.24E-03 1.63E-04 1.65E-04 0. 7.79E-04 0. 5.31E-05

TH234 6.92E-07 3.77E-08 2.OOE-08 0. 1.39E-07 0. 1.19E-04

PA231 7.57E-03 2.50E-04 3.02E-04 0. 1.34E-03 0. 7.44E-05

PA233 3.11E-08 6.09E-09 5.43E-09 0. 1.67E-08 0. 1.46E-05

U232 2.42E-02 0. 2.16E-03 0. 2.37E-03 0. 7.04E-05

U233 5.08E-03 0. 3.87E-04 0. 1.08E-03 0. 6.51 E-05

U234 4.88E-03 0. 3.80E-04 0. 1.06E-03 0. 6.37E-05

U235 4.67E-03 0. 3.56E-04 0. 9.93E-04 0. 8.1OE-05

U236 4.67E-03 0. 3.64E-04 0. 1.01 E-03 0. 5.98E-05

U237 4.95E-07 0. 1.32E-07 0. 1.23E-06 0. 2.11E-05

U238 4.47E-03 0. 3.33E-04 0. 9.28E-04 0. 5.71E-05

NP237 2.53E-03 1.93E-04 1.05E-04 0. 6.34E-04 0. 8.23E-05

NP238 1.24E-07 3.12E-09 1.92E-09 0. 6.81E-09 0. 4.17E-05

NP239 1.11E-08 9.93E-10 5.61E-10 0. 1.98E-09 0. 2.87E-05

PU238 1.34E-03 1.69E-04 3.40E-05 0. 1.21E-04 0. 7.57E-05

PU239 1.45E-03 1.77E-04 3.54E-05 0. 1.28E-04 0. 6.91E-05

PU240 1.45E-03 1.77E-04 3.54E-05 0. 1.28E-04 0. 7.04E-05

PU241 4.38E-05 1.90E-06 8.82E-07 0. 3.17E-06 0. 1.45E-06

PU242 1.35E-03 1.70E-04 3.41E-05 0. 1.23E-04 0. 6.77E-05

PU244 1.57E-03 1.95E-04 3.91E-05 0. 1.41 E-04 0. 1.01E-04

AM241 1.53E-03 7.18E-04 1.09E-04 0. 6.55E-04 0. 7.70E-05

AM242M 1.58E-03 7.02E-04 1.13E-04 0. 6.64E-04 0. 9.69E-05

AM243 1.51 E-03 6.88E-04 1.06E-04 0. 6.36E-04 0. 9.03E-05

CM242 1.37E-04 1.24E-04 9.1OE-06 0. 2.62E-05 0. 8.23E-05

CM243 1.45E-03 6.88E-04 8.98E-05 0. 3.27E-04 0. 8.1 E-05

CM244 1.22E-03 6.16E-04 7.59E-05 0. 2.71 E-04 0. 7.84E-05

CM245 1.88E-03 7.49E-04 1.13E-04 0. 4.32E-04 0. 7.30E-05

CM246 1.87E-03 7.49E-04 1.13E-04 0. 4.31E-04 0. 7.17E-05

CM247 1.82E-03 7.36E-04 1.11E-04 0. 4.24E-04 0. 9.43E-05

CM248 1.51E-02 6.07E-03 9.16E-04 0. 3.50E-03 0. 1.52E-03

CF252 1.24E-03 0. 2.95E-05 0 0. 0. 2.99E-04
Proc No ODCM

Attachment 8

Revision 25

Page 5 of 16

INGESTION DOSE COMMITMENT FACTORS

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3 0. 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07

BE10 1.35E-05 1.57E-06 3.39E-07 0. 1.11E-06 0. 2.75E-05

C14 1.21 E-05 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06

N13 3.1OE-08 3.1OE-08 3.10E-08 3.1OE-08 3.1OE-08 3.1OE-08 3.1OE-08

F18 2.49E-06 0. 2.47E-07 0. 0. 0. 6.74E-07

NA22 5.88E-05 5.88E-05 5.88E-05 5.88E-05 5.88E-05 5.88E-05 5.88E-05

NA24 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06

P32 8.25E-04 3.86E-05 3.18E-05 0. 0. 0. 2.28E-05

AR39 0. 0. 0. 0. 0. 0. 0.

AR41 0. 0. 0. 0. 0. 0. 0.

CA41 3.47E-04 0. 3.79E-05 0. 0. 0. 1.90E-07

SC46 1.97E-08 2.70E-08 1.04E-08 0. 2.30E-08 0. 3.95E-05

CR51 0. 0. 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07

MN54 0. 1.07E-05 2.85E-06 0. 3.OOE-06 0. 8.98E-06

MN56 0. 3.34E-07 7.54E-08 0. 4.04E-07 0. 4.84E-05

FE55 1.15E-05 6.1OE-06 1.89E-06 0. 0. 3.45E-06 1.13E-06

FE59 1.65E-05 2.67E-05 1.33E-05 0. 0. 7.74E-06 2.78E-05

C057 0. 4.93E-07 9.98E-07 0. 0. 0. 4.04E-06

C058 0. 1.80E-06 5.51E-06 0. 0. 0. 1.05E-05

C060 0. 5.29E-06 1.56E-05 0. 0. 0. 2.93E-05

N159 4.02E-05 1.07E-05 6.82E-06 0. 0. 0. 7.1OE-07

N163 5.38E-04 2.88E-05 1.83E-05 0. 0. 0. 1.94E-06

N165 2.22E-06 2.09E-07 1.22E-07 0. 0. 0. 2.56E-05

CU64 0. 2.45E-07 1.48E-07 0. 5.92E-07 0. 1.15E-05

ZN65 1.37E-05 3.65E-05 2.27E-05 0. 2.30E-05 0. 6.41E-06

ZN69M 7.1OE-07 1.21E-06 1.43E-07 0. 7.03E-07 0. 3.94E-05

ZN69 4.38E-08 6.33E-08 5.85E-09 0. 3.84E-08 0. 3.99E-06

SE79 0. 8.43E-06 1.87E-06 0. 1.37E-05 0. 5.53E-07

BR82 0. 0. 7.55E-06 0. 0. 0. 0.

BR83 0. 0. 1.71 E-07 0. 0. 0. 0.

BR84 0. 0. 1.98E-07 0. 0. 0. 0.

BR85 0 0. 9.12E-09 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 0. 0.

KR85M 0. 0. 0. 0. 0. 0. 0.

KR85 0. 0. 0. 0. 0. 0. 0.

KR87 0. 0. 0. 0. 0. 0. 0.

KR88 0. 0. 0. 0. 0. 0. 0.

KR89 0. 0. 0. 0. 0. 0. 0.

RB86 0. 6.70E-05 4.12E-05 0. 0. 0. 4.31E-06

RB87 0. 3.95E-05 1.83E-05 0. 0. 0. 5.92E-07

RB88 0. 1.90E-07 1.32E-07 0. 0. 0. 9.32E-09

RB89 0. 1.17E-07 1.04E-07 0. 0. 0. 1.02E-09

SR89 1.32E-03 0. 3.77E-05 0. 0. 0. 5.11E-05

SR90 1.70E-02 0. 4.31 E-03 0. 0. 0. 2.29E-04

SR91 2.40E-05 0. 9.06E-07 0. 0. 0. 5.30E-05

SR92 9.03E-06 0. 3.62E-07 0. 0. 0. 1.71 E-04
Proc No ODCM

Attachment 8

Revision 25

Page 6 of 16

INGESTION DOSE COMMITMENT FACTORS

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 4.11E-08 0. 1.10E-09 0. 0. 0. 1.17E-04

Y91M 3.82E-10 0. 1.39E-11 0. 0. 0. 7.48E-07

Y91 6.02E-07 0. 1.61 E-08 0. 0. 0. 8.02E-05

Y92 3.60E-09 0. 1.03E-10 0. 0. 0. 1.04E-04

Y93 1.14E-08 0. 3.13E-10 0. 0. 0. 1.70E-04

ZR93 1.67E-07 6.25E-08 4.45E-08 0. 2.42E-07 0. 2.37E-05

ZR95 1.16E-07 2.55E-08 2.27E-08 0. 3.65E-08 0. 2.66E-05

ZR97 6.99E-09 1.01E-09 5.96E-10 0. 1.45E-09 0. 1.53E-04

NB93M 1.05E-07 2.62E-08 8.61 E-09 0. 2.83E-08 0. 3.95E-06

NB95 2.25E-08 8.76E-09 6.26E-09 0. 8.23E-09 0. 1.62E-05

NB97 2.17E-10 3.92E-11 1.83E-11 0. 4.35E-11 0. 1.21E-05

M093 0. 2.41 E-05 8.65E-07 0. 6.35E-06 0. 1.22E-06

M099 0. 1.33E-05 3.29E-06 0. 2.84E-05 0. 1.1OE-05

TC99M 9.23E-10 1.81E-09 3.OOE-08 0. 2.63E-08 9.19E-10 1.03E-06

TC99 5.35E-07 5.96E-07 2.14E-07 0. 7.02E-06 5.27E-08 6.25E-06

TC101 1.07E-09 1.12E-09 1.42E-08 0. 1.91E-08 5.92E-10 3.56E-09

RU103 7.31E-07 0. 2.81E-07 0. 1.84E-06 0. 1.89E-05

RU105 6.45E-08 0. 2.34E-08 0. 5.67E-07 0. 4.21E-05

RU106 1.17E-05 0. 1.46E-06 0. 1.58E-05 0. 1.82E-04

RH105 5.14E-07 2.76E-07 2.36E-07 0. 1.10E-06 0. 1.71E-05

PD107 0. 4.72E-07 4.01E-08 0. 3.95E-06 0. 9.37E-07

PD109 0. 5.67E-07 1.70E-07 0. 3.04E-06 0. 3.35E-05

AG110M 5.39E-07 3.64E-07 2.91E-07 0. 6.78E-07 0. 4.33E-05

AG111 2.48E-07 7.76E-08 5.12E-08 0. 2.34E-07 0. 4.75E-05

CD113M 0. 1.02E-05 4.34E-07 0. 1.05E-05 0. 2.63E-05

CD115M 0. 5.89E-06 2.51 E-07 0. 4.38E-06 0. 8.01 E-05

SN123 1.33E-04 1.65E-06 3.24E-06 1.75E-06 0. 0. 6.52E-05

SN125 3.55E-05 5.35E-07 1.59E-06 5.55E-07 0. 0. 1.10E-04

SN126 3.33E-04 4.15E-06 9.46E-06 1.14E-06 0. 0. 2.50E-05

SB124 1.11E-05 1.44E-07 3.89E-06 2.45E-08 0. 6.16E-06 6.94E-05

SB125 7.16E-06 5.52E-08 1.50E-06 6.63E-09 0. 3.99E-06 1.71E-05

SB126 4.40E-06 6.73E-08 1.58E-06 2.58E-08 0. 2.10E-06 8.87E-05

SB127 1.06E-06 1.64E-08 3.68E-07 1.18E-08 0. 4.60E-07 5.97E-05

TE125M 1.14E-05 3.09E-06 1.52E-06 3.20E-06 0. 0. 1.10E-05

TE127M 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 0. 2.34E-05

TE127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-06 0. 1.84E-05

TE129M 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 0. 5.94E-05

TE129 1.34E-07 3.74E-08 3.18E-08 9.56E-08 3.92E-07 0. 8.34E-06

TE131M 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41E-05 0. 1.01E-04

TE131 8.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51E-07 0. 4.36E-07

TE1 32 1.01 E-05 4.47E-06 5.40E-06 6.51E-06 4.15E-05 0. 4.50E-05

TE133M 1.87E-07 7.56E-08 9.37E-08 1.45E-07 7.18E-07 0. 5.77E-06

TEl 34 1.29E-07 5.80E-08 7.74E-08 1.02E-07 5.37E-07 0. 5.89E-07

1129 1.39E-05 8.53E-06 7.62E-06 5.58E-03 1.44E-05 0. 4.29E-07

1130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 0. 2.76E-06

1131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 0. 1.54E-06
Proc No ODCM

Attachment 8

Revision 25

Page 7 of 16

INGESTION DOSE COMMITMENT FACTORS

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 8.OOE-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 0. 1.73E-06

1133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 0. 2.95E-06

1134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 0. 5.16E-07

1135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 0. 2.40E-06

XE131M 0. 0. 0. 0. 0. 0. 0.

XE133M 0. 0. 0. 0. 0. 0. 0.

XE133 0. 0. 0. 0. 0. 0. 0.

XE135M 0. 0. 0. 0. 0. 0. 0.

XE135 0. 0. 0. 0. 0. 0. 0.

XE137 0. 0. 0. 0. 0. 0. 0.

XE138 0. 0. 0. 0. 0. 0. 0.

CS134M 8.44E-08 1.25E-07 8.16E-08 0. 6.59E-08 1.09E-08 1.58E-07

CS134 2.34E-04 3.84E-04 8.1OE-05 0. 1.19E-04 4.27E-05 2.07E-06

CS135 8.30E-05 5.78E-05 5.93E-06 0. 2.04E-05 6.81E-06 4.33E-07

CS136 2.35E-05 6.46E-05 4.18E-05 0. 3.44E-05 5.13E-06 2.27E-06

CS137 3.27E-04 3.13E-04 4.62E-05 0. 1.02E-04 3.67E-05 1.96E-06

CS138 2.28E-07 3.17E-07 2.01E-07 0. 2.23E-07 2.40E-08 1.46E-07

CS139 1.45E-07 1.61 E-07 7.74E-08 0. 1.21 E-07 1.22E-08 1.45E- 11

BA139 4.14E-07 2.21E-10 1.20E-08 0. 1.93E-10 1.30E-10 2.39E-05

BA140 8.31 E-05 7.28E-08 4.85E-06 0. 2.37E-08 4.34E-08 4.21E-05

BA141 2.OOE-07 1.12E-10 6.51E-09 0. 9.69E-11 6.58E-10 1.14E-07

BA142 8.74E-08 6.29E-11 4.88E-09 0. 5.09E-11 3.70E-11 1. 14E-09

LA140 1.01E-08 3.53E-09 1.19E-09 0. 0. 0. 9.84E-05

LA141 1.35E-09 3.17E-10 6.88E-11 0. 0. 0. 7.05E-05

LA142 5.24E-10 1.67E-10 5.23E-11 0. 0. 0. 3.31E-05

CE141 3.97E-08 1.98E-08 2.94E-09 0. 8.68E-09 0. 2.47E-05

CE143 6.99E-09 3.79E-06 5.49E-10 0. 1.59E-09 0. 5.55E-05

CE144 2.08E-06 6.52E-07 1.11E-07 0. 3.61E-07 0. 1.70E-04

PR143 3.93E-08 1.18E-08 1.95E-09 0. 6.39E-09 0. 4.24E-05

PR144 1.29E-10 3.99E-11 6.49E-12 0. 2.11E-11 0. 8.59E-08

ND147 2.79E-08 2.26E-08 1.75E-09 0. 1.24E-08 0. 3.58E-05

PM147 3.18E-07 2.27E-08 1.22E-08 0. 4.01 E-08 0. 9.19E-06

PM148M 1.03E-07 2.05E-08 2.05E-08 0. 3.04E-08 0. 5.78E-05

PM148 3.02E-08 3.63E-09 2.35E-09 0. 6.17E-09 0. 9.70E-05

PM149 6.49E-09 6.90E-10 3.74E-10 0. 1.22E-09 0. 4.71E-05

PM151 2.92E-09 3.55E-10 2.31E-10 0. 6.02E-10 0. 4.03E-05

SM151 2.56E-07 3.81E-08 1.20E-08 0. 3.94E-08 0. 5.53E-06

SM153 3.65E-09 2.27E-09 2.19E-10 0. 6.91E-10 0. 3.02E-05

EU152 6.15E-07 1.12E-07 1.33E-07 0. 4.73E-07 0. 1.84E-05

EU154 2.30E-06 2.07E-07 1.89E-07 0. 9.09E-07 0. 4.81E-05

EU155 4.82E-07 3.47E-08 2.72E-08 0. 1.30E-07 0. 8.69E-05

EU156 5.62E-08 3.01E-08 6.23E-09 0. 1.94E-08 0. 6.83E-05

TB160 1.66E-07 0. 2.06E-08 0. 4.94E-08 0. 3.68E-05

H0166M 1.08E-06 2.26E-07 1.91E-07 0. 3.22E-07 0. 0.

W181 4.23E-06 1.04E-08 1.43E-09 0. 0. 0. 3.79E-07

W185 1.73E-06 4.32E-07 6.05E-08 0. 0. 0. 1.61E-05

W187 4.29E-07 2.54E-07 1.14E-07 0. 0. 0. 3.57E-05
Proc No ODCM

Attachment 8

Revision 25

Page 8 of 16

INGESTION DOSE COMMITMENT FACTORS

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 4.75E-02 1.22E-02 2.09E-03 0. 3.67E-02 0. 5.57E-05

B1210 1.97E-06 1.02E-05 1.69E-07 0. 1.15E-04 0. 5.17E-05

P0210 1.52E-03 2.43E-03 3.67E-04 0. 7.56E-03 0. 6.55E-05

RN222 0. 0. 0. 0. 0. 0. 0.

RA223 2.12E-02 2.45E-05 4.24E-03 0. 6.50E-04 0. 3.38E-04

RA224 6.89E-03 1.25E-05 1.38E-03 0. 3.31 E-04 0. 3.78E-04

RA225 2.80E-02 2.50E-05 5.59E-03 0. 6.62E-04 0. 3.21 E-04

RA226 5.75E-01 1.84E-05 4.72E-01 0. 4.88E-04 0. 3.41E-04

RA228 3.85E-01 9.99E-06 4.32E-01 0. 2.65E-04 0. 5.81E-05

AC225 1.88E-05 1.94E-05 1.26E-06 0. 2.07E-06 0. 4.31 E-04

AC227 4.12E-03 6.63E-04 2.55E-04 0. 1.46E-04 0. 8.43E-05

TH227 5.85E-05 7.96E-07 1.69E-06 0. 4.22E-06 0. 5.63E-04

TH228 2.07E-03 2.65E-05 7.OOE-05 0. 1.38E-04 0. 5.79E-04

TH229 1.38E-02 1.81 E-04 6.80E-04 0. 8.84E-04 0. 5.27E-04

TH230 3.55E-03 1.78E-04 9.91 E-05 0. 8.67E-04 0. 6.19E-05

TH232 3.96E-03 1.52E-04 3.01 E-04 0. 7.41 E-04 0. 5.27E-05

TH234 3.42E-07 1.51E-08 9.88E-09 0. 8.01E-08 0. 1.18E-04

PA231 7.07E-03 2.34E-04 2.81 E-04 0. 1.28E-03 0. 7.37E-05

PA233 1.81E-08 2.82E-09 3.16E-09 0. 1.04E-08 0. 1.44E-05

U232 1.76E-02 0. 1.26E-03 0. 1.34E-03 0. 6.98E-05

U233 3.72E-03 0. 2.25E-04 0. 6.1OE-04 0. 6.45E-05

U234 3.57E-03 0. 2.21 E-04 0. 5.98E-04 0. 6.32E-05

U235 3.42E-03 0. 2.07E-04 0. 5.61 E-04 0. 8.03E-05

U236 3.42E-03 0. 2.12E-04 0. 5.73E-04 0. 5.92E-05

U237 2.36E-07 0. 6.27E-08 0. 6.81 E-07 0. 2.08E-05

U238 3.27E-03 0. 1.94E-04 0. 5.24E-04 0. 5.66E-05

NP237 2.36E-03 1.81E-04 9.79E-05 0. 6.05E-04 0. 8.16E-05

NP238 5.83E-08 1.18E-09 9.08E-10 0. 3.76E-09 0. 4.04E-05

NP239 5.25E-09 3.77E-10 2.65E-10 0. 1.09E-09 0. 2.79E-05

PU238 1.25E-03 1.56E-04 3.16E-05 0. 1.15E-04 0. 7.50E-05

PU239 1.36E-03 1.65E-04 3.31 E-05 0. 1.22E-04 0. 6.85E-05

PU240 1.36E-03 1.65E-04 3.31 E-05 0. 1.22E-04 0. 6.98E-05

PU241 4.OOE-05 1.72E-06 8.04E-07 0. 2.96E-06 0. 1.44E-06

PU242 1.26E-03 1.59E-04 3.19E-05 0. 1.17E-04 0. 6.71E-05

PU244 1.47E-03 1.82E-04 3.65E-05 0. 1.35E-04 0. 1.OOE-04

AM241 1.43E-03 6.40E-04 1.02E-04 0. 6.23E-04 0. 7.64E-05

AM242M 1.47E-03 6.25E-04 1.04E-04 0. 6.30E-04 0. 9.61E-05

AM243 1.41E-03 6.14E-04 9.83E-05 0. 6.06E-04 0. 8.95E-05

CM242 8.80E-05 6.73E-05 5.84E-06 0. 1.87E-05 0. 8.16E-05

CM243 1.33E-03 6.03E-04 8.24E-05 0. 3.08E-04 0. 8.03E-05

CM244 1.11E-03 5.36E-04 6.93E-05 0. 2.54E-04 0. 7.77E-05

CM245 1.76E-03 6.64E-04 1.05E-04 0. 4.11E-04 0. 7.24E-05

CM246 1.74E-03 6.64E-04 1.05E-04 0. 4.1OE-04 0. 7.11E-05

CM247 1.70E-03 6.53E-04 1.03E-04 0. 4.04E-04 0. 9.35E-05

CM248 1.41 E-02 5.38E-03 8.52E-04 0. 3.33E-03 0. 1.51 E-03

CF252 1.07E-03 0. 2.54E-05 0. 0. 0. 2.96E-04
Proc No ODCM

Attachment 8

Revision 25

Page 9 of 16

INGESTION DOSE COMMITMENT FACTORS

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3 0. 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07

BE10 4.48E-06 6.94E-07 1.13E-07 0. 5.30E-07 0. 2.84E-05

C14 4.06E-06 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07

N13 1.15E-08 1.15E-08 1.15E-08 1.15E-08 1.15E-08 1.15E-08 1.15E-08

F18 8.64E-07 0. 9.47E-08 0. 0. 0. 7.78E-08

NA22 2.34E-05 2.34E-05 2.34E-05 2.34E-05 2.34E-05 2.34E-05 2.34E-05

NA24 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06

P32 2.76E-04 1.71 E-05 1.07E-05 0. 0. 0. 2.32E-05

AR39 0. 0. 0. 0. 0. 0. 0.

AR41 0. 0. 0. 0. 0. 0. 0.

CA41 1.97E-04 0. 2.13E-05 0. 0. 0. 1.95E-07

SC46 7.24E-09 1.41E-08 4.18E-09 0. 1.35E-08 0. 4.80E-05

CR51 0. 0. 3.60E-09 2.OOE-09 7.89E-10 5.14E-09 6.05E-07

MN54 0. 5.90E-06 1.17E-06 0. 1.76E-06 0. 1.21E-05

MN56 0. 1.58E-07 2.81E-08 0. 2.OOE-07 0. 1.04E-05

FE55 3.78E-06 2.68E-06 6.25E-07 0. 0. 1.70E-06 1.16E-06

FE59 5.87E-06 1.37E-05 5.29E-06 0. 0. 4.32E-06 3.24E-05

C057 0. 2.38E-07 3.99E-07 0. 0. 0. 4.44E-06

C058 0. 9.72E-07 2.24E-06 0. 0. 0. 1.34E-05

C060 0 2.81 E-06 6.33E-06 0. 0. 0. 3.66E-05

N159 1.32E-05 4.66E-06 2.24E-06 0. 0. 0. 7.31E-07

N163 1.77E-04 1.25E-05 6.OOE-06 0. 0. 0. 1.99E-06

N165 7.49E-07 9.57E-08 4.36E-08 0. 0. 0. 5.193-06

CU64 0. 1.15E-07 5.41E-08 0. 2.91E-07 0. 8.92E-06

ZN65 5.76E-06 2.00E-05 9.33E-06 0. 1.28E-05 0. 8.47E-06

ZN69M 2.40E-07 5.66E-07 5.19E-08 0. 3.44E-07 0. 3.11 E-05

ZN69 1.47E-08 2.80E-08 1.96E-09 0. 1.83E-08 0. 5.16E-08

SE79 0. 3.73E-06 6.27E-07 0. 6.50E-06 0. 5.70E-07

BR82 0. 0. 3.04E-06 0. 0. 0. 0.

BR83 0. 0. 5.74E-08 0. 0. 0. 0.

BR84 0. 0. 7.22E-08 0. 0. 0. 0.

BR85 0. 0. 3.05E-09 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 0. 0.

KR85M 0. 0. 0. 0. 0. 0. 0.

KR85 0. 0. 0. 0. 0. 0. 0.

KR87 0. 0. 0. 0. 0. 0. 0.

KR88 0. 0. 0. 0. 0. 0. 0.

KR89 0. 0. 0. 0. 0. 0. 0.

RB86 0. 2.98E-05 1.40E-05 0. 0. 0. 4.41E-06

RB87 0. 1.75E-05 6.11E-06 0. 0. 0. 6.11E-07

RB88 0. 8.52E-08 4.54E-08 0. 0. 0. 7.30E-15

RB89 0. 5.50E-08 3.89E-08 0. 0. 0. 8.43E-17

SR89 4.40E-04 0. 1.26E-05 0. 0. 0. 5.24E-05

SR90 8.30E-03 0. 2.05E-03 0. 0. 0. 2.33E-04

SR91 8.07E-06 0. 3.21 E-07 0. 0. 0. 3.66E-05

SR92 3.05E-06 0. 1.30E-07 0. 0. 0. 7.77E-05
Proc No ODCM

Attachment 8

Revision 25

Page 10 of 16

INGESTION DOSE COMMITMENT FACTORS

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 1.37E-08 0. 3.69E-10 0. 0. 0. 1.13E-04

Y91M 1.29E-10 0. 4.93E-12 0. 0. 0. 6.09E-09

Y91 2.01 E-07 0. 5.39E-09 0. 0. 0. 8.24E-05

Y92 1.21 E-09 0. 3.50E-11 0. 0. 0. 3.32E-05

Y93 3.83E-09 0. 1.05E-10 0. 0. 0. 1.17E-04

ZR93 5.53E-08 2.73E-08 1.49E-08 0. 9.65E-08 0. 2.58E-05

ZR95 4.12E-08 1.30E-08 8.94E-09 0. 1.91E-08 0. 3.00E-05

ZR97 2.37E-09 4.69E-10 2.16E-10 0. 7.11E-10 0. 1.27E-04

NB93M 3.44E-08 1.13E-08 2.83E-09 0. 1.32E-08 0. 4.07E-06

NB95 8.22E-09 4.56E-09 2.51 E-09 0. 4.42E-09 0. 1.95E-05

NB97 7.37E-11 1.83E-11 6.68E-12 0. 2.14E-11 0. 4.37E-07

M093 0. 1.06E-05 2.90E-07 0. 3.04E-06 0. 1.29E-06

M099 0. 6.03E-06 1.15E-06 0. 1.38E-05 0. 1.08E-05

TC99M 3.32E-10 9.26E-10 1.20E-08 0. 1.38E-08 5.14E-10 6.08E-07

TC99 1.79E-07 2.63E-07 7.17E-08 0. 3.34E-06 2.72E-08 6.44E-06

TC101 3.60E-10 5.12E-10 5.03E-09 0. 9.26E-09 3.12E-10 8.75E-17

RU103 2.55E-07 0. 1.09E-07 0. 8.99E-07 0. 2.13E-05

RU105 2.18E-08 0. 8.46E-09 0. 2.75E-07 0. 1.76E-05

RU106 3.92E-06 0. 4.94E-07 0. 7.56E-06 0. 1.88E-04

RH105 1.73E-07 1.25E-07 8.20E-08 0. 5.31E-07 0. 1.59E-05

PD107 0. 2.08E-07 1.34E-08 0. 1.88E-06 0. 9.66E-07

PD109 0. 2.51E-07 5.70E-08 0. 1.45E-06 0. 2.53E-05

AG110M 2.05E-07 1.94E-07 1.18E-07 0. 3.70E-07 0. 5.45E-05

AG111 8.29E-08 3.44E-08 1.73E-08 0. 1.12E-07 0. 4.80E-05

CD113M 0. 4.51E-06 1.45E-07 0. 4.99E-06 0. 2.71 E-05

CD115M 0. 2.60E-06 8.39E-08 0. 2.08E-06 0. 8.23E-05

SN123 4.44E-05 7.29E-07 1.08E-06 5.84E-07 0. 0. 6.71E-05

SN125 1.19E-05 2.37E-07 5.37E-07 1.86E-07 0. 0. 1.12E-04

SN126 1.16E-04 2.16E-06 3.30E-06 5.69E-07 0. 0. 2.58E-05

SB124 3.87E-06 7.13E-08 1.51E-06 8.78E-09 0. 3.38E-06 7.80E-05

SB125 2.48E-06 2.71E-08 5.80E-07 2.37E-09 0. 2.18E-06 1.93E-05

SB126 1.59E-06 3.25E-08 5.71E-07 8.99E-09 0. 1.14E-06 9.41E-05

SB127 3.63E-07 7.76E-09 1.37E-07 4.08E-09 0. 2.47E-07 6.16E-05

TE125M 3.83E-06 1.38E-06 5.12E-07 1.07E-06 0. 0. 1.13E-05

TE127M 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 0. 2.41E-05

TE127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 0. 1.22E-05

TE129M 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 0. 6.12E-05

TE129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 0. 2.45E-07

TE131M 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1.22E-05 0. 9.39E-05

TE131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 0. 2.29E-09

TE1 32 3.49E-06 2.21E-06 2.08E-06 2.33E-06 2.12E-05 0. 7.OOE-05

TE133M 6.44E-08 3.66E-08 3.56E-08 5.11E-08 3.62E-07 0. 1.48E-07

TE134 4.47E-08 2.87E-08 3.OOE-08 3.67E-08 2.74E-07 0. 1.66E-09

1129 4.66E-06 3.92E-06 6.54E-06 4.77E-03 7.01E-06 0. 4.57E-07

1130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 0. 2.29E-06

1131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 0. 1.62E-06
Proc No ODCM

Attachment 8

Revision 25

Page 11 of 16

INGESTION DOSE COMMITMENT FACTORS

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 0. 3.18E-07

1133 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 0. 2.58E-06

1134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.1OE-07 0. 5.1OE-09

1135 6. 1OE-07 1.57E-06 5.82E-07 1.01 E-04 2.48E-06 0. 1.74E-06

XE131M 0. 0. 0. 0. 0. 0. 0.

XE133M 0. 0. 0. 0. 0. 0. 0.

XE133 0. 0. 0. 0. 0. 0. 0.

XE135M 0. 0. 0. 0. 0. 0. 0.

XE135 0. 0. 0. 0. 0. 0. 0.

XE137 0. 0. 0. 0. 0. 0. 0.

XE138 0. 0. 0. 0. 0. 0. 0.

CS134M 2.94E-08 6.09E-08 3.13E-08 0. 3.39E-08 5.95E-09 4.05E-08

CS134 8.37E-05 1.97E-04 9.14E-05 0. 6.26E-05 2.39E-05 2.45E-06

CS135 2.78E-05 2.55E-05 5.96E-06 0. 9.73E-06 3.52E-06 4.46E-07

CS136 8.59E-06 3.38E-05 2.27E-05 0. 1.84E-05 2.90E-06 2.72E-06

CS137 1.12E-04 1.49E-04 5.19E-05 0. 5.07E-05 1.97E-05 2.12E-06

CS138 7.76E-08 1.49E-07 7.45E-08 0. 1.1OE-07 1.28E-08 6.76E-11

CS139 4.87E-08 7.17E-08 2.63E-08 0. 5.79E-08 6.34E-09 3.33E-23

BA139 1.39E-07 9.78E-11 4.05E-09 0. 9.22E- 11 6.74E- 11 1.24E-06

BA140 2.84E-05 3.48E-08 1.83E-06 0. 1.18E-08 2.34E-08 4.38E-05

BA141 6.71E-08 5.01E-11 2.24E-09 0. 4.65E- 11 3.43E-11 1.43E-13

BA142 2.99E-08 2.99E-11 1.84E-09 0. 2.53E-11 1.99E-11 9.18E-20

LA140 3.48E-09 1.71E-09 4.55E-10 0. 0. 0. 9.82E-05

LA141 4.55E-10 1.40E-10 2.31 E-11 0. 0. 0. 2.48E-05

LA142 1.79E-10 7.95E-11 1.98E-11 0. 0. 0. 2.42E-06

CE141 1.33E-08 8.88E-09 1.02E-09 0. 4.18E-09 0. 2.54E-05

CE143 2.35E-09 1.71E-06 1.91E-10 0. 7.67E-10 0. 5.14E-05

CE144 6.96E-07 2.88E-07 3.74E-08 0. 1.72E-07 0. 1.75E-04

PR143 1.31E-08 5.23E-09 6.52E-10 0. 3.04E-09 0. 4.31E-05

PR144 4.30E-11 1.76E-11 2.18E-12 0. 1.01E-11 0. 4.74E-14

ND147 9.38E-09 1.02E-08 6.11E-10 0. 5.99E-09 0. 3.68E-05

PM147 1.05E-07 9.96E-09 4.06E-09 0. 1.90E-08 0. 9.47E-06

PM148M 4.14E-08 1.05E-08 8.21 E-09 0. 1.59E-08 0. 6.61E-05

PM148 1.02E-08 1.66E-09 8.36E-10 0. 3.OOE-09 0. 9.90E-05

PM149 2.17E-09 3.05E-10 1.25E-10 0. 5.81E-10 0. 4.49E-05

PM151 9.87E-10 1.63E-10 8.25E-11 0. 2.93E-10 0. 3.66E-05

SM151 8.73E-08 1.68E-08 3.94E-09 0. 1.84E-08 0. 5.70E-06

SM153 1.22E-09 1.01E-09 7.43E-11 0. 3.30E-10 0. 2.85E-05

EU152 2.45E-07 5.90E-08 5.20E-08 0. 2.74E-07 0. 2.17E-05

EU154 7.91E-07 1.02E-07 7.19E-08 0. 4.56E-07 0. 5.39E-05

EU155 1.74E-07 1.68E-08 1.04E-08 0. 6.57E-08 0. 9.63E-05

EU156 1.92E-08 1.44E-08 2.35E-09 0. 9.69E-09 0. 7.36E-05

TB160 6.47E-08 0. 8.07E-09 0. 2.56E-08 0. 4.19E-05

H0166M 3.57E-07 1.10E-07 7.96E-08 0. 1.61E-07 0. 0.

W181 1.42E-08 4.58E-09 4.79E-10 0. 0. 0. 3.90E-07

W185 5.79E-07 1.91E-07 2.02E-08 0. 0. 0. 1.65E-05

W187 1.46E-07 1.19E-07 4.17E-08 0. 0. 0. 3.22E-05
Proc No ODCM

Attachment 8

Revision 25

Page 12 of 16

INGESTION DOSE COMMITMENT FACTORS

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 1.81E-02 5.44E-03 7.01E-04 0. 1.72E-02 0. 5.74E-05

B1210 6.59E-07 4.51E-06 5.66E-08 0. 5.48E-05 0. 5.15E-05

P0210 6.09E-04 1.07E-03 1.23E-04 0. 3.60E-03 0. 6.75E-05

RN222 0. 0. 0. 0. 0. 0. 0.

RA223 7.11E-03 1.08E-05 1.42E-03 0. 3.10E-04 0. 3.43E-04

RA224 2.31 E-03 5.52E-06 4.61 E-04 0. 1.58E-04 0. 3.71 E-04

RA225 9.37E-03 1.1OE-05 1.87E-03 0. 3.15E-04 0. 3.27E-04

RA226 3.22E-01 8.13E-06 2.39E-01 0. 2.32E-04 0. 3.51E-04

RA228 1.37E-01 4.41E-06 1.51 E-01 0. 1.26E-04 0. 5.98E-05

AC225 6.29E-06 8.59E-06 4.22E-07 0. 9.85E-07 0. 4.36E-04

AC227 2.05E-03 3.03E-04 1.22E-04 0. 8.81 E-05 0. 8.68E-05

TH227 1.96E-05 3.52E-07 5.65E-07 0. 2.01E-06 0. 5.75E-04

TH228 6.80E-04 1.14E-05 2.30E-05 0. 6.41E-05 0. 5.97E-04

TH229 8.39E-03 1.26E-04 4.11E-04 0. 6.1OE-04 0. 5.43E-04

TH230 2.16E-03 1.23E-04 6.OOE-05 0. 5.99E-04 0. 6.38E-05

TH232 2.42E-03 1.05E-04 1.63E-04 0. 5.11E-04 0. 5.43E-05

TH234 1.14E-07 6.68E-09 3.31E-09 0. 3.81E-08 0. 1.21E-04

PA231 4.31 E-03 1.62E-04 1.68E-04 0. 9.1OE-04 0. 7.60E-05

PA233 7.33E-09 1.41 E-09 1.26E-09 0. 5.32E-09 0. 1.61 E-05

U232 5.89E-03 0. 4.21 E-04 0. 6.38E-04 0. 7.19E-05

U233 1.24E-03 0. 7.543-05 0. 2.90E-04 0. 6.65E-05

U234 1.19E-03 0. 7.39E-05 0. 2.85E-04 0. 6.51E-05

U235 1.14E-03 0. 6.94E-05 0. 2.67E-04 0. 8.28E-05

U236 1.14E-03 0. 7.09E-05 0. 2.73E-04 0. 6.11 E-05

U237 7.89E-08 0. 2.1OE-08 0. 3.24E-07 0. 2.09E-05

U238 1.09E-03 0. 6.49E-05 0. 2.50E-04 0. 5.83E-05

NP237 1.44E-03 1.25E-04 5.85E-05 0. 4.33E-04 0. 8.41 E-05

NP238 1.95E-08 5.22E-10 3.04E-10 0. 1.79E-09 0. 3.83E-05

NP239 1.76E-09 1.66E-10 9.22E-11 0. 5.21E-10 0. 2.67E-05

PU238 7.21 E-04 1.02E-04 1.82E-05 0. 7.80E-05 0. 7.73E-05

PU239 8.27E-04 1.12E-04 2.01E-05 0. 8.57E-05 0. 7.06E-05

PU240 8.26E-04 1.12E-04 2.01 E-05 0. 8.56E-05 0. 7.19E-05

PU241 1.84E-05 9.42E-07 3.69E-07 0. 1.71E-06 0. 1.48E-06

PU242 7.66E-04 1.08E-04 1.94E-05 0. 8.25E-05 0. 6.92E-05

PU244 8.95E-04 1.23E-04 2.22E-05 0. 9.45E-05 0. 1.03E-04

AM241 8.62E-04 3.29E-04 5.75E-05 0. 4.31E-04 0. 7.87E-05

AM242M 8.70E-04 3.19E-04 5.80E-05 0. 4.30E-04 0. 9.90E-05

AM243 8.60E-04 3.17E-04 5.62E-05 0. 4.22E-04 0. 9.23E-05

CM242 2.94E-05 2.97E-05 1.95E-06 0. 8.89E-06 0. 8.40E-05

CM243 6.91 E-04 2.86E-04 4.09E-05 0. 1.91 E-04 0. 8.28E-05

CM244 5.32E-04 2.49E-04 3.19E-05 0. 1.49E-04 0. 8.OOE-05

CM245 1.07E-03 3.33E-04 6.1OE-05 0. 2.85E-04 0. 7.46E-05

CM246 1.06E-03 3.32E-04 6.09E-05 0. 2.84E-04 0. 7.33E-05

CM247 1.03E-03 3.27E-04 6.OOE-05 0. 2.80E-04 0. 9.63E-05

CM248 8.60E-03 2.69E-03 4.95E-04 0. 2.31 E-03 0. 1.55E-03

CR252 3.51 E-04 0. 8.37E-06 0. 0. 0. 3.05E-04
Proc No ODCM

Attachment 8

Revision 25

Page 13 of 16

INGESTION DOSE COMMITMENT FACTORS

ADULT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

H3 0. 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07

BE10 3.18E-06 4.91E-07 7.94E-08 0. 3.71 E-07 0. 2.68E-05

C14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07

N13 8.36E-09 8.36E-09 8.36E-09 8.36E-09 8.36E-09 8.36E-09 8.36E-09

F18 6.24E-07 0. 6.92E-08 0. 0. 0. 1.85E-08

NA22 1.74E-05 1.74E-05 1.74E-05 1.74E-05 1.74E-05 1.74E-05 1.74E-05

NA24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06

P32 1.93E-04 1.20E-05 7.46E-06 0. 0. 0. 2.17E-05

AR39 0. 0. 0. 0. 0. 0. 0.

AR41 0. 0. 0. 0. 0. 0. 0.

CA41 1.83E-05 0. 2.OOE-05 0. 0. 0. 1.84E-07

SC46 5.51E-09 1.07E-08 3.11E-09 0. 9.99E-09 0. 5.21E-05

CR51 0. 0. 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07

MN54 0. 4.57E-06 8.72E-07 0. 1.36E-06 0. 1.40E-05

MN56 0. 1.15E-07 2.04E-08 0. 1.46E-07 0. 3.67E-06

FE55 2.75E-06 1.90E-06 4.43E-07 0. 0. 1.06E-06 1.09E-06

FE59 4.34E-06 1.02E-05 3.91 E-06 0. 0. 2.85E-06 3.40E-05

C057 0. 1.75E-07 2.91 E-07 0. 0. 0. 4.44E-06

C058 0. 7.45E-07 1.67E-06 0. 0. 0. 1.51E-05

C060 0. 2.14E-06 4.72E-06 0. 0. 0. 4.02E-05

N159 9.76E-06 3.35E-06 1.63E-06 0. 0. 0. 6.90E-07

N163 1.30E-04 9.01E-06 4.36E-06 0. 0. 0. 1.88E-06

N165 5.28E-07 6.86E-08 3.13E-08 0. 0. 0. 1.74E-06

CU64 0. 8.33E-08 3.91 E-08 0. 2.1OE-07 0. 7.1OE-06

ZN65 4.84E-06 1.54E-05 6.96E-06 0. 1.03E-05 0. 9.70E-06

ZN69M 1.70E-07 4.08E-07 3.73E-08 0. 2.47E-07 0. 2.49E-05

ZN69 1.03E-08 1.97E-08 1.37E-09 0. 1.28E-08 0. 2.96E-09

SE79 0. 2.63E-06 4.39E-07 0. 4.55E-06 0. 5.38E-07

BR82 0. 0. 2.26E-06 0. 0. 0. 2.59E-06

BR83 0. 0. 4.02E-08 0. 0. 0. 5.79E-08

BR84 0. 0. 5.21E-08 0. 0. 0. 4.09E-13

BR85 0. 0. 2.14E-09 0. 0. 0. 0.

KR83M 0. 0. 0. 0. 0. 0. 0.

KR85M 0. 0. 0. 0. 0. 0. 0.

KR85 0. 0. 0. 0. 0. 0. 0.

KR87 0. 0. 0. 0. 0. 0. 0.

KR88 0. 0. 0. 0. 0. 0. 0.

KR89 0. 0. 0. 0. 0. 0. 0.

RB86 0. 2.11E-05 9.83E-06 0. 0. 0. 4.16E-06

RB87 0. 1.23E-05 4.28E-06 0. 0. 0. 5.76E-07

RB88 0. 6.05E-08 3.21 E-08 0. 0. 0. 8.36E-19

RB89 0. 4.01E-08 2.82E-08 0. 0. 0. 2.33E-21

SR89 3.08E-04 0. 8.84E-06 0. 0. 0. 4.94E-05

SR90 7.58E-03 0. 1.86E-03 0. 0. 0. 2.19E-04

SR91 5.67E-06 0. 2.29E-07 0. 0. 0. 2.70E-05

SR92 2.15E-06 0. 9.30E-08 0. 0. 0. 4.26E-05
Proc No ODCM

Attachment 8

Revision 25

Page 14 of 16

INGESTION DOSE COMMITMENT FACTORS

ADULT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

Y90 9.62E-09 0. 2.58E-10 0. 0. 0. 1.02E-04

Y91M 9.09E-11 0. 3.52E-12 0. 0. 0. 2.67E-10

Y91 1.41 E-07 0. 3.77E-09 0. 0. 0. 7.76E-05

Y92 8.45E-10 0. 2.47E-11 0. 0. 0. 1.48E-05

Y93 2.68E-09 0. 7.40E-11 0. 0. 0. 8.50E-05

ZR93 4.18E-08 2.34E-09 1.09E-09 0. 8.87E-09 0. 2.43E-06

ZR95 3.04E-08 9.75E-09 6.60E-09 0. 1.53E-08 0. 3.09E-05

ZR97 1.68E-09 3.39E-10 1.55E-10 0. 5.12E-10 0. 1.05E-04

NB93M 2.55E-08 8.32E-09 2.05E-09 0. 9.57E-09 0. 3.84E-06

NB95 6.22E-09 3.46E-09 1.86E-09 0. 3.42E-09 0. 2.1OE-05

NB97 5.22E-11 1.32E-11 4.82E-12 0. 1.54E-11 0. 4.87E-08

M093 0. 7.51E-06 2.03E-07 0. 2.13E-06 0. 1.22E-06

M099 0. 4.31E-06 8.20E-07 0. 9.76E-06 0. 9.99E-06

TC99M 2.47E-10 6.98E-10 8.89E-09 0. 1.06E-08 3.42E-10 4.13E-07

TC99 1.25E-07 1.86E-07 5.02E-08 0. 2.34E-06 1.58E-08 6.08E-06

TC101 2.54E-10 3.66E-10 3.59E-09 0. 6.59E-09 1.87E-10 1. 10E-21

RU103 1.85E-07 0. 7.97E-08 0. 7.06E-07 0. 2.16E-05

RU105 1.54E-08 0. 6.08E-09 0. 1.99E-07 0. 9.42E-06

RU106 2.75E-06 0. 3.48E-07 0. 5.31 E-06 0. 1.78E-04

RH105 1.21E-07 8.85E-08 5.83E-08 0. 3.76E-07 0. 1.41 E-05

PD107 0. 1.47E-07 9.40E-09 0. 1.32E-06 0. 9.11E-07

PD109 0. 1.77E-07 3.99E-08 0. 1.01E-06 0. 1.96E-05

AG110M 1.60E-07 1.48E-07 8.79E-08 0. 2.91 E-07 0. 6.04E-05

AG111 5.81E-08 2.43E-08 1.21E-08 0. 7.84E-08 0. 4.46E-05

CDI13M 0. 3.18E-06 1.02E-07 0. 3.50E-06 0. 2.56E-05

CD115M 0. 1.84E-06 5.87E-08 0. 1.46E-06 0. 7.74E-05

SN123 3.11E-05 5.15E-07 7.59E-07 4.38E-07 0. 0. 6.33E-05

SN125 8.33E-06 1.68E-07 3.78E-07 1.39E-07 0. 0. 1.04E-04

SN126 8.45E-05 1.67E-06 2.40E-06 4.92E-07 0. 0. 2.43E-05

SB124 2.80E-06 5.29E-08 1.11E-06 6.79E-09 0. 2.18E-06 7.95E-05

SB125 1.79E-06 2.OOE-08 4.26E-07 1.82E-09 0. 1.38E-06 1.97E-05

SB126 1.15E-06 2.34E-08 4.15E-07 7.04E-09 0. 7.05E-07 9.40E-05

SB127 2.58E-07 5.65E-09 9.90E-08 3.1OE-09 0. 1.53E-07 5.90E-05

TE125M 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 0. 1.07E-05

TE125M 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 0. 2.27E-05

TE127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 0. 8.68E-06

TE129M 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 0. 5.79E-05

TE129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 0. 2.37E-08

TE131M 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 0. 8.40E-05

TE1 31 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 0. 2.79E-09

TEl 32 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 0. 7.71 E-05

TE1 33M 4.62E-08 2.70E-08 2.60E-08 3.91E-08 2.67E-07 0. 6.64E-08

TE134 3.24E-08 2.12E-08 1.30E-08 2.83E-08 2.05E-07 0. 3.59E-11

1129 3.27E-06 2.81E-06 9.21E-06 7.23E-03 6.04E-06 0. 4.44E-07

1130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 0. 1.92E-06

1131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 0. 1.57E-06
Proc No ODCM

Attachment 8

Revision 25

Page 15 of 16

INGESTION DOSE COMMITMENT FACTORS

ADULT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

1132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 0. 1.02E-07

1133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 0. 2.22E-06

1134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 0. 2.51E-10

1135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 0. 1.31E-06

XE131M 0. 0. 0. 0. 0. 0. 0.

XE133M 0. 0. 0. 0. 0. 0. 0.

XE133 0. 0. 0. 0. 0. 0. 0.

XE135M 0. 0. 0. 0. 0. 0. 0.

XE135 0. 0. 0. 0. 0. 0. 0.

XE137 0. 0. 0. 0. 0. 0. 0.

XE138 0. 0. 0. 0. 0. 0. 0.

CS134M 2.13E-08 4.48E-08 2.29E-08 0. 2.43E-08 3.83E-09 1.58E-08

CS134 6.22E-05 1.48E-04 1.21 E-04 0. 4.79E-05 1.59E-05 2.59E-06

CS135 1.95E-05 1.80E-05 7.99E-06 0. 6.81E-06 2,04E-06 4.21E-07

CS136 6.51 E-06 2.57E-05 1.85E-05 0. 1.43E-05 1.96E-06 2.92E-06

CS137 7.97E-05 1.09E-04 7.14E-05 0. 3.70E-05 1.23E-05 2.11E-06

CS138 6.52E-08 1.09E-07 5.40E-08 0. 8.01 E-08 7.91E-09 4.65E-13

CS139 3.41 E-08 5.08E-08 1.85E-08 0. 4.07E-08 3.70E-09 1.10E-30

BA139 9.70E-08 6.91E-11 2.84E-09 0. 6.46E-11 3.92E-11 1.72E-07

BA140 2.03E-05 2.55E-08 1.33E-06 0. 8.67E-09 1.46E-08 4.18E-05

BA141 4.71E-08 3.56E-11 1.59E-09 0. 3.31E-11 2.02E-11 2.22E-17

BA142 2.13E-08 2.19E-11 1.34E-09 0. 1.85E-11 1.24E-11 3.OOE-26

LA140 2.50E-09 1.26E-09 3.33E-10 0. 0. 0. 9.25E-05

LA141 3.19E-10 9.90E-11 1.62E-11 0. 0. 0. 1.18E-05

LA142 1.28E-10 5.82E-11 1.45E-11 0. 0. 0. 4.25E-07

CE141 9.36E-09 6.33E-09 7.18E-10 0. 2.94E-09 0. 2.42E-05

CE143 1.65E-09 1.22E-06 1.35E-10 0. 5.37E-10 0. 4.56E-05

CE144 4.88E-07 2.04E-07 2.62E-08 0. 1.21E-07 0. 1.65E-04

PR143 9.20E-09 3.69E-09 4.56E-10 0. 2.13E-09 0. 4.03E-05

PR144 3.01E-11 1.25E-11 1.53E-12 0. 7.05E-12 0. 4.33E-18

ND147 6.29E-09 7.27E-09 4.35E-10 0. 4.25E-09 0. 3.49E-05

PM147 7.54E-08 7.09E-09 2.87E-09 0. 1.34E-08 0. 8.93E-06

PM148M 3.07E-08 7.95E-09 6.08E-09 0. 1.20E-08 0. 6.74E-05

PM148 7.17E-09 1.19E-09 5.99E-10 0. 2.25E-09 0. 9.35E-05

PM149 1.52E-09 2.15E-10 8.78E-11 0. 4.06E-10 0. 4.03E-05

PM151 6.97E-10 1.17E-10 5.91E-11 0. 2.09E-10 0. 3.22E-05

SM151 6.90E-08 1.19E-08 2.85E-09 0. 1.33E-08 0. 5.25E-06

SM153 8.57E-10 7.15E-10 5.22E-11 0. 2.31E-10 0. 2.55E-05

EU152 1.95E-07 4.44E-08 3.90E-08 0. 2.75E-07 0. 2.56E-05

EU154 6.15E-07 7.56E-08 5.38E-08 0. 3.62E-07 0. 5.48E-05

EU155 8.60E-08 1.22E-08 7.87E-09 0. 5.63E-08 0. 9.60E-06

EU156 1.37E-08 1.06E-08 1.71E-09 0. 7.08E-09 0. 7.26E-05

TB160 4.70E-08 0. 5.86E-09 0. 1.94E-08 0. 4.33E-05

H0166M 2.70E-07 8.43E-08 6.40E-08 0. 1.26E-07 0. 0.

W181 9.91E-09 3.23E-09 3.46E-10 0. 0. 0. 3.68E-07

W185 4.05E-07 1.35E-07 1.42E-08 0. 0. 0. 1.56E-05

W187 1.03E-07 8.61 E-08 3.01 E-08 0. 0. 0. 2.82E-05
Proc No ODCM

Attachment 8

Revision 25

Page 16 of 16

INGESTION DOSE COMMITMENT FACTORS

ADULT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR)

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI

PB210 1.53E-02 4.37E-03 5.44E-04 0. 1.23E-02 0. 5.42E-05

B1210 4.61E-07 3.18E-06 3.96E-08 0. 3.83E-05 0. 4.75E-05

P0210 3.56E-04 7.56E-04 8.59E-05 0. 2.52E-03 0. 6.36E-05

RN222 0. 0. 0. 0. 0. 0. 0.

RA223 4.97E-03 7.65E-06 9.94E-04 0. 2.17E-04 0. 3.21E-04

RA224 1.61E-03 3.90E-06 3.23E-04 0. 1.10E-04 0. 3.40E-04

RA225 6.56E-03 7.78E-06 1.31 E-03 0. 2.21 E-04 0. 3.06E-04

RA226 3.02E-01 5.74E-06 2.20E-01 0. 1.63E-04 0. 3.32E-04

RA228 1.12E-01 3.12E-06 1.21 E-01 0. 8.83E-05 0. 5.64E-05

AC225 4.40E-06 6.06E-06 2.96E-07 0. 6.90E-07 0. 4.07E-04

AC227 1.87E-03 2.48E-04 1.11E-04 0. 8.OOE-05 0. 8.19E-05

TH227 1.37E-05 2.48E-07 3.95E-07 0. 1.41 E-06 0. 5.40E-04

TH228 4.96E-04 8.40E-06 1.68E-05 0. 4.67E-05 0. 5.63E-04

TH229 7.98E-03 1.19E-04 3.91E-04 0. 5.75E-04 0. 5.12E-04

TH230 2.06E-03 1.17E-04 5.70E-05 0. 5.65E-04 0. 6.02E-05

TH232 2.30E-03 1.OOE-04 1.50E-04 0. 4.82E-04 0. 5.12E-05

TH234 8.01E-08 4.71E-09 2.31E-09 0. 2.67E-08 0. 1.13E-04

PA231 4.1OE-03 1.54E-04 1.59E-04 0. 8.64E-04 0. 7.17E-05

PA233 5.26E-09 1.06E-09 9.12E-10 0. 3.99E-09 0. 1.64E-05

U232 4.13E-03 0. 2.95E-04 0. 4.47E-04 0. 6.78E-05

U233 8.71 E-04 0. 5.28E-05 0. 2.03E-04 0. 6.27E-05

U234 8.36E-04 0. 5.17E-05 0. 1.99E-04 0. 6.14E-05

U235 8.01 E-04 0. 4.86E-05 0. 1.87E-04 0. 7.81 E-05

U236 8.01E-04 0. 4.96E-05 0. 1.91E-04 0. 5.76E-05

U237 5.52E-8 0. 1.47E-08 0. 2.27E-07 0. 1.94E-05

U238 7.67E-04 0. 4.54E-05 0. 1.75E-04 0. 5.50E-05

NP237 1.37E-03 1. 19E-04 5.54E-05 0. 4.12E-04 0. 7.94E-05

NP238 1.37E-08 3.69E-10 2.13E-10 0. 1.25E-09 0. 3.43E-05

NP239 1.19E-09 1.17E-10 6.45E-11 0. 3.65E-10 0. 2.40E-05

PU238 6.80E-04 9.58E-05 1.71 E-05 0. 7.32E-05 0. 7.30E-05

PU239 7.87E-04 1.06E-04 1.91E-05 0. 8.11E-05 0. 6.66E-05

PU240 7.85E-04 1.06E-04 1.91 E-05 0. 8.1OE-05 0. 6.78E-05

PU241 1.65E-05 8.44E-07 3.32E-07 0. 1.53E-06 0. 1.40E-06

PU242 7.29E-04 1.02E-04 1.84E-05 0. 7.81 E-05 0. 6.53E-05

PU244 8.52E-04 1.17E-04 2.11E-05 0. 8.95E-05 0. 9.73E-05

AM241 8.19E-04 2.88E-04 5.41E-05 0. 4.07E-04 0. 7.42E-05

AM242M 8.24E-04 2.78E-04 5.43E-05 0. 4.05E-04 0. 9.34E-05

AM243 8.18E-04 2.78E-04 5.30E-05 0. 3.99E-04 0. 8.70E-05

CM242 2.06E-05 2.1OE-05 1.37E-06 0. 6.22E-06 0. 7.92E-05

CM243 6.39E-04 2.41 E-04 3.75E-05 0. 1.75E-04 0. 7.81E-05

CM244 4.83E-04 2.07E-04 2.87E-05 0. 1.34E-04 0. 7.55E-05

CM245 1.02E-03 2.87E-04 5.76E-05 0. 2.69E-04 0. 7.04E-05

CM246 1.01E-03 2.87E-04 5.75E-05 0. 2.68E-04 0. 6.91E-05

CM247 9.84E-04 2.83E-04 5.67E-05 0. 2.64E-04 0. 9.09E-05

CM248 8.18E-03 2.33E-03 4.67E-04 0. 2.18E-03 0. 1.47E-03

CF252 2.64E-04 0. 6.29E-06 0. 0. 0. 2.88E-04
ENCLOSURE 2

PALISADES NUCLEAR PLANT

JOINT FREQUENCY TABLES MET DATA

32 Pages Follow
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe'

1/1/13 - 3/31/13

A

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12 13-18 19-24 >24 Total

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

3

1

1

1

1

2

3

7

5

4

2

3

1

2

3

0

0

0

0

3

1

10

13

2

4

16

2

11

11

7

14 2

2

7 4

4 6

4

1

3

Total 3 42 31 7 83

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 1 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe

1/1/13 - 3/31/13

B

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1

1

1

3

13-18 19-24 >24 Total

4

1

1

0

1 3

2

1

3

3

2

5

8

7

3

2

2

1

3

2

7

8

1

3

2

1

4

3

2

3

6

3

1

5

5

13

16

9

Total 0 35 31 10 0 0 76

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 2 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spei

1/1/13 - 3/31/13

C

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12 13-18 19-24 >24 Total

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

2

1

1

2

1

1 3

11

2

1 4

5

6

8

2

1

1

1

2

2

5

3

2

4

4

6

12

11

1

2

1

1

4

4

1

2

4

2

3

1

2

6

7

7

2

6

6

8

11

22

23

2

Total 3 36 56 14 3 112

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 3 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: SpeE

1/1/13 - 3/31/13

D

Ad: SP10M Direction: DIR10M Lapse: DT50M

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

Wind Speed (MPH)

1-3 4-7 8-12 13-18 19-24 >24 Total

2

2

7

2

3

1

5

2

3

5

4

4

5

7

19

36

26

18

10

6

20

27

23

12

16

14

20

34

49

21

45

19

14

13

20

13

37

36

14

10

45

68

55

110

143

67

1

2

2

2

15

18

31

19

11

24

37

64

64

19

3

3

5

67

59

49

33

50

40

92

92

39

22

75

111

119

215

262

116

3

3

1

2 -----------------------------------------------------------------------------------------------

Total 52 351 709 309 20 1441

Periods of Calm (hours):

Variable direction:

Hours of Missing Data:

3

0

0

Hours are not adjusted for Daylight Savings Time.

Page 4 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spei

1/1/13 - 3/31/13

E

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

1 4

3 8

2 9 1

3 12 4

1 13 3

2 5 1

2 17 18

3 23 28

3 41 18

2 13 9

1 9 5

5 5

7 8

1 7 2

2 9 1

1 6 1

13-18 19-24 >24 Total

4

1

4

13

5

11

12

19

18

9

41

67

62

24

16

11

15

10

12

8

1

1

Total 27 188 104 21 340

Periods of Calm (hours): 1

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 5 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spei

1/1/13 - 3/31/13

F

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

1 2

2

1

2

4

5

1

1

1

1

1

2

1

5

1

3

8

19

5

1

13-18 19-24 >24 Total

3

0

3

6

3

7

13

20

6

3

1

0

1

1

2

0

1

1

Total 22 45 2 69

Periods of Calm (hours): 1

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 6 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spei

1/1/13 - 3/31/13

G

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12 13-18 19-24 >24 Total

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1

1

1

2

1

2

1

1

2

8

8

6

0

1

0

0

1

3

10

9

8

1

0

0

1

0

0

0

Total 10 24 34

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 7 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spei

1/1/13 - 3/31/13

All

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

Wind Speed (MPH)

1-3 4-7 8-12 13-18 19-24 >24 Total

4

6

11

4

6

10

11

10

9

4

7

5

7

6

9

8

26

47

38

36

25

17

57

84

85

31

29

37

38

61

75

35

53

20

16

17

24

21

57

75

44

22

55

82

63

124

169

91

1

3

2

4

19

19

36

34

3

12

25

38

67

71

27

3

4

5

84

76

67

61

77

67

165

208

141

57

103

149

151

261

325

163

5

3

1

2

-----------------------------------------------------------------------------------------------

Total 117 721 933 361 23 2155 -----------------------------------------------------------------------------------------------

Periods of Calm (hours):

Variable direction:

Hours of Missing Data:

5

0

0

Hours are not adjusted for Daylight Savings Time.

Page 8 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record: 4/

Stability Class:

Elevation: Speed: SP10M

1/13 - 6/30/13

A

Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

2

2

1

2

1

3

6

5

1

1

1

3

1 4

8

11

4

6

4 16

23

4 31

3 56

2 20

3

5

16

18

9

3

6

12

6

22

31

5

2

8

1

1

7

4

6

8

3

13

24

35

20

7

12

32

26

41

82

58

3

1

5

Total 19 194 138 25 2 378

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 9 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe

4/1/13 - 6/30/13

B

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

2 2

1

1 1

1 1

1

1

1

2

1

2

2 2

6

9

3

2 1

12

6

8

5

4

2

1

1

7

7

3

3

1 1

4

1

2

3

1

4

13

8

6

4

8

9

6

4

19

14

2

1

Total 5 49 41 10 1 0 106

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 10 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record: 4/1/13 - 6/30/13

Stability Class: C

Elevation: Speed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12 13-18 19-24 >24 Total

N 5 1 6

NNE 1 1

NE 2 2

ENE 1 1 1 3

E 1 1

ESE 1 2 3 2 8

SE 1 6 2 9

SSE 5 4 2 4 15

S 1 6 7

SSW 3 3

SW 3 2 5

WSW 1 4 2 7

W 1 2 1 2 6

WNW 1 1 2 1 5

NW 3 6 4 13

NNW 5 5 4 14

Total 8 43 35 15 4 105

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 11 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spei

4/1/13 - 6/30/13

D

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

2 17 5

2 9 4

2 3 2

3 16 11

1 4 12

4 12 14

1 10 34

20 32

3 24 11

3 10 1

8 22 20

4 25 13

10 16 14

12 8 7

7 25 10

3 49 29

13-18 19-24 >24 Total

2

16

10

25

8

2

4

5

2

24

15

7

32

35

44

75

62

38

15

50

59

45

29

51

99

1

17

5

2

9

18

Total 65 270 219 113 13 680

Periods of Calm (hours): 2

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 12 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe

4/1/13 - 6/30/13

E

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

5

4

5

2

9

6

5

5

5

7

3

3

11

8

9

10

16

14

15

10

11

20

27

33

27

13

30

16

9

1

11

18

3

1

3

9

13

49

45

4

2

6

5

1

1

5

18

6

2

1

24

19

20

15

34

39

101

90

36

22

44

25

22

10

20

33

5

1

1

5

Total 97 271 147 36 3 554

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 13 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spew

4/1/13 - 6/30/13

F

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

2

1

2

3

6

2

1

5

6

3

4

7

4

3

4

3

7

3

4

10

7

10

10

22

17

4

2

1

1

6

1

3

1

8

10

4

6

13

16

13

19

27

23

7

6

7

5

3

5

10

Total 56 104 14 174

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 14 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: SpeE

4/1/13 - 6/30/13

G

Ad: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

1 3

1 3

3 1

5 12 3

5 13

5 10

3 14 1

4 19 1

13-18 19-24 >24 Total

4

4

4

20

18

15

18

24

21

5

6

2

4

4

5

4

5

2

5

2

4

2

5

2

16

3

1

2

2

Total 54 99 5 158

Periods of Calm (hours): 1

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 15 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe

4/1/13 - 6/30/13

All

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

10 52 17

10 31 7

14 29 4

16 56 19

21 36 28

18 58 36

11 68 122

14 108 105

19 98 34

17 39 6

20 70 36

21 70 30

30 54 17

32 44 17

31 111 43

20 106 78

13-18 19-24 >24 Total

3

21

20.,

50

25

2

4

8

9

79

48

47

94

108

136

259

261

151

63

131

141

114

96

195

232

1

5

20

13

3

10

28

Total 304 1030 599 199 23 2155

Periods of Calm (hours):

Variable direction:

Hours of Missing Data:

3

0

26

Hours are not adjusted for Daylight Savings Time.

Page 16 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spei

7/1/13 - 9/30/13

A

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

14

3

4

1 13

10

2 12

2 21

11

2 1

2 2

2 10

4 24

4 20

5 25

2 48

1 69

5

13

19

8

4

2

34

13-18 19-24 >24 Total

19

3

4

14

10

27

42

19

3

4

16

28

24

30

52

3 107

Total 27 287 85 3 402

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 17 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe

7/1/13 - 9/30/13

B

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12 13-18 19-24 >24 Total

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1

1 2

2

2

1

1

3

5

2

3

1

11

6

6

2

6

11

2

1

6

1

1

1

3

2

3

3

2

0

3

7

3

3

1

17

7

8

5

9

14

2

2

2

Total 7 63 17 0 0 0 87

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 18 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe4

7/1/13 - 9/30/13

C

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

2

3

3

2

1

3

1

3

2

1 3

1

1 1

1 22

2 7

2 3

2 4

3 3

11

1

5

3

0

2

1

5

5

4

1

2

24

9

5

6

6

15

1

3 1

Total 12 66 13 2 93

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 19 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record: 7/

Stability Class:

Elevation: Speed: SP10M

1/13 - 9/30/13

D

Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

4

2

2

2

2

1

4

2

9

2

14

17

11

3

14

3

21

13

8

9

11

9

13

21

8

14

55

14

10

9

17

56

7

2

2

2

8

12

7

16

4

3

7

23

1

32

17

10

14

15

18

29

30

17

16

85

31

25

15

38

1 83

Total 92 288 93 2 475

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 20 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe4

7/1/13 - 9/30/13

E

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

Wind Speed (MPH)

1-3 4-7 8-12 13-18 19-24 >24 Total

17

8

14

9

8

6

10

6

23

6

11

7

8

2

8

13

58

12

2

19

11

23

16

24

31

14

37

30

15

10

5

34

6

3

1

11

3

20

10

38

4

3

1

1

3

1

81

21

17

29

20

32

46

41

54

20

86

41

26

13

14

50

Total 156 341 93 1 591

Periods of Calm (hours): 2

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 21 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe4

7/1/13 - 9/30/13

F

ed: SP10M Direction: DIR10M Lapse:DT50M

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

Wind Speed (MPH)

1-3 4-7 8-12 13-18 19-24 >24 Total

8

9

10

12

5

6

8

14

23

9

4

2

2

10

5

3

17

10

18

24

22

21

15

2

1

5

1

18

14

13

29

15

25

37

37

44

24

6

2

2

0

3

7

3

7

Total 122 147 7 276

Periods of Calm (hours): 2

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 22 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spec

7/1/13 - 9/30/13

G

ad: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

,WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

3

8

8

5

12

2

14

13

2

1

1

3

8

22

30

37

45

54

10

1

4

0

11

16

27

42

39

59

67

12

2

0

0

0

0

0

Total 68 211 279

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 23 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe'

7/1/13 - 9/30/13

All

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

Wind Speed (MPH)

1-3 4-7 8-12 13-18 19-24 >24 Total

32

20

34

32

20

27

26

37

70

22

33

32

29

14

32

24

107

38

22

68

65

98

118

128

119

57

138

81

54

50

79

181

22

3

2

5

3

26

61

27

65

5

7

5

11

66

1

1

1

161

61

58

106

88

152

205

193

189

79

236

118

90

69

122

5 276 -----------------------------------------------------------------------------------------------

Total 484 1403 308 8 2203 -----------------------------------------------------------------------------------------------

Periods of Calm (hours):

Variable direction:

Hours of Missing Data:

4

0

1

Hours are not adjusted for Daylight Savings Time.

Page 24 of 32
SITE: Palisades

Period of Record:

Stability Class:

Elevation: Spe4

Hours at each Wind Speed and Direction

10/1/13 - 12/31/13

A

ed: SP10 )M Direction: DIR10M Lapse: DT50M

------------------------------------------------------------------------------------------

Wind

Direction

Wind Speed (MPH)

1-3 4-7 8-12 13-18 19-24 >24 Total

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1

1

3

2

3

6

7

1 5

3

1 6

2

6

1 2

2 10

3

1

4

4

3

5

1

5

1

0

1

3

3

4

10

11

9

3

7

7

7

3

17

3

Total 7 58 24 89

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 25 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record: 10/1/13 - 12/31/13

Stability Class: B

Elevation: Speed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12 13-18 19-24 >24 Total

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1

2

1

2

1

4

2

5

3

5

5

3

2

5

2

1

4

1

1

2

4

1

2

5

1

2

0

1

0

1

2

1

5

8

5

5

5

9

7

5

7

5

Total 5 37 20 3 1 0 66

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 26 of 32
SITE: Palisades

Period of Record:

Stability Class:

Elevation: Spei

Hours at each Wind Speed and Direction

10/1/13 - 12/31/13

C

ed: SP10 IM Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction 1-3 4-7 8-12 13-18 19-24 >24 Total

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1

3

1

1 3

6

9

2

1 7

5

1 4

1 4

2

9

4

2

4

2

2

3

1

3

1

0

0

1

3

1

2

14

13

11

6

10

7

8

5

1

4

1

2 1

Total 4 47 30 5 86

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 27 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe

10/1/13 - 12/31/13

D

Ad: SP10M Direction: DIR10M Lapse: DT50M

------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

2 5

2 12

5 14

5 17

4 10

3 10

1 22

2 50

3 71

3 36

6 24

2 10

3 34

1 23

42

1 28

7

7

8

10

8

45

62

10

11

27

58

129

130

106

39

1

6

12

11

22

8

6

42

22

19

41

1

15

21

19

30

30

33

79

137

84

50

65

76

211

176

167

110

3

1

Total 43 408 657 190 5 1303

-----------------------------------------------------------------------------------------------

Periods of Calm (hours):

Variable direction:

Hours of Missing Data:

2

0

13

Hours are not adjusted for Daylight Savings Time.

Page 28 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record: 10/1/13 - 12/31/13

Stability Class: E

Elevation: Speed: SP10M Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12 13-18 19-24 >24 Total

1

2

4

2

2

3

4

2

6

2

1

2

1

4

1

10

12

3

8

11

21

35

79

48

29

17

7

13

10

6

7

1

1

6

4

20

21

7

16

24

5

9

3

8

3

11

15

7

11

19

28

59

102

61

47

42

13

24

14

18

11

1

Total 37 316 128 1 482

Periods of Calm (hours): 1

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 29 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe'

10/1/13 - 12/31/13

F

ed: SP10M Direction: DIR10M Lapse: DT50M ------------------------------------------------------------------------------------------

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

1

2

1

3

2

2

1

4

1

3

3

18

20

15

3

2

2

3

10

13-18 19-24 >24 Total

3

1

4

1

3

7

22

33

17

3

2

0

0

0

0

2 2

Total 11 72 15 98

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 30 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record: U

Stability Class: G

Elevation: Speed: SP10M

)/11/13 - 12/31/13

Direction: DIR10M Lapse: DT50M

Wind Speed (MPH)

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

1-3 4-7 8-12

2

2

1

2

5

2

7

30

13

2

1

1

13-18 19-24 >24 Total

0

1

2

7

4

8

30

14

2

0

0

0

0

0

0

0

Total 4 62 2 68

Periods of Calm (hours): 0

Variable direction: 0

Hours of Missing Data: 0

Hours are not adjusted for Daylight Savings Time.

Page 31 of 32
SITE: Palisades

Hours at each Wind Speed and Direction

Period of Record:

Stability Class:

Elevation: Spe4

10/1/13 - 12/31/13

All

ed: SP10M Direction: DIR10M Lapse: DT50M

Wind

Direction

N

NNE

NE

ENE

E

ESE

SE

SSE

S

SSW

SW

WSW

W

WNW

NW

NNW

Wind Speed (MPH)

1-3 4-7 8-12 13-18 19-24 >24 Total

5

4

10

9

8

8

9

8

14

5

8

3

6

4

6

4

17

27

24

38

29

44

115

179

152

78

59

29

62

42

60

45

7

8

9

19

19

82

103

23

31

55

74

143

135

125

43

1

6

12

13

27

9

6

42

22

19

42

1

30

39

34

56

62

83

219

318

189

114

131

112

257

203

210

135

4

1 -----------------------------------------------------------------------------------------------

Total 111 1000 876 199 6 2192

Periods of Calm (hours):

Variable direction:

Hours of Missing Data:

3

0

13

Hours are not adjusted for Daylight Savings Time.

Page 32 of 32
ATTACHMENT 2

BIG ROCK POINT INDEPENDENT SPENT FUEL STORAGE INSTALLATION

2013 RADIOACTIVE EFFLUENT RELEASE REPORT

This report provides information relating to radioactive effluent releases and solid

radioactive waste disposal at Big Rock Point (BRP) for the year 2013. The report

format is detailed in the BRP Offsite Dose Calculation Manual (ODCM). Effluent

releases from BRP are controlled by the Defueled Technical Specifications and the

ODCM requirements. The ODCM was not revised in 2013.

2013 Operatingq History

On January 8, 2007, the Nuclear Regulatory Commission (NRC) approved release of

the former BRP nuclear plant property for unrestricted use in accordance with the BRP

License Termination Plan1 . On April 11,2007, the license for BRP, DPR-06, was

transferred to Entergy Nuclear Operations, Inc.

During 2013, normal independent spent fuel storage installation (ISFSI) operations

continued. There were no operational activities that generated any solid radioactive

waste.

Liquid and gaseous effluent monitoring is no longer conducted as the former BRP

nuclear plant property has been released from the license. Short-lived radionuclides,

including iodine and noble gas, are neither expected nor reported.

1. Supplemental Information

A. Batch Releases

There were no batch releases of gaseous or liquid effluents during

2013. All batch releases of radioactive liquids as described in the

ODCM ceased in 2004.

B. Abnormal Releases

There were no abnormal releases from BRP during 2013.

C. Radioactive Effluent Monitoring Instrumentation

BRP ODCM currently specifies required actions when less than the

minimum number of radioactive effluent monitoring instrument

channels are operable. The ODCM also specifies these actions be

taken when installed effluent monitoring systems are removed from

service for decommissioning.

All plant-installed liquid and gaseous radioactive effluent monitoring

instrument channels have been permanently removed and dismantled.

'Letter from the USNRC dated January 8, 2007, "Release of Land from Part 50 License for Unrestricted Use"

Page 1 of 8
2. Gaseous Effluents

Although there were no gaseous effluents released during 2013, Table 2

provides a summary of all gaseous radioactive effluent monitoring conducted

during the reporting period as required by the ODCM.

3. Liquid Effluents

There were no liquid effluent batch releases during 2013. Table 3 lists and

summarizes liquid effluent releases in accordance with the ODCM.

4. Solid Waste

There was no solid radioactive waste generated or shipped during 2013.

5. Summary of Radiological Impact on Man

The ODCM specifies that the annual effluent release report provide potential dose

calculations based on measured effluent to liquid and gaseous pathways, if

estimates of dose exceed one millirem to an organ or total body of any individual or

more than one person-rem to the population within 50 miles. During 2013, there

were no releases. Therefore, no calculations were required.

6. Offsite Dose Calculation Manual

The ODCM describes the radiological release requirements for the BRP site.

There were no revisions to the ODCM in 2013.

7. Process Control Program (PCP)

The Process Control Program (PCP) describes solid waste processing and

disposal methods utilized at the BRP site. The PCP was not revised during 2013.

Page 2 of 8
TABLE 1

Big Rock Point

Batch Releases

January 1, 2013 to December 31, 2013

A. GASEOUS

B. LIQUID Units 1ST QTR 2ND QTR 3RD QTR 4TH QTR

Number of Releases N/A N/A N/A N/A

Total Release Time Minutes N/A N/A N/A N/A

Maximum Release Time Minutes N/A N/A N/A N/A

Average Release Time Minutes N/A N/A N/A N/A

Minimum Release Time Minutes N/A N/A N/A N/A

Page 3 of 8
TABLE 2

Big Rock Point

Gaseous Effluent Releases

January 1, 2013 to December 31, 2013

1ST

QTR

2ND

QTR

3RD

QTR

4TH

QTR

Est Total

A. FISSION AND ACTIVATION GASES Units Error %

1. Total release Ci N/A N/A N/A N/A

2. Average release rate for period pCi/sec N/A N/A N/A N/A N/A

3. Percent of annual avg EC % N/A N/A N/A N/A

B. IODINES

1. Total iodine Ci N/A N/A N/A N/A

2. Average release rate for period JCi/sec N/A N/A N/A N/A N/A

3. Percent of annual avg EC % N/A N/A N/A N/A

C. PARTICULATES

1. Particulates with half-life >8 day Ci N/A N/A N/A N/A

2. Average release rate for period pICi/sec N/A N/A N/A N/A N/A

3. Percent of annual avg EC % N/A N/A N/A N/A

4. Gross alpha radioactivity Ci N/A N/A N/A N/A

D. TRITIUM

1. Total Release Ci N/A N/A N/A N/A

2. Average release rate for period pCi/sec N/A N/A N/A N/A

3. Percent of annual avg EC % N/A N/A N/A N/A

E. WHOLE BODY DOSE

1. Beta Air dose at Site Boundary due to Noble Gases

(ODCM Section 1, 1.3.2 a (1) (2)) mrads N/A N/A N/A N/A

2. Percent limit % N/A N/A N/A N/A

3. Gamma Air dose at Site Boundary due to Noble

Gas (ODCM Section 1, 1.3.2 a (1) (2)) mrads N/A N/A N/A N/A

4. Percent limit % N/A N/A N/A N/A

F. ORGAN DOSE (ODCM Section 1, 1.3.2b (1) (2))

1. Maximum organ dose to pubic based on Critical

Receptors (child bone) mrem N/A N/A N/A N/A

2. Percent of limit (7.5 mrem/quarter) % N/A N/A N/A N/A

Page 4 of 8
TABLE 2

Big Rock Point

Gaseous Effluent Releases

January 1, 2013 to December 31, 2013

1. FISSION GASES Units 1ST QTR 2ND QTR 3RD QTR 4TH QTR

Krypton-85m Ci N/A N/A N/A N/A

Krypton-87 Ci N/A N/A N/A N/A

Krypton-88 Ci N/A N/A N/A N/A

Xenon-133 Ci N/A N/A N/A N/A

Xenon-133m Ci N/A N/A N/A N/A

Xenon-135 Ci N/A N/A N/A N/A

Xenon-1 35m Ci N/A N/A N/A N/A

Xenon-138 Ci N/A N/A N/A N/A

Total for Period Ci N/A N/A N/A N/A

2. IODINES

Iodine-131 Ci N/A N/A N/A N/A

Iodine-132 Ci N/A N/A N/A N/A

Iodine-133 Ci N/A N/A N/A N/A

Iodine-134 Ci N/A N/A N/A N/A

Iodine-135 Ci N/A N/A N/A N/A

Total for Period Ci N/A N/A N/A N/A

Page 5 of 8
TABLE 2

Big Rock Point

Gaseous Effluent Releases

January 1, 2013 to December 31, 2013

3. PARTICULATES* Units 1ST QTR 2ND QTR 3RD QTR 4TH QTR

Chromium-51 Ci N/A N/A N/A N/A

Manganese-54 Ci N/A N/A N/A N/A

Cobalt-58 Ci N/A N/A N/A N/A

Iron-59 Ci N/A N/A N/A N/A

Cobalt-60 Ci N/A N/A N/A N/A

Zinc-65 Ci N/A N/A N/A N/A

Silver-11Om Ci N/A N/A N/A N/A

Cesium-134 Ci N/A N/A N/A N/A

Cesium--137 Ci N/A N/A N/A N/A

Barium-140 Ci N/A N/A N/A N/A

Europium-152 Ci N/A N/A N/A N/A

Strontium-89 Ci N/A N/A N/A N/A

Strontium-90 Ci N/A N/A N/A N/A

Net unidentified beta Ci N/A N/A N/A N/A

Total Ci N/A N/A N/A N/A

Particulates with half-life >8 days

Page 6 of 8
TABLE 3

Big Rock Point

Liquid Effluent Releases

January 1, 2013 to December 31, 2013

Est Total

A. FISSION AND ACTIVATION PRODUCTS Units 1ST QTR 2ND QTR 3RD QTR 4TH QTR Error %

1. Total release (not including tritium, gases, alpha) Ci N/A N/A N/A N/A

N/A

2. Average diluted concentration during period pCi/ml N/A N/A N/A N/A

3. Percent of EC % N/A N/A N/A N/A

B. TRITIUM

1. Total release Ci N/A N/A N/A N/A

N/A

2. Average diluted concentration during period pCi/ml N/A N/A N/A N/A

3. Percent of EC % N/A N/A N/A N/A

C. DISSOLVED AND ENTRAINED GASES

1. Total release Ci N/A N/A N/A N/A

N/A

2. Average diluted concentration during period pCi/ml N/A N/A N/A N/A

3. Percent of EC % N/A N/A N/A N/A

D. GROSS ALPHA RADIOACTIVITY Ci N/A N/A N/A N/A

E. VOLUME OF WASTE RELEASED 1

(Prior to dilution) Liters N/A N/A N/A N/A

F. VOLUME OF DILUTION WATER USED DURING L PERIOD Liters N/A I N/A N/A N/A

G. MAXIMUM DOSE COMMITMENT WHOLEBODY mrem N/A N/A N/A N/A

Percent of ODCM Section 1, 2.3.2 a (1.5 mrem) % N/A N/A N/A N/A

H. MAXIMUM DOSE COMMITMENT - ORGAN Mrem N/A N/A N/A N/A

Percent of ODCM Section 1, 2.3.2 b (3.0 mrem) % N/A N/A N/A N/A

Page 7 of 8
TABLE 3

Big Rock Point

Liquid Effluent Releases

January 1, 2013 to December 31, 2013

1. NUCLIDES

RELEASED Units 1ST QTR 2ND QTR 3RD QTR 4TH QTR

Chromium-51 Ci ........

Manganese 54 Ci

Cobalt-58 Ci

Iron-59 Ci

Cobalt-60 Ci --

Zinc-65 Ci --

Strontium-89 Ci

Strontium-90 Ci

Molybdenum-99 Ci

Silver-11Orn Ci

Iodine-131 Ci

Cesium-134 Ci

Cesium-137 Ci

Antimony-125 Ci

Tin-113 Ci

Net Unidentified Beta Ci

Fission & Activation

Product Total Ci ........

Xenon-133 Ci .......

Tritium Ci ......

Grand Total Ci ......

Page 8 of 8